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Summary 
Neurodegenerative diseases are associated with deposits of insoluble protein inclusions or 
aggregates. Evidence shows that different neurodegenerative diseases share some common 
underlying molecular and cellular mechanisms. However, the exact pathways by which 
disease-associated proteins form aggregates/inclusions and the steps in this cascade that are 
linked to pathogenesis, are not fully understood. In the present work, we investigated two 
known neurodegenerative disease-associated proteins, Synphilin-1 and huntingtin, in yeast 
models, to explore the aggregation management and translocation of these disease proteins. 
Synphilin-1 is a major component of the Lewy body, a hallmark of Parkinson’s disease (PD) 
(Wakabayashi et al., 2000), and a Synphilin-1 yeast model faithfully recapitulates this 
essential hallmark with Synphilin-1 inclusions formation. However, biological processes and 
pathways that involved in the inclusion formation are still not known in detail. Given the 
excellent tool that the yeast model can provide, in this thesis, we use a novel image-based 
genome-wide high-content microscopy (HCM) screening system, which enables us to validate 
inclusion body (IB) formation of Synphilin-1 in different genetic background systematically, 
and identify players controlling inclusion formation of Synphilin-1. In parallel, we study the 
Huntington's disease (HD) protein huntingtin. PolyQ-expansion of huntingtin exon-1 (Httex1) 
is responsible for the HD pathogenesis. Although the subcellular localization of 
polyQ-expanded Httex1 modulates polyQ toxicity in models of HD, the mechanisms involved 
in the nucleocytoplasmic translocation of polyQ-expanded Httex1 remain to be elucidated. To 
investigate components and pathways involved in altering the nucleocytoplasmic distribution 
of polyQ-expanded Httex1-103Q, we performed a dual channel image-based genome-wide 
HCM screen, which allows us to analyze the subcellular localization of Httex1-103Q. 
In the Synphilin-1 study we found that 133 genes are required for the IB formation of 
Synphilin-1. Functional enrichment and physical interaction network analysis revealed these 
genes to encode for functions involved in cytoskeleton organization, histone modification, 
sister chromatid segregation, glycolipid biosynthetic process, DNA repair and replication. We 
iv 
provide evidence that lower level of Synphilin-1 inclusion formation enhance cytotoxicity of 
Synphilin-1, supporting the hypothesis that matured inclusions represent an end stage of 
several events to protect cells from misfolded proteins. 
The results of our Huntingtin study show that the ribosome quality control machinery is a key 
determinant for the nucleocytoplasmic distribution of Httex1-103Q. Defect of the ribosome 
quality control components, Ltn1 or Rqc1, caused nuclear accumulation of Httex1-103Q 
through a process that requires the CAT-tail tagging activity of Rqc2 and transport via the 
nuclear pore complex. We provide evidence that nuclear accumulation of Httex1-103Q 
enhances its cytotoxicity, suggesting that the ribosome quality control machinery plays an 
important role in protecting cells against the adverse effects of polyQ expansion proteins. 
v 
Samenvatting 
Neurodegeneratieve ziekten zijn geassocieerd met afzettingen van onoplosbare proteïne 
aggregaten. Onderzoek heeft reeds aangetoond dat verschillende neurodegeneratieve ziekten 
een aantal algemene onderliggende moleculaire en cellulaire mechanismen 
gemeenschappelijk hebben. De exacte signaalwegen die verantwoordelijk zijn voor de 
aggregatie van de ziekte-gerelateerde proteïnen zijn echter nog niet volledig gekend. In deze 
studie maakten we gebruik van gehumaniseerde gistmodellen om het aggregatie-management 
en de translocatie van de neurodegeneratieve ziekte-gerelateerde proteïnen Synphiline-1 en 
Huntingtin te bestuderen. 
Synphiline-1 is een component van Lewy bodies, een belangrijk kenmerk van de ziekte van 
Parkinson (Wakabayashi et al., 2000). Een interessante eigenschap van het gehumaniseerde 
synphiline-1 gistmodel is dat Synphiline-1 in dit model aggregeert net zoals in patiënten met 
de ziekte van Parkinson. Daarom is dit gistmodel een zeer geschikte tool om het 
aggregatieproces van Synphiline-1 te bestuderen. De biologische processen en signaalwegen 
die betrokken zijn bij de aggregaatvorming van Synphiline-1 moeten echter nog verder 
worden opgehelderd. In deze thesis werd het Synphiline-1 gistmodel gebruikt in een 
genoom-wijd high-content microscopie (HCM) screeningssysteem . Dit systeem maakt het 
mogelijk om de Synphiline-1 aggregaatvorming in verschillende genetische achtergronden te 
valideren en op deze manier componenten te identificeren die verantwoordelijk zijn voor de 
Synphiline-1 aggregaatvorming. In parallel met deze studie bestudeerde we het proteïne 
Huntingtin dat gerelateerd is aan de ziekte van Huntington. Poly-Q expansie van Huntingtin 
exon-1 (Httex1) is verantwoordelijk voor de pathogenese van de ziekte van Huntington. 
Alhoewel in modellen voor de ziekte van Huntington reeds werd aangetoond dat de 
subcellulaire localizatie van verlengde poly-Q varianten van Httex1 verantwoordelijk zijn 
voor de poly-Q geïnduceerde toxiciteit, zijn de mechanismen die betrokken zijn bij hun 
nucleocytoplasmatische translocatie nog grotendeels ongekend. Om de componenten en 
signaalwegen te onderzoeken die deze nucleocytoplasmatische translocatie beïnvloeden, werd 
vi 
in deze studie een genoom-wijde HCM screening uitgevoerd, gebaseerd op beeldvorming in 
twee fluorescente kanalen. 
De Synphiline-1 studie identificeerde 133 genen die noodzakelijk zijn voor de 
aggregaatvorming van Synphiline-1. Een analyse van de netwerken voor functionele 
aanrijking en fysieke interactie toonde aan dat deze genen coderen voor proteïnen betrokken 
bij cytoskeletorganisatie, histonmodificatie, segregatie van zusterchromatiden, glycolipide 
biosynthese en DNA herstel en replicatie. Verder toonde we aan dat een verminderde 
Synphiline-1 aggregaatvorming leidt tot een verhoogde cytotoxiciteit van Synphiline-1, 
hetgeen de hypothese ondersteunt dat ‘volgroeide’ aggregaten een eindstadium 
vertegenwoordigen dat de cel beschermt tegen misvouwen proteïnen. 
In de Huntingtin studie konden we aantonen dat de machinerie voor ribosomale 
kwaliteitscontrole een belangrijke factor is voor de nucleocytoplasmatische distributie van 
Httex1-103Q. Een defect in Ltn1 of Rqc1, die betrokken zijn bij ribosomale kwaliteitscontrole, 
veroorzaakte een nucleaire accumulatie van Httex1-103Q. Dit proces vereist de zg. CAT-tail 
tagging van Rqc2 en transport via het nucleaire porie complex. Daarnaast toonden we aan dat 
de nucleaire accumulatie van Httex1-103Q zijn cytotoxiciteit verhoogt, wat aangeeft dat de 
machinerie voor ribosomale kwaliteitscontrole een belangrijke rol speelt bij het beschermen 
van cellen tegen de nadelige effecten van proteïnen met een poly-Q expansie. 
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1.1. Protein quality control 
To ensure cellular integrity, it is important to strictly control protein synthesis, (re-)folding 
and degradation. To do this, the cell is equipped with a sophisticated machinery, called the 
protein quality control (PQC) system. Malfunctioning of this system will lead to accumulation 
and eventually aggregation of misfolded proteins. Many neurodegenerative diseases, such as 
PD and HD, are related to the aggregation of amyloidogenic disease proteins such as 
α-synuclein for PD and Huntingtin (Htt) for HD. Hence, a well-balanced PQC network is 
essential for maintaining a healthy and functional proteome. 
1.1.1. Protein folding and chaperone systems 
1.1.1.1. Protein folding 
Protein folding is already initiated while the peptide is being translated at the ribosome, and 
further folding occurs in the ER or the cytosol. The process of protein folding is inherently 
error-prone, due to the countless possible conformations that a protein can adopt (Balchin et 
al., 2016). Protein folding is affected by many weak, non-covalent interactions of amino acids 
within a protein’s sequence (Brockwell and Radford, 2007). Furthermore, hydrophobic forces 
drive the formation of a polar environment by burying the non-polar amino acids within the 
core of a protein structure in order to form a thermodynamically stable conformation (Bartlett 
and Radford, 2009; Dinner et al., 2000). An in vitro study showed that small proteins refold 
spontaneously in appropriate folding conditions (Anfinsen, 1973), whereas the folding of 
larger proteins requires the assistance of chaperones (Fig. 1-1), whose major function is to 
prevent the aberrant interactions of proteins (Balchin et al., 2016). The major mechanistic 
paradigms of chaperone function in protein folding include Hsp70, chaperonin and Hsp90 
systems. 
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Figure 1-1. The chaperone-dependent network of protein quality control. 
Stalled translation or stress-induced unfolded proteins are subject to different pathways. Chaperones play a 
crucial role in maintaining the native state of the protein, as well as in refolding the unfolded protein to its 
native state. Chaperones are also required for targeting unfolded proteins for aggregation or degradation. 
NC, nascent chain; RQC, ribosome quality control; UPS, ubiquitin proteasome system. Figure adapted 
from (Doyle et al., 2013). 
1.1.1.2. Chaperone systems 
A molecular chaperone is defined as any protein that interacts with, stabilizes, or helps 
another protein to acquire its functionally active conformation, without being present in its 
final structure (Balchin et al., 2016; Hartl, 1996). A large group of chaperones are named heat 
shock proteins (HSPs) due to their up-regulated role in cellular responses to stress, such as 
high temperature. Chaperones are evolutionary conserved and typically classified by their 
molecular mass (i.e. Hsp40, Hsp60, Hsp70, Hsp90, Hsp100, Hsp110 and small Hsp).  
Proper protein folding and refolding largely depends on the functional activity of chaperones 
(Fig. 1-1). Chaperone-assisted protein folding occurs at the ribosome during de novo synthesis 
of proteins. Chaperones delay nascent chain compaction, thereby preventing misfolding and 
ensuring efficient folding of the protein (Balchin et al., 2016). In eukaryotes, the 
ribosome-binding chaperones include the ribosome-associated complex (RAC) and the 
nascent-chain-associated complex (NAC). The RAC, comprising chaperones of the Hsp70 
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and Hsp40 families, has been shown to play a role in coupling co-translational polypeptide 
folding during elongation (Chiabudini et al., 2012; Zhang et al., 2014), during which the RAC 
binds to the nascent polypeptide together with the NAC. When the NAC relocalizes from a 
ribosome-associated state to a protein aggregate-associated state as a chaperone, it diminishes 
translational capacity (Kirstein‐Miles et al., 2013). When translation is completed, both the 
newly synthesized protein and RAC/NAC are released from the ribosome. The folding 
process is further assisted by Hsp70 and Hsp40, which are required to reach the functional, 
native state of the protein (Hartl and Hayer-Hartl, 2002). In addition, Hsp70 provides a 
connection between the protein and the downstream chaperones such as the chaperonins and 
Hsp90 (Cuéllar et al., 2008; Kirschke et al., 2014). 
In eukaryotes, the group II chaperonin CCT (chaperonin containing TCP-1, also named TRiC) 
facilitates folding of about 10% of the proteome, including many essential proteins such as 
cytoskeletal components and cell cycle regulators (Lopez et al., 2015). After dissociation of 
the protein from the ribosome, CCT/TriC-mediated folding of the protein needs a direct 
interaction between Hsp70 and CCT/TriC (Cuéllar et al., 2008). The ring-shaped CCT/TriC 
assists in post-translational protein folding by driving the protein substrate through the central 
cavity of CCT/TriC. This changes the conformation of the protein in order to reach its native 
state (Spiess et al., 2004). 
Pathological conditions including environmental stress (e.g. high temperature), metabolic 
stress (e.g. oxidative stress), aging and cancer can disrupt the conformational structure of a 
protein, and enhance the production of misfolded proteins (Chen et al., 2011; Haigis and 
Yankner, 2010). The PQC system responds to this stress by recruiting the Hsp70 and small 
HSPs, to initiate protein refolding and to prevent irreversible aggregation (Haslbeck and 
Vierling, 2015). However, when the generation of misfolded proteins overwhelms the 
capacity of the PQC machinery, protein aggregates will accumulate. 
Under some circumstances, a specialized group of chaperones named disaggregases (such as 
Hsp104), extract the misfolded protein from the multiprotein aggregate, and make it 
accessible for refolding or degradation (Glover and Lindquist, 1998; Parsell et al., 1994; 
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Wendler et al., 2007) (Fig. 1-1). This re-activation of the aggregated protein requires the 
assistance of Hsp70 and Hsp40 (Glover and Lindquist, 1998).  
1.1.2. Protein degradation 
1.1.2.1. Ubiquitin proteasome system (UPS) 
In eukaryotes, the proteasome is a protein complex located in the nucleus, cytosol and ER 
(Baumeister et al., 1998; Peters et al., 1994) which functions as an intracellular degradation 
station for many proteins. Typically, the large 26S proteasome consists of a 20S core and one 
or two 19S regulatory subunits (Finley, 2009). The UPS plays a very important role in 
maintaining protein homeostasis as it targets proteins that have already fulfilled their cellular 
duties, such as proteins functioning during cell cycle, signal transduction, transcription, or 
decayed proteins from apoptosis or inflammation (Finley, 2009).  
Proteins can only be recognized for degradation by the UPS if they are tagged with multiple 
ubiquitin molecules and this process involves a cascade of enzymes including an E1, E2 and 
E3 enzyme (Finley, 2009) (Fig. 1-2). The ubiquitination process starts with the activation of a 
ubiquitin molecule, by the ubiquitin-activating enzyme (E1) (Haas et al., 1982) (Fig. 1-2). The 
activated ubiquitin is then transferred to a second enzyme, i.e. the ubiquitin-conjugating 
enzyme E2. Next, the E3 ligase selects the substrate and transfers the ubiquitin from E2 to the 
substrate (Fig. 1-2). Additional ubiquitin-tagging to the same protein substrate generates a 
polyubiquitin chain. A minimum of four ubiquitin monomers is required for efficient 
recognition by the proteasome (Thrower et al., 2000) (Fig. 1-2). In this final step, a variety of 
E3 ligases are required due to the diversity of proteins targeted by the 26S proteasome 
(Risseeuw et al., 2003), and due to the fact that different E2s conjugate with different E3 
ligases. In yeast, there is only one E1 enzyme, whereas there are 11 E2s, and a large family of 
E3s with an estimated number ranging from 60 to 100 (Finley et al., 2012). 
An ubiquitin-tagged protein is recognized by the 19S lid of the proteasome. Although several 
ubiquitin receptors (Rpn10, Rpn13, Rad23, Dsk2 and Ddi1) have been reported, it is still not 
-7- 
clear how the number and arrangement of ubiquitin groups on a substrate affect its 
recognition by the proteasome (Finley, 2009). To become actively degraded by the 
proteasome, the substrate protein needs to be translocated into the channel of the 20S core of 
the proteasome. Furthermore, de-ubiquitination of the substrate protein is mandatory before 
its degradation (Liu et al., 2006), thereby recycling the attached ubiquitin available for 
recycling. Finally, the disassembled substrate protein is then degraded in the center of the 
proteasome (Fig. 1-2). 
Studies have shown that UPS impairment is partly responsible for neuronal cell death. UPS 
impairment is induced by neurodegenerative disease-associated protein aggregation, possibly 
due to fact that aggregate formation inhibits the activity of UPS components, as well as by 
ageing, which reduces the cellular capacity to degrade misfolded protein degradation 
(Ciechanover and Kwon, 2015). 
 
 
Figure 1-2. Schematic representation of UPS. 
Activation of ubiquitin (Ub) by E1 is dependent on ATP hydrolysis. The activated Ub* is transferred to the 
ubiquitin-conjugating enzyme E2. Next, the E3 ligase recognizes both the E2-Ub* and the chaperone 
associated protein substrate and Ub* is transferredto the protein substrate. Finally, recognition of the 
poly-ubiquitinated protein substrate by the proteasome triggers removal of the ubiquitin molecules by 
deubiquitinating enzymes (DUbs), resulting in translocation of the protein substrate into the 20S core where 
the protein substrate is eventually degraded. 
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1.1.2.2. Autophagy and lysosomal degradation 
Autophagy is a process that degrades misfolded proteins and damaged organelles in the 
lysosome (vacuole in yeast) (Mizushima et al., 2008). In this way, cellular components 
including small peptides and free amino acids are recycled (Chen and Klionsky, 2011; 
Kobayashi, 2015; Mizushima and Komatsu, 2011). There are several different types of 
autophagy including macroautophagy, microautophagy and chaperone-mediated autophagy 
(CMA) (Mizushima et al., 2008). During macroautophagy, cytoplasmic constituents or even 
entire damaged organelles are engulfed by a double-membrane vesicle, which is known as an 
autophagosome. These autophagosomes are transported to and fused with the lysosome where 
the contents of the autophagosome are degraded and recycled (Mizushima et al., 2011; 
Nakatogawa et al., 2009; Xie and Klionsky, 2007). Microautophagy refers to the sequestration 
of cytosolic components by lysosomes, through invaginations of their limiting membrane. 
Both macro- and microautophagy have the capacity to engulf large structures. Conversely, 
CMA degrades only soluble proteins and involves direct translocation of unfolded substrate 
proteins across the lysosome membrane with the assistance of chaperones (Mizushima et al., 
2008). It has been reported that both macroautophagy and CMA are important for removing 
aggregated proteins (Cuervo and Wong, 2014; Iwata et al., 2005). Furthermore, it has been 
suggested that the autophagic system and the UPS system complement each other, thereby 
playing a crucial role in the cellular protein quality control. 
Several studies also show that autophagic degradation is linked to neurodegeneration. More 
specifically, the degradation of disease-related misfolded proteins such as mutant Htt and 
α-synuclein is dependent on autophagy (Iwata et al., 2005; Rubinsztein, 2006; Rubinsztein et 
al., 2005). These findings suggest that the autophagic machinery is important for the cell’s 
defense against neurodegeneration. 
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1.1.3. Spatial distribution/sequestration of proteins 
1.1.3.1. Protein aggregation 
Protein aggregation and accumulation in neurons is a common hallmark of many 
neurodegenerative disorders, including PD and HD. Neurodegenerative disease-associated 
protein aggregation represents an end-stage of molecular cascades, which might be linked to 
the pathogenesis of these diseases. Deciphering the machinery of protein aggregation will 
provide clues to minimize the toxicity of misfolded protein. 
Protein aggregation occurs when cells experience cellular stress which overwhelms the 
capacity of the PQC system (Wolfe and Cyr, 2011). Protein aggregation is dependent on 
hydrophobic forces, as well as on substrate concentration (Balchin et al., 2016; Chiti and 
Dobson, 2006). Most aggregates are amorphous/disordered, however, a subset of non-native 
protein aggregates seems to associate and fold into structural stable amyloid fibrils, which are 
forming cross-β structures (Balchin et al., 2016; Chiti and Dobson, 2006; Wolfe and Cyr, 
2011). Moreover, these fibril structures are often generated by the accumulation of oligomeric 
aggregates, which are thought to be toxic species (Arrasate et al., 2004; Balchin et al., 2016; 
Choe et al., 2016). 
Under certain circumstances, protein aggregates are also found in subcellular compartment, 
which are capable of sequestering, folding, refolding, and/or degrading aberrant proteins 
(Wolff et al., 2014). The first described subcellular compartment harboring protein aggregates 
was called aggresome (Kopito, 2000), which is a cytoplasmic microtubule-dependent 
inclusion. Protein aggregates are delivered to the aggresome via a microtubule-based transport 
(Johnston et al., 1998). More recently, also other subcellular compartments sequestering 
aggregates have been identified including IPOD, JUNQ/INQ, Q-bodies and it has been shown 
that the transport of protein aggregates to these compartments involves the actin cytoskeleton. 
(Liu et al., 2010; Ogrodnik et al., 2014; Song et al., 2014; Specht et al., 2011; Zhao et al., 
2016).  
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1.1.3.2. IPOD and JUNQ/INQ 
In 2008, Kaganovich and his colleagues reported the localization of protein aggregates in two 
spatial compartments i.e. the juxtanuclear quality control compartment (JUNQ) and the 
insoluble protein deposit (IPOD) (Kaganovich et al., 2008). JUNQ is positioned in close 
proximity of the nucleus and contains soluble ubiquitinated misfolded proteins. Moreover, 
components of the 26S proteasome and chaperones were also found in this compartment, 
which is thought to facilitate both degradation and refolding of misfolded proteins 
(Kaganovich et al., 2008). The other cytosolic compartment IPOD, is more stable, and 
preferentially harbors insoluble amyloidogenic misfolded proteins at the surface of the 
vacuolar membrane (Kaganovich et al., 2008; Spokoini et al., 2012). However, a recent study 
questioned the localization of the JUNQ compartment by showing that JUNQ resides inside 
the nucleus, and therefore re-defined this compartment as intranuclear quality control (INQ). 
Furthermore, they also demonstrated that ubiquitination of the substrate protein is not 
required for targeting both nuclear and cytosolic misfolded proteins to this compartment 
(Miller et al., 2015). This is also in contrast with the earlier findings of Kaganovich et al. 
(2008), showing that ubiquitin serves as an important signal to sort misfolded proteins to 
JUNQ (Kaganovich et al., 2008).  
1.1.3.3. Asymmetric inheritance of damaged proteins 
Spatial asymmetric distribution of proteins occurs between mother and daughter during cell 
division. Investigations in yeast have shown that damage proteins tend to accumulate in the 
mother cells, whereas daughter cells are free from damage proteins to this compartment 
(Aguilaniu et al., 2003; Erjavec et al., 2007; Liu et al., 2010). Similar asymmetric inheritance 
phenotype are observed in bacteria and mammalian cells as well (Lindner et al., 2008; Rujano 
et al., 2006). To ensure that daughter cells are born with a full replicative potential, cells have 
developed a conserved machinery for retrograde transport of heat-induced aggregates (Liu et 
al., 2010) and dysfunctional mitochondria (Higuchi et al., 2013). This retrograde transport of 
damaged cellular constituents depends on actin cables and Sir2. Asymmetric inheritance of 
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aggregated proteins is also regulated by vacuolar functions (Hill et al., 2016) and vacuolar 
acidity, in turn, impacts on cellular fitness and longevity (Hughes and Gottschling, 2012; 
Wilms et al., 2017). 
1.1.4. Protein quality control at the ribosome 
The normal translation of a protein is regulated by a variety of proteins. The messenger RNA 
(mRNA) template dependent translation guarantees that the accurate information is passed 
from the gene to its encoded protein. However, translational errors that occur at the ribosome 
can be the result of defective mRNAs, or mutation/insufficiency of tRNA that cause the 
ribosome to stall during translation and produce aberrant nascent chains (NCs). Cells have 
developed an evolutionary conserved quality control machinery to distinguish and clear the 
aberrant mRNA and NCs, hence preventing cells from consuming the limited available energy 
and substrates to synthesize defective products. 
In eukaryotes, three types of defective mRNAs have been described that trigger the mRNA 
surveillance system: (1) The absence of a stop codon causes rapid degradation of the mRNA 
through the non-stop decay (NSD) pathway (Frischmeyer et al., 2002; van Hoof et al., 2002); 
(2) mRNA bearing a nonsense mutation leads to the generation of premature termination 
codons, which subjects the mRNA to the nonsense mediated mRNA decay (NMD) pathway 
(Kervestin and Jacobson, 2012; Losson and Lacroute, 1979; Maquat et al., 1981); (3) Hairpin 
RNA structures, rare codons and polylysine-codons cause ribosomes to stall and activate the 
no-go decay (NGD) pathway to eliminate the damaged mRNAs (Chen et al., 2010; Doma and 
Parker, 2006b; Tsuboi et al., 2012; van den Elzen et al., 2010). 
The aberrant NCs from the ribosomal stall, however, will be recognized by the 
ribosome-associated quality control system and targeted for degradation (Bengtson and 
Joazeiro, 2010; Brandman et al., 2012; Choe et al., 2016). Recently, several breakthroughs 
have increased our understanding of this ribosome-associated quality control system. Here, 
we will highlight the discovery and the current insights of this quality control system. 
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1.1.4.1. The discovery of the RQC complex 
For a long time, the fate of a nascent polypeptide generated from abnormal translation was 
largely unknown. However, in 2010 Bengtson and Joazeiro reported that the 
ribosome-associated E3 ubiquitin ligase Ltn1 labels nascent non-stop (NS) proteins with 
ubiquitin to direct them to the proteasome for degradation (Bengtson and Joazeiro, 2010). 
Next, a study by Brandman et al., which aimed to identify factors that modulate the activity of 
the heat-shock response factor (Hsf1), reported that deficiency of a group of proteins in a 
conserved ribosome-bound complex induces Hsf1 activity. This complex was called the 
ribosome quality control (RQC) complex, and comprises Ltn1, Rqc1, Rqc2 (named Tae2 at 
the time), Cdc48 and its cofactors Ufd1 and Npl4 (Brandman et al., 2012). This RQC complex 
was later confirmed by Defenouillere and his colleagues using a different approach. They 
showed that Cdc48, together with Ltn1, Rqc1 and Rqc2, is required for efficient degradation 
of NS-proteins (Defenouillère et al., 2013). At the same time, an independent research group 
under the supervision of Deshaies et al. demonstrated that Cdc48, Ufd1-Npl4 and Ltn1 are 
involved in mediating the clearance of ubiquitinated, tRNA-linked nascent peptides (Verma et 
al., 2013). Overall, these studies show that the RQC complex plays an important role in the 
clearance of aberrant protein from ribosome-stall during translation. 
1.1.4.2. The RQC machinery 
The key event for triggering the RQC pathway is ribosome stalling and translation arrest. 
Ribosome stalling is induced by multiple errors, including defective mRNA and tRNA.  
Current insights in the RQC machinery are mainly obtained from studies using non-stop 
mRNAs (NS-mRNA) as substrate (Bengtson and Joazeiro, 2010; Choe et al., 2016; 
Defenouillère et al., 2013). In case the mRNA lacks a stop codon, the ribosome will read into 
the polyA tail of the mRNA during translation (Fig. 1-3) and consequently generates a 
poly-lysine (polyK) in the NCs. It has been shown that these polyKs are critical for ribosome 
stalling (Ito-Harashima et al., 2007). A similar stalling effect is observed when a polyK or 
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poly-arginine (polyR) tract was introduced into the amino acid sequence of a NC, and this 
may be identical to the effect of a NS mRNA (Dimitrova et al., 2009). Thus, the presence of a 
polybasic residue (polyK/R) in the NC seems to be sufficient to trigger ribosome stalling and 
translation arrest (Brandman et al., 2012; Choe et al., 2016; Dimitrova et al., 2009) (Fig. 1-3). 
Other situations such as truncated mRNA (Shao et al., 2013; Tsuboi et al., 2012) and 
stem-loop structure mRNA (Doma and Parker, 2006b), which are directed to the no-go 
degradation (Fig. 1-3), also trigger ribosome stalling during translation and the stalled NCs 
are subjected to the RQC pathway. Interestingly, the rare codon CGA repeat strongly affects 
the translation efficiency and results in ribosome stalling (Letzring et al., 2010; Letzring et al., 
2013) (Fig. 1-3). Moreover, mutation of a central-nervous-system-specific tRNA was found to 
cause ribosome stalling (Ishimura et al., 2014) (Fig. 1-3). Together, these findings suggest that 
the RQC mechanism is likely to be a vital part of the general machinery that recognizes 
aberrant NCs from the stalled ribosome during translation. 
 
 
Figure 1-3. Different causes of ribosome stalling during translation. 
(A) Normal mRNA template translation involves initiation (ribosome assembly), elongation, and 
termination (release of polypeptide and ribosome disassembly).  
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(B) Overview of aberrant translation in five different situations that cause ribosome stalling and translation 
arrest. The generated defective mRNAs and NCs are recognized and cleared by the mRNA decay pathway 
and the RQC pathway respectively. NC: nascent chain. Figure adapted from (Brandman and Hegde, 2016; 
Rodrigo-Brenni and Hegde, 2012). 
 
So far, little is known about ribosome stalling and how translation arrest occurs exactly. It has 
been reported that the receptor for the activated C kinase 1 (RACK1) (yeast homolog Asc1) 
participates in the translation arrest of polyR nascent peptides (Kuroha et al., 2010). In 
addition, it was found that the RING-domain-containing E3 ligase Hel2 is involved in 
mediating the stalling of translation, although by an unknown mechanism (Brandman et al., 
2012). However, it has been recently shown that Asc1, Hel2 and Slh1 are not required for the 
efficient translation arrest induced by a stalling reporter. Instead, these factors are essential for 
the RQC-mediated modification of NCs (Sitron et al., 2017). Thus, factors that are directly 
responsible for the ribosome stalling still remain to be elucidated. 
Furthermore, stalled translation is required for the recruitment of the RQC complex 
(Brandman et al., 2012). Here, we focus on the events downstream of ribosome stalling, 
including the 80S ribosome disassembly, the RQC complex recruitment and the NCs 
ubiquitination and extraction (Fig. 1-4). First of all, dissociation of the 80S ribosome requires 
the presence of Hbs1, Dom34 and Rli1 (Becker et al., 2012; Pisareva et al., 2011; Shoemaker 
and Green, 2011). An in vitro study that recapitulates the ubiquitination of stalled NCs reveals 
that the stalled 80S ribosome splits into the 60S and 40S subunit (Shao et al., 2013) (Fig. 1-4). 
Removal of the 40S subunit exposes the inter-subunit interface of the 60S subunit that 
contains the NCs (Brandman and Hegde, 2016). While the short NCs drop off the 60S-NCs 
complex (Pisareva et al., 2011; Shoemaker et al., 2010), the longer NCs together with 60S 
recruit Rqc2 and Ltn1 (Lyumkis et al., 2014; Shao et al., 2015) (Fig. 1-4). Structural analysis 
of the RQC complex provides evidence that the Rqc2/Tae2 (mammalian nuclear export 
mediator factor, NEMF) binds to the 60S-NCs prior to Ltn1, and this binding facilitates the 
recruitment of Ltn1’s N-terminal domain to the complex (Lyumkis et al., 2014; Shao et al., 
2015). By performing a cryo-electron microscopy structure study, Shen et al. were able to 
conclude that Rqc2 and Ltn1 bind to the exposed sites of the 60S subunit after 40S 
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dissociation (Shen et al., 2015). Furthermore, ribosome stalling induces NC ubiquitination 
which is highly dependent on Ltn1 (Bengtson and Joazeiro, 2010; Brandman et al., 2012), and 
results in the recruitment of Cdc48 in a Rqc2- and Rqc1-dependent manner (Brandman et al., 
2012; Defenouillère et al., 2013; Verma et al., 2013) (Fig. 1-4). In a next step, Cdc48 mediates 
extraction of NCs from the 60S-NCs complex in cooperation with its cofactors Ufd1 and Npl4. 
Finally, the ubiquitinated NCs are targeted to the proteasome for degradation (Bengtson and 
Joazeiro, 2010; Brandman et al., 2012; Verma et al., 2013) (Fig. 1-4).  
 
 
Figure 1-4. Primary steps and events of the RQC machinery. 
Ribosome stalling and translation arrest triggers the disassembly of 80S ribosome into the 60S and 40S 
subunit. Removal of the 40S subunit exposes the 60S-NCs, which recruits the Rqc2 and Ltn1. 
Ltn1-mediated ubiquitination of NCs subsequently results in the recruitment of Cdc48 and its cofactors 
Ufd1 and Npl4. Rqc1 also appears to be required for Cdc48 recruitment, but its role in the RQC pathway is 
poorly known. Next, the Cdc48-mediated extraction of NCs takes place. Finally, free ubiquitinated NCs are 
targeted to the proteasome for degradation, whereas the 60S subunit, Ltn1 and Rqc2 are thought to be 
recycled. The mechanistic details via which the 60S-NCs-RQC complex disassembles remain largely 
elusive. Figure adapted from (Brandman and Hegde, 2016). 
 
Both Ltn1 and Rqc2 are key players of the RQC machinery. While Ltn1 recognizes and 
ubiquitinates stalled NCs for degradation, Rqc2 fulfills a more diverse set of functions in the 
RQC machinery. First, Rqc2 monitors translation stress and signals to Hsf1 (Brandman et al., 
2012), or signals for misfolded protein aggregation (Yang et al., 2016). More recently, it was 
reported that stalled NCs at the 60S ribosome elongate in an mRNA-independent manner, in 
which Rqc2 recruits and attaches carboxy-terminal Ala and Thr extensions (CAT-tails) to the 
stalled NCs (Shen et al., 2015). These CAT-tails species range from 5 to 19 residues and it has 
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been hypothesized that the CAT-tails promote Hsf1 activation (Shen et al., 2015). Follow-up 
studies show that the CAT-tails mediate NCs aggregation (Choe et al., 2016; Yonashiro et al., 
2016), possibly as defense against aberrant translational stress at the ribosome. In addition, 
CAT-tails serve as a back-up mechanism that enables the degradation of RQC substrates that 
failed to be recognized by Ltn1 (Kostova et al., 2017). The exact role of these CAT-tails in 
NCs aggregation remains unclear, and other characteristics of the CAT-tails still need to be 
further explored. 
1.1.4.3. Defective RQC and neurodegenerative diseases 
It has been shown that the RQC machinery is highly conserved from yeast to mammals. As 
translation is under surveillance of the RQC system to guarantee the quality of the 
translational products, it is not surprising that malfunctioning of the RQC system has been 
implicated to play a crucial role in various protein misfolding diseases (Choe et al., 2016). 
Indeed, it was shown that mutation of Listerin (mammalian orthologue of LTN1) causes 
neurodegeneration in a mouse model by an unclear mechanism (Chu et al., 2009). Mutation of 
tRNA synthetase, which results in low levels of mischarged tRNA, very likely triggers 
aberrant translation and can lead to an intracellular accumulation of misfolded proteins in 
neurons (Lee et al., 2006). Interestingly, mutation of a tRNA gene that is specifically 
expressed in the central nervous system under the GTPBP2-deficient background, causes 
ribosome stalling and widespread neurodegeneration in mice (Ishimura et al., 2014). A study 
aimed to identify players involved in IB formation of mutant Htt (mHtt103QP) in a yeast 
model, revealed the involvement of the RQC-Hsf1 system to direct compartmentalization of 
mHtt103QP (Yang et al., 2016). Thus, these studies provide evidence that there exists a 
connection between the RQC surveillance system and neurodegeneration. However, 
mechanisms underlying the defective-RQC instigated neurodegeneration are still largely 
unknown. 
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1.2. PD and the humanized Synphilin-1 yeast model 
1.2.1. Introduction to PD 
PD is, after Alzheimer’s disease (AD), the second most common neurodegenerative disease. 
Moreover, it is the most prevalent movement disorder in elderly people. The disease is 
characterized by a decline in normal movement and daily functions. PD patients suffer from 
resting tremor, balance impairment, stiffness and bradykinesia. Furthermore, non-motor 
manifestations, including autonomic and cognitive dysfunction, have been associated with PD 
(Bostantjopoulou et al., 2013; Tolosa et al., 2006). In affected brains, there is a continuous and 
specific loss of dopaminergic neurons in the substantia nigra pars compacta, a brain section 
important in motor control. Another typical characteristic feature of PD is the presence of 
proteinaceous inclusion deposits, termed Lewy bodies, in the surviving neurons (Schneider 
and Obeso, 2014).  
Different factors have been identified to increase the risk for developing PD. First, the 
prospect of sporadic PD increases with age and above the age of 60, the risk can rise up to 4%. 
Furthermore, the risk for PD onset can increase by certain environmental factors (De Lau and 
Breteler, 2006) or it can have a genetic cause. In fact, there are 21 loci and genes that are 
associated with familial forms of PD (Kalinderi et al., 2016). 
The first gene discovered was the autosomal dominant gene, SCNA, which encodes 
α-synuclein, a 140 amino acid presynaptic protein (Polymeropoulos et al., 1997). Five 
missense mutations in α-synuclein (i.e. A30P (Krüger et al., 1998), E46K (Zarranz et al., 
2004), H50Q (Porcari et al., 2015), G51D (Lesage et al., 2013), A53E (Pasanen et al., 2014) 
and A53T (Puschmann et al., 2009)), a duplication and a triplication of the gene are found in 
certain familial forms of PD (Chartier-Harlin et al., 2011; Singleton et al., 2003). Furthermore, 
this protein is the major component of the PD-typical Lewy bodies (Spillantini et al., 1997). 
Although the exact cellular function of α-synuclein remains unclear, several roles have been 
suggested, such as regulation of dopamine neurotransmission, synaptic vesicular recycling 
(Tofaris and Spillantini, 2007) and a role in the lipid metabolism (Golovko et al., 2009).  
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Overall, the discovery of PD risk genes made it possible to use modified cellular and animal 
models, carrying the mutant gene, to explore its effect on PD pathogenesis. Here we will 
focus on the use of Saccharomyces cerevisiae as a tool to study the role of Synphilin-1, an 
interaction partner of α-synuclein in PD. 
1.2.2. Yeast model to study the role of Synphilin-1 in PD 
In 2010 Büttner et al. established a yeast model to investigate the role of Synphilin-1 in PD 
(Büttner et al., 2010; Swinnen et al., 2011). Synphilin-1 is a α-synuclein interaction partner, 
which is found in Lewy bodies, together with α-synuclein. So far, the exact function of 
Synphilin-1 remains unclear. However, since it binds to presynaptic vesicles in the 
presynaptic terminal, a role in dopamine release, similar to α-synuclein, has been suggested 
(Szargel et al., 2009), in addition to a role as adaptor protein (Engelender et al., 1999). Studies 
in yeast models revealed that overexpression of Synphilin-1 induced a moderate growth 
defect on the cells during the exponential phase. However, Synphilin-1 gained toxicity in aged 
yeast cells and this appeared to be dependent on the sirtuin Sir2. Localization studies showed 
that Synphilin-1 initially spreads throughout the cytoplasm and forms inclusions in about one 
third of the yeast cells. Upon entering the diauxic shift, these small inclusions merge into one 
or a few large inclusions, often located at the poles of the cell (Büttner et al., 2010). Further 
investigation of these large Synphilin-1 inclusions suggested that they have a cytoprotective 
character and that both microtubules and the actin cytoskeleton are involved in the transport 
of the small Synphilin-1 inclusions into large aggregates (Büttner et al., 2010; Zhao et al., 
2016). The fact that this model recapitulates an important hallmark of PD, i.e. the aggregation 
of disease proteins, makes it a useful tool to further investigate the mechanisms underlying 
aggregation management. 
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1.3. HD and the humanized Htt yeast model 
1.3.1. Characteristics of HD and toxicity mechanisms 
1.3.1.1. HD 
HD is a neurodegenerative disorder characterized by uncontrolled movements, loss of 
cognition and behavioural changes. First symptoms arise around an age of 40 years and 
progress to death within 10-20 years after the disease onset. HD has a prevalence of 5-10 
persons per 100,000 in the western world and many others carry a risk of developing the 
disease.  
 
 
Figure 1-5. Schematic representation of the sequence and interaction domains of the Htt protein. 
Studies highlight the protein domains within the Htt, HEAT repeats and a nuclear export sequence (NES). 
Exon1 includes the first 17 amino acids of Htt (N17), the polyQ repeat domain, and the proline-rich region 
(PRR) and has shown to be critical for determining the toxicity of Htt. In our research, we use a construct 
containing N17 and 103Q repeats, which are widely used to study the HD pathogenesis. Figure adapted 
from (Truant et al., 2007). 
 
A genetic defect in the gene named huntingtin (HTT) is directly responsible for HD. The HTT 
gene was first identified in 1993 and is located at chromosome 4p16.3 (MacDonald et al., 
1993). An expanded CAG trinucleotide repeat in this gene was found in disease families 
compared to unaffected individuals. The expansion of the CAG triplet repeat encodes a 
polyglutamine (polyQ) domain in the N-terminus of the Htt protein (Fig. 1-5). Researchers 
have confirmed that the CAG repeat is unstable, and that individuals with more than 35 CAG 
repeats in HTT are under high risk of developing HD (MacDonald et al., 1993). However, 
mechanisms underlying the polyQ-induced toxicity or neuronal selective death remain 
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elusive. 
1.3.1.2. Expanded polyQ in mutant Htt-induced cytotoxicity 
Extensive effort has been made to understand the role of polyQ in HD. Deletion of HTT in 
mice resulted in the decease of homozygotes during embryonic development, indicating that 
normal Htt protein plays an important role in maintaining a healthy individual (Cattaneo et al., 
2005; Duyao et al., 1995; Nasir et al., 1995; Walker, 2007). This suggest that mutant HTT is 
linked to a loss-of-function (Cattaneo et al., 2001). Nevertheless, increasing evidence supports 
the idea that the polyQ expansion results in a toxic gain-of-function. First, a single copy of the 
mutant HTT is sufficient to cause the neurological HD phenotype (Mangiarini et al., 1996), 
and the polyQ expansion does not block the expression of the HTT gene in mice (Schilling et 
al., 1995). Secondly, expression of mutant HTT in transgenic mice causes behavioral 
abnormalities, even in the presence of endogenous HTT with a normal expression level 
(Schilling et al., 1999). Finally, expression of the N-terminal part of mutant HTT exon 1 with 
103Q is toxic to yeast cell (Meriin et al., 2002). 
The accumulation of neuronal inclusions in neurons is a hallmark of HD pathology. However, 
whether the inclusion formation of mutant Htt is toxic or cytoprotective remains controversial. 
The observation of inclusions and the onset of neurological dysfunction of HD during the 
early phase of inclusion formation leads to the assumption that inclusions may be a causative 
species of HD (Morton et al., 2000). However, there is also evidence against a link between 
inclusions and HD pathology since behavioural changes, motor dysfunction and striatal 
neuronal loss can also be observed months before the detection of Htt inclusions (Slow et al., 
2003; Van Raamsdonk et al., 2005). Furthermore, many neurons die without forming IB s, and 
the amount of diffuse intracellular Htt predicts whether and when IB formation or death will 
occur, thereby leading to the conclusion that IB formation reduces the levels of mutant Htt 
and the risk of neuronal death (Arrasate et al., 2004). 
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1.3.1.3. Localization and toxicity of mutant Htt 
Studies investigating the Htt localization in neuronal cells, mammalian cell lines and 
transgenic mice reveal that both full-length and truncated N-terminal fragments of Htt are 
found in the nucleus and cytoplasm (Davies et al., 1997; De Rooij et al., 1996; DiFiglia et al., 
1997; Saudou et al., 1998). These observations point towards a possible role for the nuclear 
localization of polyQ in HD pathology. Introducing a polyQ expanded Htt with a nuclear 
localization signal sequence (NLS) into transgenic mice enabled the majority of the mutant 
Htt to localize to the nucleus. In addition, the accumulation of the mutant Htt in the nucleus 
caused sufficient toxicity to elicit behavioral abnormalities. The results suggests that 
disruption of the nuclear processes may be a dominant mechanism causing toxicity in mouse 
models of HD (Schilling et al., 2004). Later studies also found that transcription factors 
co-localize with mutant Htt in nuclear inclusions, which provides evidences that polyQ 
protein causes cellular toxicity by sequestering essential proteins in the nucleus (Choi et al., 
2012; Jiang et al., 2006; Schaffar et al., 2004). Moreover, a study in a striatal neurons cellular 
model reveals that nuclear localization of Htt induced neurodegeneration by an apoptotic 
mechanism (Saudou et al., 1998). Another study in a yeast model revealed that polyQ protein 
interferes with the degradation of other misfolded protein by sequestrating Sis1, an essential 
chaperone of Hsp40 family (Park et al., 2013). Nevertheless, it is still not clear how the 
mutant Htt is transported between the nucleus and the cytoplasm. 
1.3.2. Budding yeast models for the investigation of mutant Htt-induced 
toxicity 
By expressing different versions of human Htt protein, yeast models to investigate polyQ 
expanded Htt have been established successfully (Krobitsch and Lindquist, 2000; Meriin et al., 
2002; Willingham et al., 2003). In these models, mutant Htt-induced toxicity behaves in a 
polyQ length-dependent manner. Overexpression of mutant Htt with 72 or 103 glutamines 
suppressed the growth of the yeast cells and induced the formation of misfolded protein 
aggregates, similar to those formed in human neuron (Krobitsch and Lindquist, 2000; Meriin 
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et al., 2001). This suggests that yeast models can faithfully recapitulate HD pathologic 
phenotypes, and the key steps in pathologic pathways might be shared in both human neuron 
and yeast. Indeed, several important findings in yeast have been successfully validated in 
mammalian models, or even patients. For example, kynurenine 3-monooxygenase was 
identified as a target to inhibit mutant Htt toxicity, which was confirm later in mammalian 
models (Mason and Giorgini, 2011; Winderickx et al., 2008). 
Furthermore, insights in the mechanisms of mutant Htt-induced toxicity were obtained from 
yeast models. Many factors determining the mutant Htt-induced toxicity have been identified, 
including the sequence flanking the Htt polyQ domain, chaperone system, prion status, 
autophagy and cytoskeleton. 
1.3.2.1. The flanking sequence of polyQ region affects mutant Htt toxicity 
The proline-rich region (PRR) is a flanking sequence that belongs to the full length Htt, right 
behind the polyQ sequence in human cell. It has been shown that a toxic Htt polyQ construct 
without this PRR formed small, multiple and amorphous aggregates in yeast, which are 
considered to be the toxic species (Duennwald et al., 2006b; Meriin et al., 2002). In contrast, 
the Htt polyQ construct including the PRR formed big, tight inclusions, which were later 
described as “aggresome” (Wang et al., 2009), These “aggresomes” did not produce clear 
cytotoxicity effects in yeast (Dehay and Bertolotti, 2006; Duennwald et al., 2006b; Wang et 
al., 2009), supporting the notion that sequestration of misfolded protein into a tight, narrow 
compartment has a protective role in yeast. Interestingly, the cytotoxicity of 103Q was greatly 
reduced when co-expressed with a 25Q tract containing a PRR (25QP) (Duennwald et al., 
2006a), suggesting that the PRR plays a critical role in antagonize the polyQ toxicity in yeast. 
By comparing the structure of the polyQ region in the presence and in the absence of the PRR, 
Lakhani et al were able to show that the PRR forms polyproline type II helices and decreases 
the probability of the polyQ region to form a β-rich state. This β-rich state formation is 
positive correlated to polyQ expansion length (Lakhani et al., 2010), These findings indicate 
that the PRR antagonizes the polyQ toxicity by interfering with the Htt polyQ domain folding 
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state. 
1.3.2.2. Chaperones and prion status determine mutant Htt toxicity 
The importance of the chaperone system and prion status in mutant Htt-induced toxicity has 
been reported intensively in yeast model systems. Investigation of the polyQ expanded Htt 
shows that polyQ protein aggregation depends on Hsp104, Sis1, Ssa1/2 and Rnq1. Moreover, 
it has been shown that the aggregation of the polyQ expanded protein is directly correlated to 
its cytotoxicity (Krobitsch and Lindquist, 2000; Meriin et al., 2002).  Interestingly, 
overexpression of Hsp104, Sis1 or Ssa1 reduces the aggregation of mutant Htt in yeast 
(Krobitsch and Lindquist, 2000), and overexpression of Hsp104 in a mammalian cell model 
or mouse model reduced the aggregation and toxicity of the polyQ expanded protein (Bao et 
al., 2002; Carmichael et al., 2000; Vacher et al., 2005), even in the absence of a Hsp104 
ortholog in the animal genome. Taken together, these findings suggest that a proper dosage of 
chaperone Hsp104 is required to maintain aggregation and cytotoxicity of polyQ expanded 
Htt. This is probably due to the essential role of Hsp104 in propagation of endogenous yeast 
prions, including [PSI+] and [PIN+] (Chernoff et al., 1995; Derkatch et al., 1997), which are 
thought to promote polyQ expanded Htt aggregation and toxicity (Gokhale et al., 2005). Thus, 
deletion of HSP104 will decrease prion formation, which results in the absence of clear 
mutant Htt induced toxicity. On the other hand, overexpression of Hsp104 cures yeast [PSI+] 
by promoting dissolution of the prion seeds (Park et al., 2014), which also explains the 
detoxification effect of Hsp104 overexpression. 
1.3.3. Yeast genome-wide screens to understand mutant Htt toxicity 
mechanism and to identify toxicity modifiers 
The well-studied genomic sequence of Saccharomyces cerevisiae, easy DNA transformation 
and highly specific genetic modification through DNA recombination, make it possible to 
construct several yeast libraries such as the single deletion mutant collection (Tong et al., 
2001) and the yeast GFP clone collection (Huh et al., 2003), These collections allow 
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automated high-throughput genetic modification through synthetic genetic array (SGA) 
analysis (Tong et al., 2001). Taking advantage of these techniques, researchers have 
performed several genome-wide screens in yeast model, and illustrate numerous fundamental 
molecular and biological processes of the mutant Htt, many of which can be recapitulated in 
multicellular organisms. 
1.3.3.1. Genetic screens to identify toxicity modifiers of mutant Htt 
In 2003 Willingham et al pioneered on using the yeast single deletion library to identify genes 
that influence the mutant Htt toxicity (Willingham et al., 2003), In this screen they identified 
52 loss-of-function nonessential genes that enhance mutant Htt toxicity. These genes were 
clustered in proteins related to stress response, chaperones responsible for protein folding and 
UPS. A similar screen was performed for the PD associated protein α-synuclein. This screen 
identified different non-overlapping categories of loss-of-function genes that enhance 
α-synuclein toxicity, indicating that distinct pathogenic mechanisms underlie HD and PD. 
Following study, which performed the screen in a yeast deletion library, focused on 
loss-of-function genes that suppress mutant Htt toxicity (Fig. 1-6). Among the 28 genes that 
suppressed the toxicity of mutant Htt was Bna4 (kynurenine 3-monogenase), an enzyme in the 
kynurenine pathway of tryptophan degradation. These findings suggest a role for the 
kynurenine pathway in modulating mutant Htt toxicity (Giorgini et al., 2005), and thereby 
providing novel potential therapeutic targets for HD. 
Three screens, which were performed almost simultaneously, introduced mutant Htt into a 
genome-wide overexpression collection (Fig. 1-6), to examine proteins that suppress polyQ 
expanded Htt toxicity. The screen overexpressing Htt103Q and an ORF library using two 
high-copy plasmids that both carried a galactose-inducible promoter, and identified two main 
suppressors of mutant Htt toxicity i.e.GPX1 and HYR1. In addition, overexpression of GPX1 
in mammalian cells and Drosophila, also reported to ameliorate HD-relevant metrics (Mason 
et al., 2013). However, two other conceptually similar screens show no overlap with the 
identified mutant Htt toxicity modifiers of this screen, and provide evidence that the role of 
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GPX1 in suppressing Htt103Q toxicity is controversial. On the other hand, the two other 
screens identified proteins with prion-like domains to be key suppressors of mutant Htt 
toxicity (Kayatekin et al., 2014; Wolfe et al., 2014). Replacing asparagines with glutamines 
potently suppressed Htt103Q toxicity, while replacing glutamines with asparagines failed to 
suppress Htt103Q toxicity, suggests that the prion-like sequences of these proteins were 
themselves potent suppressors of polyQ expanded Htt toxicity (Kayatekin et al., 2014). A 
screen to identify modifiers of mutant Htt toxicity with a distinct strategy, in which yeast 
genomic DNA library (with endogenous promoter of each gene) was transformed into cells 
containing 103Q-GFP construct with galactose-inducible promoter. By validating 
transformants which were able to grow on induction of 103Q-GFP, Ripaud et al identified six 
suppressors of Htt103Q, three of which are glutamine-rich prion-like proteins (Ripaud et al., 
2014). These findings suggest a critical role for glutamine-rich prion-like proteins in 
suppressing mutant Htt toxicity. 
1.3.3.2. Chemical compound based screens 
Apart from yeast genetic screens, libraries of chemical components and natural product 
extracts have been used to identify compounds that eliminate polyQ protein aggregation and 
toxicity. By expressing Htt103Q in a library of 16,000 small chemical compounds, Zhang et al. 
identified nine compounds that increased the growth of the yeast cells in the presence of 
Htt103Q (Zhang et al., 2005). Overexpression of Htt103Q in cell cultures with natural product 
extracts, led to the discovery of actinomycin D as a strong inhibitor of mutant Htt aggregation 
and toxicity (Walter et al., 2014). 
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Figure 1-6. Key strategies of yeast based genome-wide screens. 
Disease proteins (XX) with a specific selection marker can be introduced into the query strain, by 
integration in yeast genomic DNA or by expression from a plasmid. Examples of disease proteins for which 
such screens have been established are mutant Huntingtin (mHtt), α-synuclein (α-syn), Synphilin-1 (Sy1) 
and Amyloid beta (Aβ). A yeast collection (YY) with a different selection marker than the XX disease 
protein can be used as a starting collection. This YY collection can be a Yeast Knock-Out (YKO) collection, 
a yeast essential gene temperature sensitive (TS) alleles collection or a yeast overexpression collection, or a 
yeast GFP collection. Taking advantage of the SGA methodology, a new YY collection containing the XX 
disease protein (YY-XX) can be generated, by crossing the query strain (containing XX) with the YY 
collection. Further analysis of the YY-XX collection, such as growth analysis, can be used to identify 
enhancers or suppressors of XX disease protein. By combining the YY-XX collection with a recently 
developed HCM system, systematically analysis of factors affecting XX disease protein aggregation, 
localization can be identified, or by analyzing proteins co-localize with XX disease protein, proteins 
interact with XX disease protein can also be identified. Figure adapted from (Fruhmann et al., 2016). 
 
1.3.3.3. Image-based HCM screen 
Recently, a technique combining automated yeast genetics, SGA and HCM has been applied 
to study protein localization, protein-protein interaction and aggregate morphology in yeast 
(Chong et al., 2015; Vizeacoumar et al., 2010; Yang et al., 2016). This image-based screening 
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system, greatly relies on the SGA technique, either plasmid-borne fluorescence protein, or 
endogenous fluorescence proteins are tagged. This can be achieved by an elaborated design of 
the strain construction using the SGA technique (Fig. 1-6). Compared to the traditional SGA 
analysis which usually monitors growth, the HCM screening system allows more detailed 
analysis, including protein aggregation, protein localization, or protein interaction (Fig. 1-6). 
Based on this unique high-throughput approach, a screen that focuses on stress granule (SG) 
formation has been performed. In this study, Yang et al. introduced a RFP-labeled Pab1 (a 
marker of SGs, which enables the visualization of SG in vivo) to a yeast single deletion 
collection, induced of SG formation and obtained images by the HCM system. This approach 
identified numerous genes involve in SG formation, providing valuable insights for 
understanding the mechanism involved in SG formation (Yang et al., 2014). A similar strategy 
was used in a later screen, in which an IB marker was introduced into the yeast GFP clone 
collection. By analyzing proteins that co-localize with IBs, the researchers found two proteins 
that exhibited strong interactions with lipid droplets, revealing an essential role for lipid 
droplets in cytosolic IBs clearance (Moldavski et al., 2015). More recently, Yang et al 
introduced the inclusion-forming mutant Htt (mHtt103QP) into the yeast collection, and 
induced the expression of mHtt103QP. The samples were applied to the HCM system, which 
allows automated image acquisition and analysis. They focused on the IB formation under 
different genetic backgrounds and were able to demonstrate the involvement of the RQC-Hsf1 
system in directing compartmentalization of mHtt103QP (Yang et al., 2016). 
Thus, we can expect more breakthroughs by using this versatile HCM system in investigating 
HD and other neurodegenerative diseases in yeast. 
 
  
-28- 
Aim of this thesis  
Lewy body formation is a hallmark of PD, and Synphilin-1 was found as one of the major 
components of the Lewy body (Wakabayashi et al., 2000). However, the mechanisms 
involved in aggregation of these proteins are poorly understood. 
The polyQ expansion of Htt is responsible for polyQ aggregation, and this is intimately linked 
with the polyQ-induced cytotoxicity that is typically associated with HD (Mangiarini et al., 
1996). Fragments of polyQ-expanded Htt have been reported to localize both in the cytoplasm 
and nucleus (Davies et al., 1997; DiFiglia et al., 1997; Saudou et al., 1998), and alter the 
Htt-mediated cytotoxicity, suggests a potential role for the nuclear localization of polyQ 
proteins in HD pathology. However, the mechanisms involved in the translocation of 
polyQ-expanded Htt between the cytoplasm and the nucleus remain to be elucidated. 
The main objectives of this thesis were: 
1. To identify genes required for the inclusion formation of Synphilin-1 systematically. To this 
end, we performed an image-based genome-wide HCM screen, crossing the 
dsRed-Synphilin-1 to the yeast single knockout collection and the essential temperature 
sensitive allele collection. And to elucidate links and differences among hits involved in 
Synphilin-1 inclusion management, by analyzing enrichment of Gene Ontology (GO) 
categories, and classified them into several functional groups. 
2. To identify players that alters the nucleocytoplasmic distribution of polyQ-expanded Httex1. 
Towards this aim, we performed a dual channel image-based genome-wide HCM screen, 
which allowed us to inspect the Httex1-103Q and nucleus simultaneously in different genetic 
background. And to decipher the roles of the components identified from HCM genome-wide 
screen in regulating the nucleocytoplasmic transport of Httex1-103Q. 
 
 
 
-29- 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Establishment of genome-wide screening systems in yeast 
model 
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2.1. Introduction 
A SGA analysis is a technique that makes the systematic construction of double mutants 
possible. In a typical SGA analysis a yeast query strain is crossed to an ordered array of 
~5000 viable deletion mutants. The versatile SGA analysis allows genetic elements, which are 
marked by selectable markers, to cross to the ordered array of strains (Yan Tong and Boone, 
2006). These genetic elements include specific alleles of genes, point mutants and 
temperature-sensitive alleles, or plasmids. This makes it possible to construct yeast strains 
systematically and investigate synthetic genetic interactions in a large scale (Tong et al., 2001; 
Tong et al., 2004). These advantages allowed researchers to perform genome-wide screens in 
yeast (Liu et al., 2010; Tong et al., 2001). 
In this thesis we took advantage of the SGA methodology to address two important questions. 
The first question concerns the formation of Synphilin-1 inclusions. In 2010, Büttner et al. 
developed a yeast model to study the PD associated protein Synphilin-1. They were able to 
show that Synphilin-1 forms inclusions in yeast, which are often located at the poles of the 
cell (Büttner et al., 2010). However, the players involved in the inclusion formation of 
Synphilin-1 remain largely unknown. The second question involves another disease related 
protein Huntingtin. Similar as for Synphilin-1, a yeast model to study polyQ length-dependent 
toxicity of mutant Htt was established. The subcellular distribution of mutant Htt was shown 
to be important for determining its cytotoxicity, however, the exact mechanisms by which 
mutant polyQ-expanded Htt causes cytotoxicity and neuropathology remain unclear, and 
nuclear translocation of mutant Htt is poorly understood. To study both research questions in 
detail we designed several SGA screens. In this chapter, we give a detailed description of the 
strategies used for the different screens, the different steps of the SGA analysis and the 
SGA-based HCM screening systems. The results of these screens will be discussed in the 
following chapters. 
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2.2. Materials and methods 
2.2.1. Construction of the Synphilin-1 SGA collection  
Since the Synphilin-1 yeast model faithfully recapitulates one of the essential hallmarks of PD 
development i.e. the aggregation of Synphilin-1 in inclusions, this model is an excellent tool 
to search for players involved in the formation of Synphilin-1 inclusions (Büttner et al., 2010; 
Engelender et al., 1999). In this study, we used the same Synphilin-1 construct as described 
previously (Büttner et al., 2010). The construct has a pYX212 backbone and carries the 
dsRed-Sy1 under the control of the constitutive TPI1 promoter (pYX212-dsRed Sy1) (Fig. 
2-1). The pYX212-dsRed construct served as a control. The Synphilin-1 SGA collection is 
used in the study described in chapter 3. 
 
 
 
Figure 2-1. Schematic representation of the Synphilin-1 construct used in this study. 
dsRed and Synphilin-1 were cloned and inserted into the pYX212 backbone plasmid, which carries an 
URA3 selective marker (Büttner et al., 2010). Sy1 represents Synphilin-1. 
 
To start the screen, we introduced the pYX212-dsRed Sy1 plasmid into a yeast genome-wide 
single deletion array (SGA-V2) (Tong et al., 2001) and a yeast temperature-sensitive 
conditional mutant array (ts-V5) (Li et al., 2011), all mutants are derived from BY4741.  
2.2.1.1. Query strain 
To cross the pYX212-dsRed Sy1 plasmid with the (SGA-V2) and (ts-V5) collection, we first 
introduced the pYX212-dsRed Sy1 plasmid into the starting query strain Y7092 (Tong and 
Boone, 2007). This Y7092 strain harbors reporters and markers necessary for SGA haploid 
-33- 
strain selection following meiotic recombination. In the MATα Y7092 strain, the CAN1 is 
replaced by the SGA reporter STE2pr-Sp_his5, and the STE2pr represents the MATa-specific 
STE2 promoter, driving the Schizosaccharomyces pombe his5 (Sp_his5) gene, which 
complements S. cerevisiae HIS3 (Baryshnikova et al., 2010). In addition, the pYX212-dsRed 
Sy1 carries a selective marker URA3 (Fig. 2-1). The obtained query strain Y7092 
pYX212-dsRed Sy1 was used for the Synphilin-1 SGA strain construction. 
2.2.1.2. Mating, sporulation and selections 
Haploid yeast cells have mating type a (MATa) or α (MATα). The query strain Y7092 
pYX212-dsRed Sy1 is a MATα strain and carries selective markers including URA3, 
can1Δ::STE2pr-Sp_his5 and lyp1Δ. This query strain is crossed to the (SGA-V2) and (ts-V5) 
array, which are MATa strains carrying a gene deletion mutation or temperature sensitive 
allele linked to a kanMX marker that confers resistance to the antibiotic geneticin (G418). The 
contact of MATa and MATα cells makes it possible to generate the zygotes (diploid cells) (Fig. 
2-2). The zygotes are then transferred to the minimal medium with limited carbon and 
nitrogen to induce the sporulation. The spores together with the zygotes are transferred to the 
medium lacking histidine, thereby allowing the selection of cells carrying the STE2pr-Sp_his5 
reporter (Fig. 2-2). Since the STE2 promoter is MATa-specific, only MATa meiotic progeny 
are able to proliferate. Furthermore, the administration of canavanine and thialysine (S-AEC, 
(S-(2-Aminoethyl)-L-cysteine hydrochloride)), kill the unwanted diploid cells and spores with 
the CAN1 and LYP1 gene (Grenson et al., 1966; ZWOLSHEN and Bhattacharjee, 1981). 
Therefore, the haploid selection medium (SD-His/Arg/Lys/Ura + canavanine & S-AEC) 
selects the haploid MATa cells with the marker can1Δ::STE2pr-Sp_his5 and lyp1Δ (Fig. 2-2). 
Cells are then transferred to the KanR selection medium with G418, which selects the cells 
with a KanR marker (Fig. 2-2). All mediums are lacking uracil to maintain the 
pYX212-dsRed Sy1 plasmid in the cells throughout the construction. The medium protocol 
for the construction of the Synphilin-1 SGA collection is described in Appendix. 
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Figure 2-2. SGA methodology to cross the pYX212-dsRed Sy1 plasmid into the SGA-V2 or (ts-V5) 
collection (Figure adapted from (Baryshnikova et al., 2010; Tong and Boone, 2007)). The MATα strain, 
carries the selective markers can1Δ::STE2pr-Sp_his5, lyp1Δ and pYX212-dsRed Sy1 URA3 and is crossed 
into the (SGA-V2) and (ts-V5) array. These arrays are ordered with MATa strains each carrying a gene 
deletion mutation or temperature sensitive allele linked to a kanMX marker that confers resistance to the 
antibiotic geneticin (G418). Contact of MATa and MATα cells generates the diploid cells. Following, the 
diploid cells are incubated in minimal medium with limited carbon and nitrogen to induce the sporulation. 
Next, the spores and the remaining diploid cells are transferred to medium lacking histidine, which allows 
the selection of MATa cells carrying the STE2pr-Sp_his5 reporter. The can1Δ and lyp1Δ strains confered 
resistance to canavanine and S-AEC respectively. While addition of canavanine and S-AEC to the selection 
medium kills CAN1 and LYP1 cells. Finally, the cells are transferred to the KanR selection medium with 
G418, which selects the cells with the KanR marker.  
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2.2.2. Construction of the Httex1-103Q SGA collection  
The Exon-1 of HTT contains a polyQ tract and it has been demonstrated that expansion of this 
polyQ tract is responsible for the development of HD (MacDonald et al., 1993). In this study, 
we used a construct that contains the N17 sequence of the HTT gene, as well as an expansion 
region with 103 glutamines (103Q) under the control of the GAL1 galactose-inducible 
promoter and a FLAG tag at the N-terminus of the construct (Fig. 2-3). In addition the pYES2 
backbone contains the selective marker URA3 and a C-terminal GFP tag enabling in vivo 
visualization of the 103Q protein (Meriin et al., 2002) (Fig. 2-3). Expression of this construct 
has shown to induce toxicity in yeast cells (Meriin et al., 2002). 
To construct the Httex1-103Q SGA collection we used the same strategy as described for the 
construction of the Synphilin-1 SGA collection in 2.2.1, i.e. we crossed the 
pYES2-Httex1-103Q-GFP plasmid to the (SGA-V2) and (ts-V5) collection. The Httex1-103Q 
SGA collection is used in the study described in chapter 4. 
 
 
Figure 2-3. Schematic representation of the mutant Htt construct used in this study. 
The sequence and domains of the Htt protein are described in Figure 1-5. The construct used in this study is 
a gift from Dr. Sherman (Meriin et al., 2002). The N17 and polyQ repeat region of Htt were replicated, 
together with a N-terminal tagged FLAG, and a C-terminal tagged GFP. These segments were inserted in 
the high copy pYES2 plasmid with the galactose-inducible GAL1 promoter and a selective URA3 marker in 
the backbone.  
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2.2.2.1. Query strain 
The query strain used is the Y7092 strain containing the pYES2-Httex1-103Q-GFP plasmid. 
The genetic background of the Y7092 strain is described in 2.2.1.1. 
2.2.2.2. Mating, sporulation and selections 
The different steps to construct the Httex1-103Q SGA collection including mating, 
sporulation and selections are identical to the steps that are described in 2.2.1.2 for the 
construction of the Synphilin-1 SGA collection. Details of the genetic modification processes 
are described in Fig. 2-4, and the medium protocol for the construction of the Httex1-103Q 
SGA collection is described in Appendix. 
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Figure 2-4. SGA methodology to cross the pYES2-Httex1-103Q-GFP plasmid into the SGA-V2 or 
(ts-V5) collection (Figure adapted from (Baryshnikova et al., 2010; Tong and Boone, 2007)). The MATα 
strain, carries the selective markers can1Δ::STE2pr-Sp_his5, lyp1Δ and pYES2-Httex1-103Q-GFP URA3 
and is crossed into the (SGA-V2) and (ts-V5) array. These arrays are ordered with MATa strains each 
carrying a gene deletion mutation or temperature sensitive allele linked to a kanMX marker that confers 
resistance to the antibiotic geneticin (G418). Contact of MATa and MATα cells generates the diploid cells. 
Following, the diploid cells are incubated in minimal medium with limited carbon and nitrogen to induce 
the sporulation. Next, the spores and the remaining diploid cells are transferred to medium lacking histidine, 
which allows the selection of MATa cells carrying the STE2pr-Sp_his5 reporter. The can1Δ and lyp1Δ 
strains confered resistance to canavanine and S-AEC respectively. While addition of canavanine and 
S-AEC in the selection medium kills CAN1 and LYP1 cells. Finally, the cells are transferred to the KanR 
selection medium with G418, which selects the cells with the KanR marker.  
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2.2.3. Construction of the ltn1Δ Httex1-103Q SGA collection 
The construction of the ltn1Δ Httex1-103Q SGA collection is similar to the construction of 
the Httex1-103Q SGA collection described in section 2.2.2.  
2.2.3.1. Query strain 
The query strain Y7092 ltn1Δ pYES2-Httex1-103Q-GFP was used for the construction of the 
ltn1Δ Httex1-103Q SGA collection. To obtain this query strain, an insertion of the 
nourseothricin-resistance natR cassette into the LTN1 loci (ltn1Δ::natR) was made in the 
query strain Y7092 pYES2-Httex1-103Q-GFP (2.2.2.1) . 
2.2.3.2. Mating, sporulation and selections 
The different steps to construct the Httex1-103Q SGA collection including mating, 
sporulation and selections are similar to the steps described in 2.2.1.2 for the construction of 
the Synphilin-1 SGA collection. Additional clonNAT is added to select cells carrying the natR 
cassette. Details of the genetic modification processes are described in Fig. 2-5. The medium 
protocol for the construction of the ltn1Δ Httex1-103Q SGA collection is described in 
Appendix. 
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Figure 2-5. SGA methodology to cross the LTN1 deletion and pYES2-Httex1-103Q-GFP plasmid into 
the SGA-V2 or (ts-V5) collection (Figure adapted from (Baryshnikova et al., 2010; Tong and Boone, 
2007)). The query strain, which is MATα, carries the selective markers can1Δ::STE2pr-Sp_his5, lyp1Δ and 
pYES2-Httex1-103Q-GFP URA3 in the ltn1Δ background and is crossed into the (SGA-V2) and (ts-V5) 
array. These arrays are ordered with MATa strains each carrying a gene deletion mutation or temperature 
sensitive allele linked to a kanMX marker that confers resistance to the antibiotic geneticin (G418). Contact 
of MATa and MATα cells generates the diploid cells. Following, the diploid cells are incubated in minimal 
medium with limited carbon and nitrogen to induce the sporulation. Next, the spores and the remaining 
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diploid cells are transferred to medium lacking histidine, which allows the selection of MATa cells carrying 
the STE2pr-Sp_his5 reporter. The can1Δ and lyp1Δ strains confered resistance to canavanine and S-AEC 
respectively. While addition of canavanine and S-AEC in the selection medium kills CAN1 and LYP1 cells. 
The cells are then transferred to the KanR selection medium with G418, which selects the cells with a 
KanR marker. This is followed by natR selection by adding additional clonNAT to the selective medium.  
2.2.3.3. Validation of Httex1-103Q toxicity suppressors in ltn1Δ background 
We replicated the ltn1Δ Httex1-103Q SGA collection to an agar plate with medium containing 
SD-His/Arg/Lys/Ura + canavanine, S-AEC, G418 & clonNAT and galactose as the sole 
carbon source of the medium. The cells were kept at 30 oC for 3 days, and the growth was 
recorded by imaging the colonies on the plates. We assessed the Httex1-103Q cytotoxicity of 
the different double mutants by scoring the size of the colonies (Wagih and Parts, 2014). 
2.2.4. Construction of the Httex1-103Q-mRFP Yeast GFP Clone Collection  
To investigate proteins that interact with Httex1-103Q in vivo, we performed an image-based 
screen to visualize both endogenous GFP-tagged proteins and Httex1-103Q. To achieve this 
goal, we first constructed a Yeast GFP Clone Collection (Huh et al., 2003) containing the 
Httex1-103Q-mRFP reporter (Wang et al., 2007). 
2.2.4.1. Query strain 
To cross the pYES2-Httex1-103Q-mRFP plasmid (Wang et al., 2007) to the Yeast GFP Clone 
Collection, we first introduced the pYES2-Httex1-103Q-mRFP plasmid into the starting strain 
Y7039 (Tong and Boone, 2007). The Y7039 strain harbors the reporters and markers 
necessary for the SGA haploid strain selection following meiotic recombination. In the MATα 
Y7039 strain, the CAN1 is replaced by the SGA reporter STE2pr-Sp_LEU2. The query strain 
Y7039 pYES2-Httex1-103Q-mRFP is used for the construction of the Httex1-103Q-mRFP 
Yeast GFP Clone Collection. 
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Figure 2-6. SGA methodology to cross the pYES2-Httex1-103Q-mRFP plasmid into the Yeast GFP 
Clone Collection (Figure adapted from (Baryshnikova et al., 2010; Tong and Boone, 2007)). The query 
strain, which is MATα, carries the selective markers can1Δ::STE2pr-Sp_LEU2, lyp1Δ and 
pYES2-Httex1-103Q-mRFP URA3 and is crossed to the Yeast GFP Clone Collection. This collection is 
ordered with MATa strains each carrying a gene that is follow by a GFP cassette and HIS3 cassette. Contact 
of MATa and MATα cells generates the diploid cells. Following, the diploid cells are incubated in minimal 
medium with limited carbon and nitrogen to induce the sporulation. Next, the spores and the remaining 
diploid cells are transferred to medium lacking leucine, which allows the selection of MATa cells carrying 
the STE2pr-Sp_LEU2 reporter. The can1Δ and lyp1Δ strains confered resistance to canavanine and S-AEC 
respectively. While addition of canavanine and S-AEC in the selection medium kills CAN1 and LYP1 cells. 
Finally, the cells are transferred to the SD-His medium that lacks histidine, which selects the cells with the 
HIS3 cassette. 
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2.2.4.2. Mating, sporulation and selections 
The query strain Y7039 pYES2-Httex1-103Q-mRFP is a MATα strain and carries selective 
markers including URA3, can1Δ::STE2pr-Sp_LEU2 and lyp1Δ. This strain is crossed to the 
Yeast GFP Clone Collection, which is ordered with MATa strains each carrying a gene that is 
followed by a GFP cassette and HIS3 marker. Details of the genetic modification processes 
are described in Fig. 2-6. The medium protocol for the construction of the 
Httex1-103Q-mRFP Yeast GFP Clone Collection is described in Appendix. 
2.2.5. Image-based HCM screening systems 
2.2.5.1. HCM to investigate Synphilin-1 inclusion formation 
The collection obtained from section 2.2.1 was applied to the HCM system. We used the 
Singer ROTOR HDA robot (SINGER INSTRUMENTS, Somerset) to pin cells to 96-well 
plate with 200μl minimal selective SC-Ura liquid medium with antibiotics at 30°C（22°C for 
ts mutants）for 3 days without shaking. Subsequently, each pre-culture was diluted to a 
starting OD600nm around 0.1 in a 200μl culture in SC-Ura medium, by using the Automated 
Liquid Handling robot (HAMILTON, Reno NV). After 12h (16h for ts mutants) growing with 
shaking at 30°C (for both single and ts mutants), cells were fixed by adding 20 μl 37% 
formaldehyde to a final concentration of 3.7% for 30min at room temperature. Then cells 
were washed twice with 1xPBS (4,000 rpm for 3min). Finally, the cells were re-suspended in 
200μl 1xPBS and stored at 4°C overnight. For imaging, 9μl re-suspended cells were 
transferred to new 96-well glass bottom plates (Matri-plate) with 200μl 1×PBS in each well. 
The OD600nm values were adjusted to 0.06-0.08, which corresponds to about 6-8×104 cells. 
The cells in the 96-well plate were spun down at 400rpm for 45s, and kept in dark for 30 min 
before imaging (Texas Red channel, Exposure time: 400ms) with the automated cellular 
imaging system ImageXpress MICRO, Molecular Devices Corporation (MDC). 
The key procedures of this screen are described in Fig. 2-7. 
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Figure 2-7. Schematic representation of the HCM screening system to investigate Synphilin-1 
inclusion formation. Cells generated as described in the section 2.2.1 were pre-cultured in selective 
medium, until cells reached saturation. The cells were diluted to OD600nm ~0.1 in selective medium for 12h 
or 16h (ts). Next, the cells were collected and fixed with 3.7% formaldehyde. Finally, the cells were applied 
to the HCM imaging microscope. Images were obtained in Texas Red channel. 
 
2.2.5.2. HCM to investigate the subcellular localization of Httex1-103Q 
We used the Singer ROTOR HDA robot (SINGER INSTRUMENTS, Somerset) to pin cells 
from the Httex1-103Q SGA (section 2.2.2) collection to the agar plate (SD-His/Arg/Lys/Ura + 
canavanine, S-AEC & G418). The strains were laid out in 12-by-8 arrays, and incubated at 
30oC for 2 days. Subsequently, cells were inoculated in the 96-well plates with liquid medium 
(SD-His/Arg/Lys/Ura + canavanine, S-AEC & G418) and incubated at 30oC for 2 days. We 
used the Automated Liquid Handling robot (HAMILTON, Reno NV) to transfer 10µl cells 
from the SGA 96-well liquid plate to the pre-culture plate, containing 190µl liquid medium 
(SD-His/Arg/Lys/Ura + canavanine, S-AEC & G418) with 2% raffinose and incubated the 
cells at 30oC without shaking for 2 days.  
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The OD600nm for each sample was measured by using the Plate Reader (POLARstar Omega, 
BMG LABTECH). The pre-cultured cells were diluted in fresh liquid medium with 2% 
raffinose (SD-His/Arg/Lys/Ura + canavanine, S-AEC & G418) to an OD600nm of 0.1 in a final 
volume of 180µl. Then the cells were incubated overnight at 30oC while shaking, until most 
of the cells reached OD600nm ~0.5. Next, 20µl 20% galactose was added to each well and 
incubated again at 30oC for 3 hours while shaking. After this 22µl 37% formaldehyde was 
added to each well and mixed thoroughly by pipetting. The samples were kept at room 
temperature for 30 minutes, and centrifuged at 4000 rpm for 3 min. The supernatant was 
removed and washed with 1xPBS twice. 
Subsequently, a proper volume of the cells was transferred to 96-well clean bottom optical 
imaging microplates (Brooks, MGB096-1-2-LG-L) and the OD600nm of the samples was 
adjusted to ~0.15 with 1xPBS. Then 20µl 1µg/ml 4',6-diamidino-2-phenylindole (DAPI) was 
added to each well to obtain a total volume 200µl. The samples were kept in the dark at room 
temperature for 30min and spun down to the bottom of the imaging microplates at 400rpm for 
30s. 
Finally, the cells were imaged by using the high-content imaging microscope (ImageXpress 
MICRO) in both GFP and DAPI channels with an exposure time of 400 ms for GFP and 100 
ms for DAPI. 
The key procedures of this screen are described in Fig. 2-8. 
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Figure 2-8. Schematic representation of the HCM screening system to investigate subcellular 
localization of Httex1-103Q. Cells generated as described in section 2.2.2 were incubated in selective 
medium (containing 2% glucose), until the cells reached saturation and subsequently diluted cells to 
OD600nm ~0.1 in selective medium with 2% raffinose. When the OD600nm reached ~0.5, galactose (final 
concentration 2%) was added directly to the medium to start the induction of Httex1-103Q-GFP expression. 
The cells were stained with DAPI to visualize the nucleus. Images were obtained under GFP and DAPI 
channels. 
2.2.5.3. HCM to identify proteins that co-localized with Httex1-103Q 
Induction of Httex1-103Q-mRFP for this HCM screen was similarly as described in 2.2.5.2, 
and the SD-Leu/Arg/Lys/Ura/His medium with canavanine and S-AEC was used. Samples 
were prepared without the DAPI staining procedure (Fig. 2-9). 
The cells were imaged by using the high-content imaging microscope (ImageXpress MICRO) 
in both GFP and Texas Red channels, with an exposure time of 3000 ms for GFP and 400 ms 
Texas Red. 
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Figure 2-9. Schematic representation of the HCM screening system to identify proteins that 
interacted with Httex1-103Q. Cells generated as described in the section 2.2.4 were incubated in selective 
medium (containing 2% glucose), until the cells reached saturation. Then the cells were diluted to an 
OD600nm ~0.1 in selective medium with 2% raffinose. When the OD600nm reached ~0.5 galactose (final 
concentration 2%) was added directly to the medium to start the induction of Httex1-103Q-mRFP 
expression. Images were obtained under GFP and Texas Red channels. Red circle represent the 
pYES2-Httex1-103Q-mRFP plasmid and green dots represent endogenous GFP-tagged protein. 
 
2.2.5.3. Super-resolution three-dimensional structured illumination microscopy 
(3D-SIM) 
For super-resolution 3D-SIM, we used the same setting as previously described (Song et al., 
2014). Excitation light wavelengths of 561nm (mRFP), and 488nm (GFP) were used 
respectively. Image acquisition, super-resolution processing and calculation were performed 
by ZEN black 2-1SP1 (Carl Zeiss, Jena, Germany).  
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2.3. Results 
2.3.1. Yeast strains obtained in this study 
In this study, by using the SGA methodology, we systematically generated four yeast 
genome-wide collections: (1) the Synphilin-1 SGA collection, which contains the 
pYX212-dsRed Sy1 plasmid; (2) the Httex1-103Q SGA collection, which contains the 
pYES2-Httex1-103Q-GFP plasmid; (3) the ltn1Δ Httex1-103Q SGA collection, in which all 
cells have a LTN1 deletion background and contain the pYES2-Httex1-103Q-GFP plasmid; (4) 
the Httex1-103Q-mRFP Yeast GFP Clone Collection, in which the 
pYES2-Httex1-103Q-mRFP plasmid is crossed into the Yeast GFP Clone Collection. 
2.3.2. Genes involved in Synphilin-1 inclusion formation 
The Synphilin-1 SGA collection (section 2.2.1) was used in the HCM screen to identify genes 
required for the Synphilin-1 inclusion formation in yeast (section 2.2.5.1). The results are 
presented and discussed in Chapter 3. 
2.3.3. Genes affect subcellular distribution of Httex1-103Q 
The Httex1-103Q SGA collection (section 2.2.1) was used in the HCM screen to identify 
genes that alter the subcellular distribution of the polyQ protein Httex1-103Q in yeast (section 
2.2.5.2). The results are presented and discussed in Chapter 4. 
2.3.4. Loss-of-function genes suppress toxicity of Httex1-103Q in ltn1Δ 
background 
To identify the factors that contribute to the Httex1-103Q-induced cytotoxicity in the ltn1Δ 
cells, we assessed the suppressors of Httex1-103Q in the ltn1Δ background (section 2.2.3). 
The results are presented and discussed in Chapter 4. 
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2.3.5. Proteins that co-localized with Httex1-103Q 
Expression of Httex1-103Q in yeast perturbs the fitness of the cells and the cytotoxicity of 
Httex1-103Q is at least in part regulated by Q-rich and prion-like proteins (Duennwald et al., 
2006a; Kayatekin et al., 2014). Proteins that physically interact with Httex1-103Q will 
provide valuable insights in elucidating aggregation formation of Httex1-103Q and 
Httex1-103Q-induced cytotoxicity. To achieve this goal, we designed a novel approach for 
studying protein-protein interactions, by identifying GFP-tagged proteins that co-aggregate 
with the Httex1-103Q-mRFP aggregates. We performed a HCM screen using the Yeast GFP 
Clone Collection in which we introduced the pYES2-Htt103Q-mRFP plasmid by means of the 
SGA methodology (section 2.2.4 and 2.2.5.3).  
Using this approach, we were able to simultaneously visualize both the mRFP-tagged 
Httex1-103Q protein and the endogenous GFP-tagged proteins. We manually inspected the 
images obtained from the HCM system and obtained confirmation by conventional 
fluorescence microscopy. This revealed that several proteins co-localized with Httex1-103Q. 
Consistent with earlier studies showing that Q-rich and prion-like proteins sequester polyQ 
proteins (Duennwald et al., 2006a; Kayatekin et al., 2014), the obtained hits included Sup35, 
Pan1 and Rnq1 (Fig. 2-10A) (Kayatekin et al., 2014). We further analyzed the spatial 
distribution of Sup35 and Httex1-103Q by 3D-SIM analysis and this confirmed that the 
majority of the Sup35 was tightly sequestered by Httex1-103Q (Fig. 2-10B). Sup35 is a 
translation termination factor that contains N-terminal QN-rich prion domains. These QN-rich 
domains of Sup35 interact with polyQ protein (Gong et al., 2012) (Fig. 2-10B) and therefore 
might play a role in polyQ protein aggregation. The translation termination role of Sup35 
might be interrupted by protein aggregation of polyQ protein and Sup35. 
Previously it was reported that Ltn1-EGFP co-localized with the proline-rich containing 
reporter Httex1-103QP-mRFP (Yang et al., 2016). As Ltn1-EGFP is not included in the Yeast 
GFP Clone Collection, we manually introduced the pYES2-Htt103Q-mRFP plasmid into the 
Ltn1-EGFP strain, and validated the localization of Ltn1-EGFP and Httex1-103Q-mRFP by 
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3D-SIM analysis. This clearly shows that Ltn1 was recruited to the Httex1-103Q aggregates 
(Fig. 2-10B), which indicates that the RQC machinery may be involved in detoxification and 
translocation of Httex1-103Q. 
 
 
Figure 2-10. Genome-wide screen to identify proteins that co-localize with Httex1-103Q aggregates.  
(A) Fluorescence microscopy images that shows proteins which co-localize with Httex1-103Q aggregates. 
These proteins include the Q-rich proteins Pan1, Sup35 and Rnq1 and the RQC component Ltn1. Yellow 
spots in the merge channel indicate the overlap of Httex1-103Q and the proteins. Scale represents 2 μm. 
(B) Super-resolution fluorescence microscopy images of Httex1-103Q and Sup35/Ltn1 in WT cells. Yellow 
spots in the merge channel indicate the overlap of Httex1-103Q and Sup35/Ltn1. Scale represents 1 μm. 
 
2.4. Summary 
In this chapter, we described the establishment of different screening systems in a yeast model, 
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including the purposes, strategies, systematic genetic modification of yeast strains and HCM 
screening systems. We generated four yeast collections, and performed unbiased screens by 
combining the collection with the HCM screening system. The results from the screens have 
contributed to the identification of genes that are involved in the Synphilin-1 inclusion 
formation (Chapter 3) and the discovery of the ribosome quality control machinery in 
regulating the subcellular distribution of polyQ proteins (Chapter 4) and will be further 
discussed in the following chapters. 
Furthermore, we found that Q-rich and prion-like proteins interact with the polyQ protein, 
which is in line with earlier studies (Duennwald et al., 2006a; Kayatekin et al., 2014), 
Moreover, we demonstrated that a key component of the RQC complex, Ltn1, as well as the 
translational termination factor Sup35 interact with the polyQ protein. These results indicate 
that the RQC pathway is somehow connected with the polyQ protein, consistent with later 
studies in Chapter 4. The role of RQC in detoxification and translocation of polyQ protein is 
further discussed in Chapter 4. 
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Chapter 3 
A genome-wide imaging-based screening to identify genes 
involved in Synphilin-1 inclusion formation in 
Saccharomyces cerevisiae 
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Abstract 
Synphilin-1 is a major component of PD IB implicated in PD pathogenesis. However, the 
machinery controlling Synphilin-1 inclusion formation remains unclear. Here, we investigated 
Synphilin-1 inclusion formation using a systematic genome-wide HCM in the yeast 
Saccharomyces cerevisiae. By combining this with a secondary screening for mutants 
showing significant changes in fluorescence signal intensity, we filtered out hits that 
significantly decreased the expression level of Synphilin-1. We found 133 yeast genes that 
didn’t affect Synphilin-1 expression but that were required for the formation of Synphilin-1 
inclusions. Functional enrichment and physical interaction network analysis revealed these 
genes to encode for functions involved in cytoskeleton organization, histone modification, 
sister chromatid segregation, glycolipid biosynthetic process, DNA repair and replication. In 
addition, all hits were confirmed by conventional microscopy. Complementation assays were 
performed with a selected group of mutants. The results indicated that the observed 
phenotypic changes in Synphilin-1 inclusion formation were directly caused by the loss of 
corresponding genes of the deletion mutants. Further growth assays of these mutants showed 
a significant synthetic sick effect upon Synphilin-1 expression, which supports the hypothesis 
that matured inclusions represent an end stage of several events meant to protect cells against 
the Synphilin-1 cytotoxicity. 
3.1. Introduction 
Increasing evidence shows that neurodegenerative diseases such as PD, AD, and HD share 
common underlying molecular and cellular mechanisms and that protein IB formation is a 
typical hallmark for these diseases. PD affects about 2% of the population over 65 years old, 
is an age-associated neurodegenerative disease that is characterized by degeneration of 
dopaminergic neurons and the formation of intracellular protein inclusions called Lewy 
bodies. It has been shown that the protein alpha-synuclein is the major component in these 
Lewy bodies (Baba et al., 1998). In addition to alpha-synuclein, the presynaptic protein 
Synphilin-1 was also found as one of the constituents of Lewy bodies (Wakabayashi et al., 
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2000). Synphilin-1 not only interacts with alpha-synuclein (Engelender et al., 1999) but also 
with other proteins involved in the pathogenesis of PD, such as parkin and LRRK2 (Chung et 
al., 2001; Ito et al., 2003). This suggests that it may link several PD related gene products to a 
common pathogenic mechanism based on protein aggregation. Hence, a systematic analysis 
of mechanisms governing Synphilin-1 inclusion formation will increase our understanding of 
the pathogenesis of PD.  
Synphilin-1, encoded by the gene SNCAIP, contains 919 amino acids and 3 characterized 
domains: two protein-protein interaction domains (ankyrin-like repeats and coiled coil domain) 
and a predicted ATP/GTP-binding motif (Ribeiro et al., 2002). However, the physiological 
functions of Synphilin-1 are still not fully understood. When expressed in yeast Synphilin-1 
forms aggregates, similar as in mammalian systems (Büttner et al., 2010). To further 
investigate the mechanisms involved in Synphilin-1 IB formation, we performed a 
genome-wide imaging-based screening to isolate yeast deletion mutants that altered the 
formation of Synphilin-1 inclusions. To this end, we applied the yeast SGA methodology 
(Costanzo et al., 2010; Tong et al., 2001; Tong et al., 2004) and further developed a yeast 
HCM approach to monitor the Synphilin-1 inclusion phenotype. Several groups are currently 
applying yeast HCM screening approaches to investigate a wide range of biological questions. 
The pioneer proof-of-principle studies from Vizeacoumar and colleagues (Vizeacoumar et al., 
2010) applied their high-content screening system to examine mitotic spindle morphogenesis. 
Recent results from the same group provided a proteome scale evaluation of protein 
abundance and localization in the cell (Chong et al., 2015). Studies using the HCM approach 
have been performed in other research groups as well. Yang and colleagues investigated the 
machinery for the formation of SGs as well as IB by the misfolded Von Hippel–Lindau tumor 
suppressor protein (Moldavski et al., 2015; Yang et al., 2014). Combined, these results 
demonstrate that the yeast HCM approach is a powerful tool for investigating mechanisms 
underlying different cellular processes. 
The results of our current study led us to identify the interaction networks and components 
involved in the formation of Synphilin-1 inclusions. The synthetic sick effect, observed from 
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the identified mutants by expressing Synphilin-1, supports the hypothesis that Synphilin-1 
inclusion formation has a cytoprotective effect to the cell. These results provide a molecular 
basis for understanding potential roles of Synphilin-1 in the pathogenesis of PD. 
3.2. Materials and methods 
3.2.1. Screening design 
3.2.1.1. Yeast strains 
The strain Y7092 was used as the SGA starting strain for query strain constructions. The 
plasmid pYX212-dsRed-Sy1 was described previously (Büttner et al., 2010) and used for 
expressing N-terminally tagged dsRed-Sy1 in the query strain. The yeast single gene 
knock-out collection (SGA-V2) and the essential gene temperature sensitive allele collection 
(ts-V5) (Li et al., 2011) are kind gifts from Prof. Charlie Boone. Detailed information 
regarding the strains used in this study is listed in the Supplementary Table 3-1. Plasmids 
p4339, pSG32, pYM28 were used to amplify the natMX4, hphMX4 and EGFP cassettes, 
respectively. A full list of plasmids used in this study is shown in the Supplementary Table 
3-2. 
3.2.1.2. Construction of a genome-wide collection of S. cerevisiae single 
deletion mutants expressing Synphilin-1-dsRed 
Query strains were constructed by transferring the pYX212-dsRed-Sy1 (sample) into the 
yeast Y7092 query background. Further, the query strain with Synphilin-1-dsRed marker was 
combined with the SGA-V2 single gene knock-out collection and the ts-V5 array by an 
automatic SGA method (Costanzo et al., 2010; Tong et al., 2001; Tong et al., 2004). A control 
set of the same collection was constructed by introducing the plasmid pYX212-dsRed (control) 
into both collections. A Singer RoToR HDA robot (Singer Instrument) was used for all the 
pinning steps for collection handling. 
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3.2.1.3. Genome-wide high content screening with Synphilin-1 inclusions 
The collections obtained from the previous steps were stored at -80°C in 96-well plates. Cells 
(both single and the ts mutants) were pre-cultured in 200 μl minimal selective SC-Ura liquid 
medium with antibiotics at 30°C（22°C for ts mutants）for 3 days without shaking. 
Subsequently, each pre-culture was diluted to a starting OD600nm around 0.1 in 200 μl liquid 
SC-Ura medium. After 12h (16h for ts mutants) growing with shaking at 30°C (for both single 
and ts mutants), cells were fixed by adding 20 μl 37% formaldehyde to a final concentration 
of 3.7% for 30 min at room temperature. Then cells were washed twice with 1xPBS (4,000 
rpm for 3 min). Finally, the cells were re-suspended in 200 μl 1xPBS and stored at 4°C 
overnight. For imaging, 9μl re-suspended cells were transferred to new 96-well glass bottom 
plates (Matri-plate) with 200μl 1×PBS in each well. The OD600nm values were adjusted to 
0.06-0.08, which corresponds to about 4-8×104 cells. The cells in the 96-well plate were 
spun down at 400 rpm for 45 s, and kept in dark for 30 min before imaging (Texas Red 
channel, Exposure time: 400 ms) with the automated cellular imaging system ImageXpress 
MICRO, Molecular Devices Corporation (MDC). 
3.2.1.4. Phenotypes 
Based on the dsRed-labelled Synphilin-1 fluorescence signal, cells expressing Synphilin-1 
have two distinct phenotypes i.e. a diffused or an aggregated phenotype. The percentage of 
cells with Synphilin-1 inclusion was defined as the amount of cells with Synphilin-1 
inclusions among all cells showing Synphilin-1-dsRed fluorescent signal. The percentage of 
cells with Synphilin-1 inclusions was recorded as the phenotypic readout from the screening. 
To automatically quantify the Synphilin-1 aggregation phenotype, a customized sub-program 
of the software MetaXpress (MDC) was applied on the obtained images for quantification of 
percentage of cells carrying Synphilin-1 inclusions and to measure the average fluorescence 
intensity within the cells. Parameters used for the software quantification are set as follows: 
the signal intensity threshold for cell isolation: ≥300 grayscale units difference between 
cellular regions and the background of the image, which allow the MDC software recognize 
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specific area as a “cell”; the threshold for Synphilin-1 inclusion isolation: ≥400 grayscale 
units difference between inclusion regions and cellular regions, which allow the MDC 
software recognize specific area within a cell as a “inclusion”. 
3.2.1.5. Verification of mutants and complementation assay 
All mutants that showed statistically significant differences from the wild type were 
re-streaked and tested manually in triplicates to confirm the phenotypic differences observed 
in the screening. Statistical analysis was conducted using the Student’s t- test, and p<0.05 was 
used as the cutoff for selecting significant hits. At least 300 cells were counted in the manual 
confirmation for each mutant. For manual confirmation, cells were grown from starting 
OD600nm of 0.1 in in a 3 ml liquid SC-Ura medium for 20 h (22 h for TS mutants), 
subsequently fixed and washed in 1xPBS as described above. All potential hits generated 
from our high content screening were manually verified by using conventional microscopy. 
The aggregation phenotype of any high content screening hit, which cannot be repeated in our 
manual conformation, will be excluded from the final confirmed hits list. To handle the 
difference between our high content screening and the manual confirmation results, we used 
the actual values from the manual confirmation as the final results showed in supplementary 
tables. Complementation assays were performed with a selected group of mutants using the 
corresponding MoBY plasmids and the empty vector control (Ho et al., 2009).  
3.2.1.6. Functional enrichment and interaction network analysis 
The functional enrichment analysis was based on the results from Gene Ontology Term Finder. 
P-values were calculated using a hypergeometric distribution with multiple hypothesis 
correction as described in Boyle et al (Boyle et al., 2004). Manually confirmed hits 
(Supplementary Table 3-3) were analyzed for enrichment of GO biological processes, cellular 
components and molecular functions by comparison to a background set list of SGA-V2 
(4368 genes) plus ts-V5 array (787 ts alleles, covering 497 essential genes) with a P-value 
cut-off p<0.05. 
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The Synphilin-1 interaction network diagrams were extracted from the interaction analysis by 
using Osprey 1.2.0(Breitkreutz et al., 2003) and the physical interactions between confirmed 
hits were added according to the BioGRID interaction database (Breitkreutz et al., 2008). 
Osprey extracts all experimental interaction data (including large-scale survey and classical 
genetics) from the BioGRID interaction database, and represents genes as nodes and 
interactions as edges between nodes. A filter was set for excluding any genetic interactions 
between the hits, and only presented physical interactions in the diagrams.  
3.2.2. Fluorescence microscopy 
Cell images were obtained by using a Zeiss Axio Observer.Z1 inverted microscope with 100x 
oil objectives (NA1.4). Filter sets used were GFP, dsRed, Texas Red and DAPI. 
3.2.3. Western blot analysis 
Protein extractions and Western blot analysis were performed as previously described(Büttner 
et al., 2010). The primary antibodies used were specific for Synphilin-1 (Sigma Aldrich, St. 
Louis, MO, USA) and Adh2 (Merck-Millipore, Overijse, Belgium) 
3.2.4. Synphilin-1 cytotoxicity assay 
The Synphilin-1 cytotoxicity assays were performed by micro-cultivation experiments in 
triplicate at 30°C using the Bioscreen C system (Labsystems Oy, Helsinki, Finland). The 
optical density was measured every 30 min for 72 h. The significant test was performed and 
p-values were calculated as described previously (Liu et al., 2010). 
3.2.5. Statement on data and reagent availability 
Strains are available upon request. File Supplementary Table 3-1 contains genotypes for each 
individual strain used. File Supplementary Table 3-2 contains plasmids used in this study. Full 
lists of confirmed hits involved in Synphilin-1 inclusion formation and their functional 
enrichment analysis results are listed in File Supplementary Table 3-3, 3-4, 3-6 and 3-7. File 
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Supplementary Table 3-5 contains the homologues of yeast genes with function enriched. 
Mutants showing a decrease in both the percentage of cells with Synphilin-1 inclusion and 
fluorescence intensity are listed in Supplementary Table 3-8.  
3.3. Results 
It was previously demonstrated that expression of the N-terminal fusion protein dsRed-Sy1 
leads to inclusion/aggregate formation in yeast cells, similarly to expression of 
WT-Synphilin-1. This indicates that Synphilin-1 is being processed in a similar way in yeast 
and mammalian cells (Büttner et al., 2010; Swinnen et al., 2011). To identify components 
regulating Synphilin-1 inclusion formation in vivo, we performed a yeast genome-wide 
high-throughput imaging screening. The plasmid pYX212 carrying dsRed-Sy1 under the 
control of constitutive TPI1 promoter was introduced into yeast Y7092 query strains. The 
morphology of the Synphilin-1 inclusions was tested manually as shown in Fig. 3-1a.  
The setup of the robotic screening system is shown in Fig. 3-1b. This high content imaging 
screening system was designed to explore inclusion phenotypes through assessing fluorescent 
labeled protein markers in the yeast single deletion collection (SGA-V2) and the essential 
gene temperature sensitive (ts) allele collection (ts-V5) that contains yeast mutants harboring 
ts alleles of the essential genes. To incorporate the control plasmid expressing only dsRed or 
the plasmid for dsRed-Sy1 into the collections, we applied the yeast SGA methodology 
(Costanzo et al., 2010; Tong et al., 2001; Tong et al., 2004). In this robotic procedure, 
standard mating and meiotic recombination is used to select the haploid cells that combine a 
specific deletion or ts-mutant allele with the presence of the desired plasmid (Fig. 3-1b). We 
also designed a scoring program to automatically process the large amount of acquired images. 
It has the ability to automatically query and identify the cells on the images, extract the 
number of cells carrying IBs and export the measurements as a separate output (Fig. 3-1c). 
The phenotype scored in this screening is the percentage of cells carrying inclusions formed 
by dsRed-Sy1. 
There is a possibility that certain mutants would show an altered inclusion formation 
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phenotype because of changes in the Synphilin-1 expression level. To address this possibility, 
we also monitored steady-state levels of Synphilin-1 by measuring the dsRed-Sy1 
fluorescence intensity on the acquired images. Mutants with no significant difference (p>0.05, 
Student’s t-test) in their fluorescence level compared to the wild-type cells are more likely to 
represent strains affected in the cellular machinery that supports inclusion formation and 
aggregation.  
The criteria to include a particular mutant strain as a potential hit is based on the following: 1) 
the difference in the number of cells with Synphilin-1 inclusions between wild type and 
mutant cells is statistically significant (p<0.05, Student’s t-test), 2) the absolute difference of 
the percentage of wild type and mutant cells carrying Synphilin-1 inclusions must be at least 
25% and 3) no significant (p>0.05, Student’s t-test ) fluorescence intensity changes can be 
observed between wild type and mutant cells. Potential hits acquired from the screening were 
confirmed for their aggregation phenotype by using a manual microscopy approach. Based on 
these criteria and our manual confirmation, a total of 148 confirmed hits were obtained from 
the screening of the SGA collection and the ts collection (totally 5155 yeast mutants, 
including 4368 single deletion mutants and 787 ts alleles). Of these, 15 mutants showed an 
increase of cells carrying Synphilin-1 inclusions, but most of them also display a significantly 
increased Synphilin-1 expression level as measured by fluorescence intensity. The remaining 
133 mutants showed a decrease in the percentage of cells carrying Synphilin-1 inclusions 
without significant changes in the signal intensity of Synphilin-1 (Supplementary Tables 3-3 & 
3-6). Among these, 100 were non-essential gene deletion mutants and 33 were essential gene 
ts alleles. For the mutants with a decrease in Synphilin-1 inclusion formation, the 
confirmation rate obtained by this manual microscopic inspection was 92.9% when using a 
cutoff of 25% difference between the wild type and the mutants for the number of cells with 
Synphilin-1 inclusions.  
Mutants showing significant decrease (p<0.05, Student’s t-test) in both the percentage of cells 
with Synphilin-1 inclusions and the fluorescence intensity are listed in Supplementary Table 
3-8. For these mutants, there is a possibility that the observed decreased inclusion formation 
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phenotype is caused by the low expression level of the Synphilin-1 protein. 
 
Figure 3-1. Genome-wide HCM approach to identify components involved in Synphilin-1 inclusion 
formation. a) Phenotype of WT cells harboring Synphilin-1 inclusions. Right panel: dsRed-tagged 
Synphilin-1 (SY1); Left panel: Bright field. Scale bar, 5 μm. b) Workflow of the HCM to identify mutants 
altering the Synphilin-1 inclusion formation. c) Software approach for Synphilin-1 inclusion identification 
and quantification. Image pre-processing with shade correction and background subtraction (Top left); 
Cells (Top right) and IBs (Bottom left) were isolate from their background based on the signal intensity 
differences. Then the percentage of cells with inclusions were extracted (Bottom right) by combining the 
two (cells and IBs) masks. 
 
3.3.1. Mutants displaying a decreased capacity to form Synphilin-1 
inclusions 
Representative images of some top hits with high significant differences on decreased 
inclusion formation by dsRed-Sy1 are shown in Fig. 3-2a, and their quantitative differences as 
compared to the wild type strain are presented in Fig. 3-2b. Next, the mutants were analyzed 
for the enrichment of Gene Ontology (GO) categories, which classified them into different 
functional groups, including cytoskeleton organization, histone modification, sister chromatid 
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segregation, glycolipid biosynthetic process, DNA repair, and DNA replication (Fig. 3-3a, 
Supplementary Table 3-4). Within these functional groups several protein complexes were 
identified such as the dynein complex, dynactin, prefoldin complex, the Ctf18 RFC-like 
complex, the RNA polymerase complex and the Cdc73/Paf1 complex (Fig. 3-3b). Overall, 
this analysis revealed the complexity of the machinery involved in the formation of 
dsRed-Sy1 inclusions. Furthermore, we identified the human homologues of these enriched 
hits using YeastMine web-based software (a multifaceted search and retrieval system) 
(Balakrishnan et al., 2012). The results are shown in Supplementary Table 3-5.  
 
Figure 3-2. Top hits showing a decreased percentage of cells with Synphilin-1 inclusions obtained 
from the HCM screening. a) Images of mutants displaying less Synphilin-1 inclusions than WT (his3Δ) 
cells. Left panel: bright field, right panel: dsRed-Sy1. Scale bar, 2 μm. b) Quantification of the percentage 
of cells with inclusions in WT and mutant strains. Statistical analysis was performed using Student’s t-test. 
Error bars represent standard deviation from triplicates of about 200 cells each. Asterisks denote significant 
differences between WT and mutants: *P, 0.05; **P, 0.01; ***P, 0.001.  
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3.3.2. Genes involved in cytoskeleton organization, dynein, dynactin and 
prefoldin complex 
It has previously been reported that the actin cytoskeleton is involved in Synphilin-1, Htt and 
heat induced protein inclusion/aggregate management (Büttner et al., 2010; Liu et al., 2010; 
Liu et al., 2011; Song et al., 2014). Consistently, the GO term analysis showed a moderate 
enrichment for gene products involved in cytoskeleton organization (12.0% vs 1.9%, relative 
vs background frequency, P=4.9×10-6), which included genes such as ACT1 (Fig. 3-3a & b). 
These genes are involved in cell polarization, endocytosis and other cytoskeleton-related 
functions. Also genes encoding for dynein motor components (DYN1, DYN3, and PAC11) and 
a microtubule plus-end binding protein (PAC1) were retrieved (Fig. 3-3a & b). Cytoplasmic 
dynein is responsible for transport of cargo along microtubules, organization of the 
microtubule network with respect to the cell cortex and positioning of microtubule organizing 
center (Moore et al., 2009). There is also a considerable enrichment of genes encoding for the 
dynactin complex (2.4% vs 0.1%, relative to the background frequency, P=0.013) including 
LDB18, JNM1 and NIP100 (Fig. 3-3a & b). Dynactin, a widely conserved multi-subunit 
complex, is necessary for the function of dynein in cytoplasm and takes part in a variety of 
microtubule-based transport and anchoring processes. It has also been found to interact with 
dynein, microtubules and various types of cargo (Schroer, 2004). Moreover, the movement 
and position of the mitotic spindle and nucleus are known to be impaired when dynactin is 
absent (Moore et al., 2008). In our screening, we found that prefoldin complex components 
(GIM4, YKE2 and PAC10) as being required for proper Synphilin-1 inclusion formation in 
yeast cells. This result not only confirms previously reported data (Büttner et al., 2010; 
Swinnen et al., 2011), but it is especially interesting because the prefoldin complex is a 
chaperone that delivers unfolded proteins to cytosolic chaperonin (Vainberg et al., 1998), 
which has been implicated as a potent modulator of protein misfolding disease (Leroux and 
Hartl, 2000). Further understanding of the role of prefoldin complex and its co-player 
chaperonin in Synphilin-1 inclusion formation is likely to provide important insight into basic 
pathogenesis mechanisms of these proteins (Leroux and Hartl, 2000). Whether the 
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cytoskeletal components identified from our screening are involved in the formation of the 
inclusions or in their partitioning remains to be elucidated. 
 
 
 
Figure 3-3. Functional enrichment and network analysis for the confirmed hits with decreased 
Synphilin-1 inclusion formation. a) Functional enrichment analysis of mutants with decreased 
Synphilin-1 inclusion formation. Confirmed mutants were analyzed for enrichment of GO functional 
categories. Enriched groups were scored by comparing to a background list of SGA-V2+ ts-V5 array using 
a cut-off of p<0.05. Functional groups are marked with different colors. b) Network analysis of mutants 
with decreased Synphilin-1 inclusion formation. Mutants showing fewer cells with Synphilin-1 inclusion 
were grouped into modules based on their known physical interactions and published information of the 
cellular components. The cellular components are shown in different colored nodes. The circles indicate 
subunits or protein complexes. 
 
3.3.3. Genes involved in sister chromatid cohesion 
Our screening results also show that the formation of Synphilin-1 inclusions is impinged in 
mutants involved in sister chromatid cohesion and spindle orientation function. GO term 
enrichment analysis showed that mitotic sister chromatid cohesion was about 5 fold enriched 
and this included genes encoding the Ctf18 RFC-like complex (CTF18, CTF8, RFC2) (Fig. 
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3-3a & b). The RFC complex is required for sister chromatid cohesion and chromosome 
transmission, and mutants carrying a CTF8, CTF18, or DCC1 deletion display a severe sister 
chromatid cohesion defect (Mayer et al., 2001). It is possible that the establishment of sister 
chromatid cohesion plays a role in the formation of Synphilin-1 inclusions. Moreover, the 
Ctf18 protein co-localizes with the replication fork during DNA replication where it has an 
important role for sister chromatid cohesion (Lengronne et al., 2006). Related to this result, 
there was also a moderate enrichment for gene products involved in DNA replication 
initiation/Primase complex, such as RFA1, PSF1, MCM3, and POL1 (Fig. 3-3a & b). However, 
for these mutants it is not clear whether the observed decrease in the inclusion formation 
phenotype of the corresponding mutants is functionally linked to the sister chromatid hits or 
whether it is simply due to a general reduction of DNA replication.  
3.3.4. Genes involved in glycolipid biosynthetic process 
The list of genes whose deletion is associated with decreased Synphilin-1 inclusion formation 
is also enriched in members of the glycolipid biosynthetic process (CSG2, GPI19, LAS21, 
GWT1, ARV1 and SPT14; 4.7% vs 0.4% in the background; P=9.8×10-3; Fig. 3-3a & b). Five 
of them (GPI19, LAS21, GWT1, ARV1 and SPT14) are especially involved in the 
glycosylphosphatidylinositol (GPI) anchor biosynthetic process. Among these, GPI19 and 
SPT14 belong to the glycosylphosphatidylinositol-N- acetylglucosaminyltransferase 
(GPI-GnT) complex, which mediates the first step in GPI biosynthesis. 
Defects in the GPI-anchor synthesis has been linked with congenital diseases such as 
hyperphosphatasia with mental retardation syndrome (HPMRS), also known as Mabry 
syndrome (Thompson et al., 2010). Moreover, GPI anchors have been identified as factors 
that are required for the neurotoxic effect of scrapie prions (Chesebro et al., 2005). Here we 
show that the GPI anchor biosynthetic process components are required for Synphilin-1 
inclusion formation, whether this indicates that there is a direct interaction between 
Synphilin-1 and GPI anchors needs to be tested. It is known that the Synphilin-1 associates 
with cell membrane structures such as lipid droplets and lipid rafts in mammalian and yeast 
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cells (Büttner et al., 2010; Takahashi et al., 2006). Further in-depth investigation on the 
interplay among Synphilin-1, GPI-anchor and cell membrane structures will provide novel 
clues on the pathological role of Synphilin-1.  
3.3.5. Genes involved in Cdc73/Paf1 complex 
We also found several mutants carrying deletions of genes belonging to the Cdc73/Paf1 
complex that regulates transcription elongation from RNA polymerase (rtf1Δ, cdc73Δ, leo1Δ; 
2.4% vs 0.1% in the background, P=3.5×10-3; Fig. 3-3a & b). This complex was initially 
identified as the RNA polymerase II-associated protein in yeast (Koch et al., 1999). The yeast 
Rtf1 protein is not only essential for Set1-mediated histone H3 methylation but also required 
for Dot-mediated methylation of histone H3 (Krogan et al., 2003). Moreover, there were also 
a few mutants with decreased Synphilin-1 inclusion formation that affect histone H3 
methylation via the COMPASS (Complex Proteins Associated with Set1) complex, such as 
swd1Δ, swd3Δ, and orc2Δ (Fig. 3-3a & b). Whether this observation indicates that the 
Cdc73/Paf1 complex has a direct role in Synphilin-1 inclusion formation needs to be further 
investigated, since the decreased percentage of cells carrying Synphilin-1 inclusions may also 
be due to a general reduction of expression of the marker proteins. 
3.3.6. Inclusion formation defective mutants showing increased 
Synphilin-1 cytotoxicity effect in yeast cells 
It was previously demonstrated that Synphilin-1 inclusions are beneficial and have a positive 
effect on viability of human cell lines (Tanaka et al., 2004) and humanized yeast cells (Büttner 
et al., 2010). To test this further, we selected mutants of different cellular functional groups 
from the screening and analyzed their growth. For each of these mutants, the Synphilin-1 
inclusion phenotype was manually checked (Fig. 3-4a) and this confirmed the decreased 
capacity to form inclusions (Fig. 3-4b). In addition, we further measured the expression of 
Synphilin-1 by Western blot, results showed no significant difference in the mutants as 
compared to the wild type (p>0.05, Student’s t-test, Fig. 3-4c). Furthermore, we performed 
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complementation assays using Molecular Barcoded Yeast (MoBY) plasmids and this 
established that the reduced inclusion formation capacity is indeed solely due to the lack of 
function caused by the corresponding deletion in the mutants (Fig. 3-4d). Intriguingly, when 
assessing the growth rate all mutants showed a significantly prolonged generation time 
(Student’s t-test, p<0.05), which is indicative for a synthetic sick effect when the expression of 
dsRed-Sy1 is combined with the deletion of these genes. No such effect was observed upon 
expression of solely dsRed, which served as control (Fig. 3-4e). This result strongly supports 
the hypothesis that the formation and maturation of inclusions is a cytoprotective process that 
helps to sequester soluble cytotoxic mis-conformers into inert deposits (Tan et al., 2009). 
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Figure 3-4. Complementation assays and growth analysis of mutants with decreased inclusion 
formation capacity. a) Images of selected mutants with a decreased number of cells showing Synphilin-1 
(SY1) inclusions and the corresponding control mutant strains with only dsRed expression. Left panel, 
bright field; right panel, dsRed-Sy1 or dsRed. Scale bar, 5 μm. b) Quantification of the percentage of cells 
with Synphilin-1 inclusions in WT and mutants. A value of 0% means that there are no cells of that mutant 
with Synphilin-1 inclusions. Error bars represent standard deviation from triplicates each containing about 
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200 cells. c) Western blot analysis of the WT (his3Δ) strain and mutants expressing Synphilin-1. 
Immunodetection was performed using primary antibodies directed against Synphilin-1 or Adh2, which 
served as internal control protein. The quantification of Synphilin-1 expression levels is shown. Error bars 
represent standard deviation from triplicates samples. Asterisks denote significant differences between WT 
and mutants (Student’s t-test): *P, 0.05; **P, 0.01; ***P, 0.001. d) Complementation assays further 
confirmed that the reduced inclusion formation capacity of the mutants is solely due to the lack of function 
caused by the corresponding deletion. The complementation assays were performed with MoBY plasmids 
and the empty vector control (p5586). Error bars represent standard deviation from triplicates containing 
about 200 cells. e) An increased Synphilin-1 cytotoxicity effect (prolonged generation time) was observed 
from the selected mutants. The generation times of mutants expressing dsRed-Sy1 and solely dsRed 
(control) were measured at 30°C. The differences of generation time increase between WT and mutants are 
shown. Data are represented as mean ± standard deviation SD. Asterisks denote significant differences 
between samples (Student’s t-test): *P, 0.05; **P, 0.01; ***P, 0.001. 
 
3.3.7. Mutants displaying an increased percentage of cells carrying 
Synphilin-1 inclusions 
Our screening also identified 15 mutants that showed an increased percentage of cells with 
dsRed-Sy1 inclusions. In each case, the phenotype of the mutant was confirmed by manual 
analysis. Representative images of strong hits and their quantitative difference from wild-type 
cells are shown in Fig. 3-5a & b. Interestingly, when measuring the fluorescence signal 
intensity many mutants showed elevated levels as compared to the wild type strain, which 
suggests that the increased inclusion formation phenotype might be caused by an elevated 
level of Synphilin-1 expression (Supplementary Table 3-6). GO term analysis of these 
mutants revealed an enrichment for the transcription factor IID (TFIID) complex components 
(TAF2, TAF4, TAF11 and TAF12; P=2.94E-06) (Fig. 3-5c & d and Supplementary Table 3-7). 
Hence, it will be informative to elucidate whether the increased inclusion formation 
phenotype is caused by a general transcription defect or whether it is the effect of 
dysregulation of specific downstream targets of the TFIID complex. For six mutants, i.e. 
crm1-1, rtc1Δ, cdc24-3, arx1Δ rox1Δ and gdh1Δ, their fluorescence intensities of the 
dsRed-Sy1 fusion were similar to that of the wild type strain. Here, the presence of GDH1, a 
NADP(+)-dependent glutamate dehydrogenase, is especially intriguing. Indeed, changes in 
the activity and regulation of human GDH have been reported in a number of conditions that 
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lead to neurodegeneration (McKenna, 2011). 
 
 
Figure 3-5. Mutants identified from the HCM screening with an increased percentage of cells 
carrying Synphilin-1 inclusions a) Representative images of strong hits from the imaging based screening 
showing cells with expression of dsRed-Sy1 or dsRed alone. Left panel, bright field; right panel, 
dsRed-Sy1 or dsRed. Scale bar, 5 μm. b) Quantification of percentage of cells with inclusions in WT and 
mutants. Error bars represent standard deviation from triplicates of about 200 cells each. Asterisks denote 
significant differences between WT and mutants (Student’s t-test): *P, 0.05; **P, 0.01; ***P, 0.001. c) 
Functional enrichment analysis of mutants displaying increased Synphilin-1 inclusion formation. 
Confirmed mutants were analyzed for enrichment of GO functional categories. Enriched groups were 
scored by comparing to a background list of SGA-V2+ ts-V5 array. Functional groups are marked with 
different colors. d) Network analysis of mutants with an increased percentage of cells with Synphilin-1 
inclusions. Mutants showing more cells with Synphilin-1 inclusions were grouped into modules based on 
their known physical interactions and published information of the cellular components. The cellular 
components are shown in different colored nodes. The circles indicate subunits or protein complexes. 
 
In summary, we developed and validated a yeast HCM screening approach for the 
fluorescently tagged human Synphilin-1 protein. This genome-wide imaging screening 
enabled us to identify cellular components that regulate Synphilin-1 aggregation with 
unexpected functionalities. We found that dynein complex, dynactin, prefoldin complex, the 
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Ctf18 RFC-like complex, the RNA polymerase complex and the Cdc73/Paf1 complex are 
required for the formation of Synphilin-1 inclusions. These results gave an unbiased global 
view on the complexity of the machinery underlying inclusion formation by Synphilin-1 and 
provided further supports on the hypothesis that the Synphilin-1 inclusion formation has a 
cytoprotective effect to the cell. Synphilin-1 was found to be one of the constituents of Lewy 
bodies, a hallmark for PD (Wakabayashi et al., 2000). Our findings acquired from the yeast 
model, especially genes/pathways with homologues in human, provided valuable clues 
concerning the machinery controlling Synphilin-1 inclusion formation. Further investigation 
of these human homologue hits can provide novel insights for our understanding of the 
mechanisms of pathogenesis causing PD as well as other protein folding disorders. 
3.4. Discussion 
IBs formation is a hallmark of PD, overexpression of Synphilin-1 in yeast reproduces IBs 
formation, similar as in neuronal cells. Processes governing Synphilin-1 inclusion formation 
are rarely known, we provide a systematic analysis of factors required for Synphilin-1 
inclusion formation. We developed and validated a yeast HCM screening approach for the 
fluorescently tagged human Synphilin-1 protein. This genome-wide imaging screening 
enabled us to identify cellular components that regulate Synphilin-1 aggregation with 
unexpected functionalities.  
We found that dynein complex, dynactin and prefoldin complex are required for the formation 
of Synphilin-1 inclusions. Interestingly, a certain aggregated proteins deposit called 
aggresomes, is formed based on dynein-dependent retrograde transport along microtubules 
(Kopito, 2000; Tanaka et al., 2004). Moreover, cytoskeletal proteins are also reported 
involved in both formation and maintenance of yeast prions (Bailleul et al., 1999; Chernova et 
al., 2011; Ganusova et al., 2006). Thus it is very likely that cytoskeleton organization plays a 
crucial role in Synphilin-1 inclusion formation, the exact role of cytoskeletal components 
such as dynein, dynactin and prefoldin complex and their co-player chaperonin, remains to be 
further investigated. Thus, it is important to study the dynamic process of Synphilin-1 
inclusion formation, leading edge techniques, such super-resolution live cell video 
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microscopy, will help us to obtain more details of cytoskeleton in the process of Synphilin-1 
inclusion formation. 
Even Synphilin-1 inclusions was considered to be the toxic species in some studies, due to the 
observation of Synphilin-1 inclusion associated with cerebellum (Nuber et al., 2010) and 
dopaminergic neurons (Krenz et al., 2009). However, increasing evidences show that 
inclusion formation of misfolded proteins is benefit for cells. For instance, a study reported 
that no signs of neurodegeneration were observed in the presence of insoluble Synphilin-1 
deposits (Jin et al., 2008); spatial sequestration of mutant Htt decreases cytotoxicity of mutant 
Htt (Yang et al., 2016). Our study provides an unbiased global view on the complexity of the 
machinery underlying inclusion formation of Synphilin-1 and further provides supports on the 
hypothesis that the Synphilin-1 inclusion formation has a cytoprotective effect to the cell.  
It is known that the Synphilin-1 associates with cell membrane structures such as lipid 
droplets and lipid rafts in mammalian and yeast cells (Büttner et al., 2010; Takahashi et al., 
2006). Further in-depth investigation on the interplay among Synphilin-1, GPI-anchor and 
cell membrane structures will provide novel clues on the pathological role of Synphilin-1.  
Our findings acquired from the yeast model, especially genes/pathways with homologues in 
human, provided valuable clues concerning the machinery controlling Synphilin-1 inclusion 
formation. Further investigation of these human homologue hits can provide novel insights 
for our understanding of the mechanisms of pathogenesis causing PD as well as other protein 
folding disorders. 
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3.5. Supplementary information 
SUPPLEMENTARY TABLES 
Supplementary Table 3-1: Strains used in Chapter 3 
 
    
Strain Name   Genotype and markers Background/Source 
BY4741 (WT) 
 
MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 
EUROSCARF; Wt control 
for  strains constructed by 
PCR approach  
Y7092-pSY285 
 
MATα can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 
leu2Δ0 his3Δ1 met15Δ0 LYS2+  
pYX212-dsRed-SY1 (URA+) 
This study, query strain 
Y7092-pSY244 
 
MATα can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 
leu2Δ0 his3Δ1 met15Δ0 LYS2+  
pYX212-dsRed (URA+) 
This study, query strain, 
Control for strain expressing 
Synphilin-1 
BY4741-pSY285 
 
BY4741 with pYX212-dsRed-SY1 (URA+) This study 
BY4741-pSY244 
 
BY4741 with pYX212-dsRed (URA+) 
This study, Control for strain 
expressing Synphilin-1 
BY4741-pSY285' 
 
BY4741 with pYX212-dsRed-SY1 (Hyg+) This study 
BY4741-pSY244' 
 
BY4741 with pYX212-dsRed  (Hyg+) 
This study, Control for strain 
expressing Synphilin-1 
his3∆-244 
 
MATa his3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed  (URA+) 
This study; Wt control for 
strains expressing 
Synphilin-1 
his3∆-285 
 
MATa his3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study; Wt control for 
strains constructed by 
crossing 
dyn3Δ-285 
 
MATa dyn3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
gim4Δ-285 
 
MATa gim4Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
yke2Δ-285 
 
MATa yke2Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
kar3Δ-285 
 
MATa kar3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
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she4Δ-285 
 
MATa she4Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
vac14Δ-285 
 
MATa vac14Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
idh1Δ-285 
 
MATa idh1Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
cbc2Δ-285 
 
MATa cbc2Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
ctf18Δ-285 
 
MATa ctf18Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
srb2Δ-285 
 
MATa srb2Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
idh2Δ-285 
 
MATa idh2Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
rtg3-285 
 
MATa rtg3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
irc14-285 
 
MATa irc14Δ::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
tid3-1-285 
 
MATa tid3-1::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
cdc3-1-285 
 
MATa cdc3-1::kanMX4 can1Δ::STE2pr-Sp_his5 
lyp1Δ ura3Δ0 leu2Δ0 met15Δ0 LYS2+ 
pYX212-dsRed-SY1  (URA+) 
This study 
his3∆ 
 
BY4741 with his3Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
dyn3Δ 
 
BY4741 with dyn3Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
gim4Δ 
 
BY4741 with gim4Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
yke2Δ 
 
BY4741 with yke2Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
kar3Δ 
 
BY4741 with kar3Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
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she4Δ 
 
BY4741 with she4Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
vac14Δ 
 
BY4741 with vac14Δ::KanMX4 
SGA-V2 collection, Boone 
lab 
dyn3Δ-SM 
 
BY4741 with dyn3Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+) 
+MoBY-DYN3(URA+) 
This study 
gim4Δ-SM 
 
BY4741 with gim4Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+) 
+MoBY-GIM4(URA+) 
This study 
yke2Δ-SM 
 
BY4741 with yke2Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+) 
+MoBY-YKE2(URA+) 
This study 
kar3Δ-SM 
 
BY4741 with kar3Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+) 
+MoBY-KAR3(URA+) 
This study 
she4Δ-SM 
 
BY4741 with she4Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+) 
+MoBY-SHE4(URA+) 
This study 
vac14Δ-SM 
 
BY4741 with vac14Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+) 
+MoBY-VAC14(URA+) 
This study 
his3∆-SP 
 
BY4741 with his3Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
dyn3Δ-SP 
 
BY4741 with dyn3Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
gim4Δ-SP 
 
BY4741 with gim4Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
yke2Δ-SP 
 
BY4741 with yke2Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
kar3Δ-SP 
 
BY4741 with kar3Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
she4Δ-SP 
 
BY4741 with she4Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
vac14Δ-SP 
 
BY4741 with vac14Δ::KanMX4 
+pYX212-dsRed-SY1 (Hyg+)+p5586(URA+) 
This study 
SGA-V2 
collection  
BY4741 with xxxΔ::KanMX4 collection Boone lab 
Ts-V5 collection 
 
BY4741 background, essential gene temperature 
sensitive allele collection 
Boone lab 
S2YDSY1 
collection  
SGA-V2 with pYX212-dsRed-Sy1 This study 
S2YD collection 
 
SGA-V2 with pYX212-dsRed (control for This study 
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S2YDSY1 collection 
Sts5YDSY1 
collection  
Ts-V5 with pYX212-dsRed-Sy1 This study 
Sts5YD collection   
Ts-V5 with pYX212-dsRed (control for 
Sts5YDSY1 collection ) 
This study 
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Supplementary Table 3-2: Plasmids used in Chapter 3 
 
   
 Plasmid Name   Genotype and markers Background/Source 
pYX285 
 
pYX212-SY1-dsRed, (URA3+, AmpR) BÜTTNER et al. 2010  
pYX244 
 
pYX212-dsRed, (URA3+, AmpR) BÜTTNER et al. 2010  
pYX285' 
 
pYX212-SY1-dsRed, (Hygromycin B+, 
AmpR) 
This study 
pYX244' 
 
pYX212-dsRed, (Hygromycin B+, AmpR) This study 
p5586 
 
p5472+URA3+CEN+MAGIC (URA3+, 
tetracycline+, kanamycin+, 
chloramphenicol+ ) 
MoBY-ORF library 
pMoBY-DYN3 
 
p5586-DYN3 ORF (URA3+, Hygromycin 
B+, tetracycline+, kanamycin+, 
chloramphenicol+ ) 
MoBY-ORF library 
pMoBY-GIM4 
 
p5586-GIM4 ORF (URA3+, Hygromycin 
B+, tetracycline+, kanamycin+, 
chloramphenicol+ ) 
MoBY-ORF library 
pMoBY-YKE2 
 
p5586-YKE2 ORF (URA3+, Hygromycin 
B+, tetracycline+, kanamycin+, 
chloramphenicol+ ) 
MoBY-ORF library 
pMoBY-KAR3 
 
p5586-KAR3 ORF(URA3+, Hygromycin 
B+, tetracycline+, kanamycin+, 
chloramphenicol+ ) 
MoBY-ORF library 
pMoBY-SHE4 
 
p5586-SHE4 ORF (URA3+, Hygromycin 
B+, tetracycline+, kanamycin+, 
chloramphenicol+ ) 
MoBY-ORF library 
pMoBY-VAC14 
 
p5586-VAC14 ORF (URA3+, tetracycline+, 
kanamycin+, chloramphenicol+ ) 
MoBY-ORF library 
pSG32  (Hygromycin B+) For hphMX4 amplify 
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Supplementary Table 3-3: Mutants with manually confirmed decreased Synphilin-1 
inclusions phenotype 
     
Number Mutant 
Percentage of cells with SY1 
inclusions (%) 
Relative 
intensity 
Intensity t-test 
(Pvalue) 
0 wt 50.00 100.00 
 
1 cbc2Δ 0.20 22.71 0.0702  
2 ctf18Δ 1.37 61.44 0.2371  
3 tid3-1 1.70 67.78 0.1161  
4 idh2Δ 1.70 74.41 0.3265  
5 cdc3-1 2.66 68.16 0.0531  
6 srb2Δ 2.76 103.01 0.5860  
7 rtg3Δ 2.91 42.39 0.0855  
8 irc14Δ 3.24 62.78 0.0980  
9 idh1Δ 3.41 68.76 0.0832  
10 cdc5-1 4.22 70.19 0.0616  
11 cdc73Δ 4.23 70.79 0.1479  
12 bre1Δ 4.41 70.47 0.1634  
13 rad14Δ 4.83 123.66 0.0013  
14 bap2Δ 5.84 61.73 0.2459  
15 psf1-1 5.90 98.45 0.6070  
16 abd1-5 6.11 59.33 0.0731  
17 gpi19-2 6.18 848 0.2261  
18 act1-112 6.23 62.15 0.1426  
19 cdc20-1 6.38 58.30 0.1508  
20 jnm1Δ 6.67 71.07 0.0656  
21 rfc2-1 6.77 89.79 0.3747  
22 kar3Δ 6.99 47.55 0.1204  
23 soh1Δ 7.05 99.93 0.9894  
24 pac10Δ 7.27 88.78 0.6408  
25 rpn12-1 7.29 93.00 0.1913  
2 spt14-1-10c 7.35 92.17 0.2130  
27 orc2-2 7.45 97.09 0.6545  
28 cdc53-1 7.67 60.00 0.0983  
29 act1-133 7.87 62.94 0.0613  
30 rpn10Δ 8.12 82.93 0.3363  
31 hur1Δ 8.28 96.68 0.8663  
32 pmr1Δ 8.38 80.18 0.2948  
33 ctf4Δ 8.51 47.63 0.1020  
34 act1-105 73 64.67 0.1957  
35 pol1-13 8.93 88.12 0.3093  
36 spe3Δ 8.99 86.02 0.1787  
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37 smc1-2 9.23 77.97 0.0543  
38 spt8Δ 9.30 67.17 0.2603  
39 act1-3 9.65 86.73 0.0884  
40 mcm3-1 10.07 74.84 0.2017  
41 mms22Δ 10.15 60.34 0.3571  
42 ira2Δ 10.45 63.52 0.1043  
43 apc11-22 10.47 72.38 0.1282  
44 gpr1Δ 10.48 92.81 0.5443  
45 pds5-1 10.92 58.63 0.1094  
46 isc1Δ 10.99 93.85 0.9580  
47 rvs161Δ 11.27 102.33 0.7764  
48 stu1-6 11.38 90.15 0.2789  
49 est1Δ 11.60 83.33 0.4955  
50 rfa1-m2 11.92 90.36 0.1263  
5 rpo21-1 11.99 62.24 0.0547  
52 stu2-10 12.64 108.87 0.7958  
53 mms1Δ 12.78 65.37 0.3096  
54 rcy1Δ 13.11 64.18 0.1897  
55 act1-125 13.28 66.49 0.1024  
56 ctf8Δ 13.85 61.49 0.0987  
57 she4Δ 14.42 65.36 0.2147  
58 asf1Δ 14.42 78.89 0.2732  
59 cdc20- 14.42 60.24 0.0866  
60 act1-129 14.55 94.62 0.1015  
61 pib2Δ 14.59 108.39 0.7504  
62 aro2Δ 14.67 81.65 0.3638  
63 lat1Δ 14.96 73.78 0.0602  
64 leo1Δ 15.18 98.54 0.1710  
65 arg2Δ 15.37 92.61 0.3546  
66 rad52Δ 15.59 73.62 0.2094  
67 csg2Δ 15.81 92. 0.7368  
68 lge1Δ 15.85 76.55 0.4217  
69 aah1Δ 16.17 76.85 0.3225  
70 rpe1Δ 16.17 91.34 0.9704  
71 rad27Δ 16.20 91.37 0.0791  
72 rtf1Δ 16.37 75.43 0.0947  
73 cdc15-2 16.61 86.59 0.1059  
74 clb5Δ 16.71 81.56 0.9800  
75 pcf11-ts2 16.81 75.80 0.1105  
76 pde2Δ 16.91 91.56 0.3362  
77 nip100Δ 17.01 67.94 0.5268  
78 dia2Δ 17.34 150.63 0.0421  
79 sec66Δ 17.44 89.21 0.1357  
-81- 
80 yta7Δ 17.54 97.63 0.6665  
81 sub1Δ 17.64 79.22 0.6241  
82 yke2Δ 17.85 89.72 0.6966  
83 gwt1-20 17.97 107.70 0.9268  
84 dyn3Δ 18.03 81.67 0.3326  
85 arv1Δ 18.52 95.78 0.8862  
86 sla1Δ 19.45 73.56 0.5605  
87 spf1Δ 19.51 82.87 0.0528  
88 swd1Δ 19.52 66.96 0.7769  
89 bts1Δ 19.59 80.62 0.8082  
90 ubp15Δ 19.85 64.47 0.0589  
91 dyn1Δ 19.98 79.14 0.5109  
92 kem1Δ 20.12 59.61 0.1279  
93 num1Δ 20.14 81.76 0.0780  
94 swi6Δ 20.27 62.52 0.0688  
95 chl1Δ 20.96 78.81 0.4542  
96 gtr2Δ 21.10 89.08 0.2366  
97 dep1Δ 21.28 75.51 0.3573  
98 hex3Δ 22.09 92.89 0.7206  
99 rtt109Δ 22.17 103.60 0.1670  
100 ssk1Δ 22.52 64.47 0.2329  
101 lrp1Δ 22.63 107.11 0.2375  
102 ldb18Δ 22.73 75.88 0.3947  
103 ade1Δ 22.86 73.75 0.5854  
104 vac14Δ 23.42 96.55 0.6339  
105 pac1Δ 23.55 76.11 0.1951  
106 pdb1Δ 23.98 60.15 0.1658  
107 ost4Δ 24.17 93.49 0.3114  
108 swd3Δ 24.30 79.39 0.7011  
109 spe2Δ 24.32 80.62 0.5859  
110 gim4Δ 24.53 88.24 0.2892  
111 thr4Δ 24.54 73.25 0.1908  
112 las21Δ 24.72 93.23 0.3713  
113 sac1Δ 26.76 79.32 0.2403  
114 ded1-199 27.03 67.87 0.0536  
115 stt3-7 27.23 102.65 0.8626  
116 tps1Δ 27.25 57.46 0.1786  
117 ecm8Δ 2.64 81.81 0.8692  
118 hoc1Δ 27.84 77.74 0.4873  
119 pac11Δ 28.55 87.05 0.1662  
120 mct1Δ 28.70 74.61 0.1654  
121 nkp2Δ 29.14 78.15 0.7418  
122 ecm33Δ 30.06 75.96 0.9666  
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123 nup133Δ 30.21 88.16 0.7494  
124 gyp1Δ 30.47 74.13 0.1783  
125 sic1Δ 30.48 88.67 0.8745  
126 etr1Δ 31.07 62.67 0.2541  
127 ald6Δ 32.28 83.63 0.9568  
128 clb2Δ 32.67 65.62 0.3195  
129 hom6Δ 33.72 86.16 0.1411  
130 slm4Δ 34.81 73.46 0.5164  
131 lip5Δ 34.87 65.44 0.1015  
132 tip1Δ 35.50 73.06 0.5078  
133 syg1Δ 36.67 59.63 0.0813  
     * p<0.05  indicates significant signal intensity difference between wild-type and mutant 
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Supplementary Table 3-4: Functional enrichment analysis of confirmed hits with decrease of 
cells with Synphilin-1 inclusion 
  
Terms  Gene(s) annotated to the term 
Microtubule cytoskeleton organization 
CDC15/STU1/NUM1/PAC11/ACT1/NDC80/DYN1/LD
B18/STU2/CDC5/JNM1/NIP100/CLB2/CLB5/KAR3 
DNA replication 
DEP1/RFA1/ORC2/BRE1/PSF1/MCM3/HUR1/RFC2/R
AD27/MMS22/CTF18/POL1/DIA2/LGE1/CLB5/CTF4/
MMS1 
Positive regulation of DNA-templated 
transcription, elongation 
XRN1/RTF1/ASF1/YKE2/CDC73/SUB1/LEO1 
Histone modification 
DEP1/SWD1/ORC2/SWD3/BRE1/ACT1/RTF1/ASF1/R
TT109/SPT8/CDC73/LEO1/LGE1 
Sister chromatid segregation 
SMC1/CDC20/SOH1/CTF8/RFC2/DYN1/MMS22/PDS
5/CTF18/CHL1/CLB2/CTF4/KAR3 
Glycolipid biosynthetic process CSG2/GPI19/LAS21/GWT1/ARV1/SPT14 
DNA repair 
RFA1/BRE1/RPO21/PSF1/MCM3/SMC1/ACT1/SOH1/
RTF1/RFC2/RAD27/NUP133/RTT109/MMS22/CDC73
/RAD52/SUB1/PDS5/CTF18/RAD14/POL1/LEO1/CH
L1/CTF4/MMS1 
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Supplementary Table 3-5: Human homologues of functional enriched yeast genes 
 
Yeast 
Gene 
Name 
Homologue 
Standard 
Name 
Homologue 
Organism 
Cross 
References 
Identifier 
Homologue Diseases Source 
ACT1 ACTA1 H. sapiens 255310 
MYOPATHY, CONGENITAL, 
WITH FIBER-TYPE 
DISPROPORTION; CFTD 
Ensembl 
ACT1 ACTA2 H. sapiens 614042 
MOYAMOYA DISEASE 5; 
MYMY5 
Ensembl 
ACT1 ACTB H. sapiens 243310 
BARAITSER-WINTER 
SYNDROME 1; BRWS1 
Ensembl 
ACT1 ACTBL2 H. sapiens 
  
Ensembl 
ACT1 ACTC1 H. sapiens 613424 
CARDIOMYOPATHY, 
DILATED, 1R; CMD1R LEFT 
VENTRICULAR 
NONCOMPACTION 4, 
INCLUDED; LVNC4, 
INCLUDED 
Ensembl 
ACT1 ACTG2 H. sapiens 155310 
VISCERAL MYOPATHY; 
VSCM 
Ensembl 
ACT1 ACTR1A H. sapiens 
  
Ensembl 
ACT1 ACTR1B H. sapiens 
  
Ensembl 
ACT1 ACTRT1 H. sapiens 
  
Ensembl 
ACT1 ACTRT2 H. sapiens 
  
Ensembl 
ACT1 ACTRT3 H. sapiens 
  
Ensembl 
ASF1 ASF1A H. sapiens 
  
Ensembl 
ASF1 ASF1B H. sapiens 
  
Ensembl 
BRE1 RNF20 H. sapiens 
  
Ensembl 
BRE1 RNF40 H. sapiens 
  
Ensembl 
CDC15 MAP3K14 H. sapiens 
  
Ensembl 
CDC15 MAP3K15 H. sapiens 
  
Ensembl 
CDC15 MAP3K5 H. sapiens 
  
Ensembl 
CDC15 MAP3K6 H. sapiens 
  
Ensembl 
CDC15 MAP3K8 H. sapiens 211980 
LUNG CANCER ALVEOLAR 
CELL CARCINOMA, 
INCLUDED 
Ensembl 
CDC5 PLK1 H. sapiens 
  
Ensembl 
CDC5 PLK2 H. sapiens 
  
Ensembl 
CDC5 PLK3 H. sapiens 
  
Ensembl 
CDC5 PLK4 H. sapiens 616171 
MICROCEPHALY AND 
CHORIORETINOPATHY, 
Ensembl 
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AUTOSOMAL RECESSIVE, 2; 
MCCRP2 
CDC73 CDC73 H. sapiens 608266 
PARATHYROID 
CARCINOMA 
Ensembl 
CDC73 CDC73 H. sapiens 145001 
HYPERPARATHYROIDISM 2; 
HRPT2 
Ensembl 
CDC73 CDC73 H. sapiens 145000 
HYPERPARATHYROIDISM 1; 
HRPT1 
Ensembl 
CHL1 BRIP1 H. sapiens 609054 
FANCONI ANEMIA, 
COMPLEMENTATION 
GROUP J; FANCJ 
Ensembl 
CHL1 BRIP1 H. sapiens 114480 BREAST CANCER Ensembl 
CHL1 DDX11 H. sapiens 613398 
WARSAW BREAKAGE 
SYNDROME; WABS 
Ensembl 
CHL1 RTEL1 H. sapiens 616373 
PULMONARY FIBROSIS 
AND/OR BONE MARROW 
FAILURE, 
TELOMERE-RELATED, 3; 
PFBMFT3 
Ensembl 
CHL1 RTEL1 H. sapiens 615190 
DYSKERATOSIS 
CONGENITA, AUTOSOMAL 
RECESSIVE 5; DKCB5 
DYSKERATOSIS 
CONGENITA, AUTOSOMAL 
DOMINANT 4, INCLUDED; 
DKCA4, INCLUDED 
Ensembl 
CLB2 CCNA1 H. sapiens 
  
Ensembl 
CLB2 CCNA2 H. sapiens 
  
Ensembl 
CLB2 CCNB1 H. sapiens 
  
Ensembl 
CLB2 CCNB2 H. sapiens 
  
Ensembl 
CLB2 CCNB3 H. sapiens 
  
Ensembl 
CLB2 CCND1 H. sapiens 193300 
VON HIPPEL-LINDAU 
SYNDROME; VHL VON 
HIPPEL-LINDAU 
SYNDROME, MODIFIERS 
OF, INCLUDED 
Ensembl 
CLB2 CCND1 H. sapiens 114500 
COLORECTAL CANCER; 
CRC 
Ensembl 
CLB2 CCND1 H. sapiens 254500 
MYELOMA, MULTIPLE 
AMYLOIDOSIS, SYSTEMIC, 
INCLUDED; AL, INCLUDED 
Ensembl 
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CLB2 CCND2 H. sapiens 615938 
MEGALENCEPHALY-POLYM
ICROGYRIA-POLYDACTYLY
-HYDROCEPHALUS 
SYNDROME 3; MPPH3 
Ensembl 
CLB2 CCND3 H. sapiens 
  
Ensembl 
CLB2 CCNE1 H. sapiens 
  
Ensembl 
CLB2 CCNE2 H. sapiens 
  
Ensembl 
CLB2 CCNO H. sapiens 615872 
CILIARY DYSKINESIA, 
PRIMARY, 29; CILD29 
Ensembl 
CLB5 CCNA1 H. sapiens 
  
Ensembl 
CLB5 CCNA2 H. sapiens 
  
Ensembl 
CLB5 CCNB1 H. sapiens 
  
Ensembl 
CLB5 CCNB2 H. sapiens 
  
Ensembl 
CLB5 CCNB3 H. sapiens 
  
Ensembl 
CLB5 CCND1 H. sapiens 193300 
VON HIPPEL-LINDAU 
SYNDROME; VHL VON 
HIPPEL-LINDAU 
SYNDROME, MODIFIERS 
OF, INCLUDED 
Ensembl 
CLB5 CCND1 H. sapiens 114500 
COLORECTAL CANCER; 
CRC 
Ensembl 
CLB5 CCND1 H. sapiens 254500 
MYELOMA, MULTIPLE 
AMYLOIDOSIS, SYSTEMIC, 
INCLUDED; AL, INCLUDED 
Ensembl 
CLB5 CCND2 H. sapiens 615938 
MEGALENCEPHALY-POLYM
ICROGYRIA-POLYDACTYLY
-HYDROCEPHALUS 
SYNDROME 3; MPPH3 
Ensembl 
CLB5 CCND3 H. sapiens 
  
Ensembl 
CLB5 CCNE1 H. sapiens 
  
Ensembl 
CLB5 CCNE2 H. sapiens 
  
Ensembl 
CLB5 CCNO H. sapiens 615872 
CILIARY DYSKINESIA, 
PRIMARY, 29; CILD29 
Ensembl 
CTF18 CHTF18 H. sapiens 
  
Ensembl 
CTF4 WDHD1 H. sapiens 
  
Ensembl 
GIM4 PFDN2 H. sapiens 
  
Ensembl 
GWT1 PIGW H. sapiens 616025 
HYPERPHOSPHATASIA 
WITH MENTAL 
RETARDATION SYNDROME 
5; HPMRS5 
Ensembl 
KAR3 KIF25 H. sapiens 
  
Ensembl 
KAR3 KIFC1 H. sapiens 
  
Ensembl 
KAR3 KIFC3 H. sapiens 
  
Ensembl 
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LEO1 LEO1 H. sapiens 
  
Ensembl 
MCM3 MCM3 H. sapiens 
  
Ensembl 
NDC8
0 
NDC80 H. sapiens 
  
Ensembl 
NIP10
0 
CLIP1 H. sapiens 
  
Ensembl 
NIP10
0 
CLIP2 H. sapiens 
  
Ensembl 
NIP10
0 
CLIP3 H. sapiens 
  
Ensembl 
PAC10 VBP1 H. sapiens 
  
Ensembl 
PDS5 PDS5A H. sapiens 
  
Ensembl 
PDS5 PDS5B H. sapiens 
  
Ensembl 
POL1 POLA1 H. sapiens 310465 N SYNDROME; NSX Ensembl 
PSF1 GINS1 H. sapiens 
  
Ensembl 
RFA1 RPA1 H. sapiens 
  
Ensembl 
RFC2 RFC4 H. sapiens 
  
Ensembl 
RTF1 RTF1 H. sapiens 
  
Ensembl 
SMC1 SMC1A H. sapiens 300590 
CORNELIA DE LANGE 
SYNDROME 2; CDLS2 
Ensembl 
SMC1 SMC1B H. sapiens 
  
Ensembl 
SPT14 PIGA H. sapiens 300868 
MULTIPLE CONGENITAL 
ANOMALIES-HYPOTONIA-S
EIZURES SYNDROME 2; 
MCAHS2 
Ensembl 
SPT14 PIGA H. sapiens 300818 
PAROXYSMAL NOCTURNAL 
HEMOGLOBINURIA 1; PNH1 
Ensembl 
STU2 CKAP5 H. sapiens 
  
Ensembl 
SUB1 SUB1 H. sapiens 
  
Ensembl 
SWD1 RBBP5 H. sapiens 
  
Ensembl 
XRN1 XRN1 H. sapiens 
  
Ensembl 
YKE2 PFDN6 H. sapiens 
  
Ensembl 
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Supplementary Table 3-6: Mutants with manually confirmed increased Synphilin-1 inclusions 
phenotype 
  
    
Number Mutant 
Percentage of cells with SY1 
inclusions (%) 
Relative 
intensity 
Intensity t-test (P 
value) 
0 wt 50.00 100.00 
 
1 mob2-26 73.01 141.41 0.0453  
2 taf11-ts2 72.52 214.15 0.0165  
3 crm1-1 68.70 110.51 0.5755  
4 rtc1Δ 68.22 116.51 0.2105  
5 taf4-18 67.69 141.59 0.0179  
6 cdc24-3 67.21 113.76 0.6103  
7 taf12-W486 65.61 163.97 0.0214  
8 arx1Δ 63.23 124.13 0.5328  
9 ktr7Δ 62.89 128.45 0.0253  
10 rox1Δ 61.78 92.71 0.9362  
11 taf12-L464A 58.07 266.95 0.0045  
12 taf12-9 57.77 154.13 0.0385  
13 taf12-L446A 57.71 193.79 0.0061  
14 taf2-1 57.28 216.78 0.0040  
15 gdh1Δ 54.82 102.01 0.0978  
 
 
    
 * p<0.05  indicates significant signal intensity difference between wild-type and mutant 
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Supplementary Table 3-7: Functional enrichment analysis of confirmed hits with increase of cells with 
Synphilin-1 inclusion 
  
Terms  Gene(s) annotated to the term 
DNA binding transcription factor activity TAF2/TAF12/TAF11/TAF4/ROX1 
Transcription factor TFIID complex TAF2/TAF12/TAF11/TAF4 
 
 
Supplementary Table 3-8: Mutants showed significant decrease in both the percentage of cells 
with Synphilin-1 inclusion and the fluorescence intensity 
     
Number Mutant 
Percentage of cells with SY1 
inclusions (%) 
Relative 
intensity 
Intensity t-test 
(P value) 
0 wt 50.00 100.00 
 
1 sem1Δ 0.00 61.94 0.0002  
2 dbp5-2 0.00 34.32 0.0030  
3 cdc10-5 0.00 42.79 0.0162  
4 cdc40-ts 0.29 47.33 0.0114  
5 bbp1-2 0.42 23.54 0.0097  
6 dbp5-1 0.46 25.95 0.0027  
7 hsl1Δ 0.61 65.14 0.0442  
8 yhc1-7 0.98 61.08 0.0135  
9 scd5-D338 1.37 59.15 0.0303  
10 cks1-38 1.52 39.71 0.0124  
11 nop2-10 1.75 51.24 0.0481  
12 spt3Δ 1.80 70.61 0.0299  
13 cdc28-td 1.92 38.01 0.0259  
14 spc29-20 2.04 59.88 0.0106  
15 nip7-1 2.15 53.83 0.0098  
16 srm1-G282S 2.21 60.57 0.0328  
17 cdc123-4 2.28 35.70 0.0030  
18 pri2-1 2.59 76.96 0.0201  
19 prp18-1202 3.01 74.75 0.0490  
20 rtg2Δ 3.09 53.06 0.0280  
21 med6-ts 3.13 41.44 0.0092  
22 orc3-70 3.14 67.46 0.0096  
23 cks1-35 3.41 25.26 0.0200  
24 scd5-PP1D2 3.47 42.85 0.0133  
25 mtr3-ts 3.53 51.54 0.0110  
26 stu1-8 3.56 50.81 0.0171  
27 apc11-13 3.91 43.41 0.0072  
28 pol1-2 4.06 67.81 0.0174  
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29 orc2-1 4.06 48.64 0.0205  
30 ded1-95 4.20 52.68 0.0131  
31 las17-13 4.83 49.88 0.0460  
32 act1-155 4.95 52.21 0.0114  
33 act1-132 5.31 61.03 0.0074  
34 dcc1Δ 5.73 65.61 0.0094  
35 sup35-td 6.02 45.82 0.0076  
36 bem2Δ 6.05 50.21 0.0149  
37 spt6-14 6.07 49.81 0.0281  
38 slu7-ts2 6.09 65.87 0.0225  
39 cdc37-ts 6.19 45.76 0.0036  
40 rmp1-ts 6.75 54.20 0.0337  
41 cdc48-3 6.97 58.69 0.0225  
42 rtg1Δ 7.69 40.06 0.0359  
43 rna15-58 7.77 71.03 0.0184  
44 cft2-1 8.01 70.40 0.0286  
45 stu2-11 8.26 73.30 0.0408  
46 lcb1-10 8.35 58.60 0.0149  
47 lst8-6 8.85 68.69 0.0329  
48 elm1Δ 8.98 46.75 0.0176  
49 stu2-12 8.99 55.24 0.0116  
50 cik1Δ 9.02 57.19 0.0047  
51 mnn10Δ 9.38 46.61 0.0081  
52 mps3-7 9.40 43.24 0.0333  
53 arp1Δ 9.44 81.88 0.0034  
54 stp1Δ 9.83 80.72 0.0305  
55 orc2-4 9.93 74.93 0.0468  
56 mud2Δ 10.14 48.14 0.0037  
57 sub2-1 10.45 35.45 0.0088  
58 ssd1Δ 10.86 90.76 0.0497  
59 cdc28-4 10.99 62.28 0.0200  
60 afg2-18 11.16 57.09 0.0118  
61 spt5-194 11.17 57.34 0.0382  
62 swi4Δ 11.31 92.23 0.0495  
63 nup192-15 11.32 65.10 0.0331  
64 cdc8-2 12.30 88.38 0.0366  
65 cdc28-13 12.30 56.84 0.0461  
66 xrs2Δ 12.32 86.78 0.0159  
67 med8-51 12.73 59.44 0.0191  
68 pfy1-4 12.79 46.65 0.0294  
69 mre11Δ 14.13 66.29 0.0471  
70 bim1Δ 14.27 49.17 0.0270  
71 cdc33-E72G 14.33 57.95 0.0094  
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72 dam1-19 14.59 46.89 0.0021  
73 pri1-M4 15.66 79.81 0.0214  
74 sse1Δ 15.96 53.16 0.0385  
75 gas1Δ 17.47 77.04 0.0209  
76 mks1Δ 20.12 46.09 0.0164  
77 cdc4-3 20.20 67.39 0.0428  
78 rpo41Δ 20.34 72.04 0.0171  
79 tfa2-45 22.67 70.31 0.0223  
80 pol12-ts 24.92 62.32 0.0186  
81 gcr2Δ 26.82 41.63 0.0299  
82 enp1-1 30.34 67.76 0.0337  
83 ume6Δ 32.50 66.11 0.0210  
84 wbp1-1 33.11 72.31 0.0313  
85 rio2-1 35.75 65.69 0.0268  
86 pda1Δ 36.10 79.11 0.0205  
     
* p<0.05  indicates significant signal intensity difference between wild-type and mutant 
 
 
SUPPLEMENTARY FIGURE 
 
Supplementary Figure 3-1. Manual confirmation status of hits from HCM screening.  a) The 
distribution of the confirmation status of decreased Synphilin-1 inclusion formation hits, sorted based on 
their difference (from high to low) from the WT strain. Blue dots represented confirmed hits, and red ones 
represented unconfirmed mutants. b) Confirmation rate of hits with decrease Synphilin-1 inclusion 
formation rate. Bars showed the confirmation rate by manual confirmation with different cut off values.   
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Chapter 4 
Role of the ribosomal quality control machinery in 
nucleocytoplasmic translocation of polyQ-expanded 
huntingtin exon-1 
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Abstract 
The subcellular localization of polyQ-expanded huntingtin exon-1 (Httex1) modulates polyQ 
toxicity in models of HD. Using genome-wide screens in a yeast model system, we report that 
the ribosome quality control (RQC) machinery, recently implicated in neurodegeneration, is a 
key determinant for the nucleocytoplasmic distribution of Httex1-103Q. Deletion of the RQC 
genes, LTN1 or RQC1, caused the accumulation of Httex1-103Q in the nucleus through a 
process that required the CAT-tail tagging activity of Rqc2 and transport via the nuclear pore 
complex. We provide evidence that nuclear accumulation of Httex1-103Q enhances its 
cytotoxicity, suggesting that the RQC machinery plays an important role in protecting cells 
against the adverse effects of polyQ expansion proteins. 
 
Keywords: polyQ protein; Huntington’s disease; RQC; nucleocytoplasmic translocation 
 
4.1. Introduction 
HD is a neurodegenerative disorder caused by mutations expanding the CAG repeats in the 
exon-1 of Htt. These mutations result in expanded polyQ regions in the N-terminus of the 
mutant protein. The expanded polyQ region is responsible for polyQ aggregation and this is 
intimately linked with the Htt-mediated cytotoxicity that is typically associated with HD 
(Mangiarini et al., 1996). However, the exact mechanisms by which polyQ-expanded Httex1 
causes cytotoxicity remain unclear. Although no conserved NLS have been identified in Htt, 
full-length and truncated N-terminal fragments of polyQ-expanded Htt have been reported to 
localize both in the cytoplasm and nucleus (Davies et al., 1997; DiFiglia et al., 1997; Saudou 
et al., 1998). These observations point towards a potential role of the nuclear localization of 
the polyQ protein in HD pathology. In a knock-in mouse polyQ toxicity model, expression of 
a polyQ construct that contains a NLS directed the majority of the polyQ proteins to the 
nucleus, which in turn was associated with enhanced toxicity and behavioral abnormalities 
(Schilling et al., 2004). Moreover, studies in a striatal cell model revealed that the nuclear 
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localization of polyQ-expanded Httex1 induced cell death by an apoptotic mechanism 
(Saudou et al., 1998). Later studies in yeast revealed that polyQ proteins interfered with 
protein quality control and clearance of misfolded proteins through sequestration of Sis1, an 
essential chaperone of the Hsp40 family (Park et al., 2013). However, the mechanisms 
involved in distribution of polyQ-expanded Httex1 between the cytoplasm and the nucleus 
remain to be elucidated. 
The translation of truncated mRNAs or NS mRNAs results in ribosome stalling (Doma and 
Parker, 2006a; Inada and Aiba, 2005) and the dissociation of the stalled ribosomes into the 
40S and 60S subunits (Brandman et al., 2012; Shao et al., 2013). The RQC complex, which 
comprises Ltn1/Rkr1, Rqc1, Rqc2/Tae2 and Cdc48 (Bengtson and Joazeiro, 2010; Brandman 
et al., 2012; Defenouillère et al., 2013), recognizes the 60S subunit and the aberrant nascent 
chain (NC). Rqc2 first binds to the 60S subunit, and recruits the RING domain E3 ubiquitin 
ligase Ltn1 (Defenouillère et al., 2013; Lyumkis et al., 2014; Shao et al., 2015) to ubiquitinate 
the aberrant NC to facilitate its degradation via the proteasome (Lyumkis et al., 2014; Shao et 
al., 2015; Shen et al., 2015). Meanwhile, Rqc2 adds carboxy-terminal Ala and Thr extensions 
(CAT-tails) to the stalled NC(Shen et al., 2015), and these CAT-tails have been shown to 
trigger aggregation of the NCs (Choe et al., 2016; Defenouillère et al., 2016; Yonashiro et al., 
2016). 
The yeast model has previously been used to study the toxicity of polyQ proteins (Gong et al., 
2012; Meriin et al., 2002; Wang et al., 2009), and overexpression suppressor screens and 
screens based on the genome-wide deletion collection have been performed in order to 
elucidate the mechanisms and processes by which polyQ proteins induce cytotoxicity and to 
identify toxicity modifiers (Kayatekin et al., 2014; Mason et al., 2013; Willingham et al., 
2003). Recently, Yang et al. established an image-based HCM system to identify the players 
involved in IB formation of a form of Httex1 with a 103Q repeat containing the proline-rich 
region of wild-type Htt (Supplementary Fig. 4-1A, right box). This revealed the involvement 
of the RQC-Hsf1 system to direct compartmentalization of polyQ-expanded Httex1 (Yang et 
al., 2016). Moreover, disruption of the RQC system by mutation of Listerin, the mammalian 
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homologue of LTN1, was shown to trigger neurodegeneration (Chu et al., 2009), while 
mutation of a central-nervous-system-specific tRNA was found to cause ribosome stalling and 
enhanced neurodegeneration (Ishimura et al., 2014).  
In order to further investigate factors that alter the subcellular localization of polyQ-expanded 
Httex1, we performed a HCM screen in yeast using a toxic polyQ form of polyQ-expanded 
Httex1, Httex1-103Q, lacking the polyPro sequence (Supplementary Fig. 4-1A, left box) 
(Meriin et al., 2002). Surprisingly, we found that Httex1-103Q specifically accumulates in the 
nucleus in Ltn1-deficient cells. We also found that the RQC plays a key role in regulating the 
nuclear localization and toxicity of Httex1-103Q. In addition, we demonstrate that the nuclear 
pore complex (NPC) is required for nucleocytoplasmic transport of Httex1-103Q and that 
blocking nuclear import rescues the toxicity caused by this polyQ protein. 
4.2. Materials and methods 
4.2.1. S. cerevisiae strains 
S. cerevisiae strains used in this study are listed in Supplementary Table 4-3. For the setup of 
the screens, the following starting query strains were constructed: Y7092 (see Supplementary 
Table 4-3 and reference (Tong and Boone, 2007) for more details) containing the 
pYES2-Httex1-103Q-GFP plasmid; ltn1Δ in the Y7092 background containing the 
pYES2-Httex1-103Q-GFP. The yeast single gene knock-out collection (SGA-V2)(Tong et al., 
2001; Tong et al., 2004) and the essential gene temperature sensitive allele collection 
(ts-V5)(Li et al., 2011) were used as starting yeast collections for the query strain Y7092 
pYES2-Httex1-103Q-GFP and ltn1Δ Y7092 pYES2-Httex1-103Q-GFP.  
4.2.2. Growth conditions 
SGA-V2 yeast cells were maintained and pre-cultured at 30°C. Temperature sensitive strains 
were kept at 22°C. The strains were grown on YPD or minimal selective medium 
supplemented with 2% glucose.  
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For the induction of Httex1-103Q expression, the yeast cells were diluted to OD600nm=0.1 in 
minimal selective medium supplemented with 2% raffinose and grown at 30°C till an OD600nm 
of 0.5. Subsequently 2% galactose was added to culture medium and the cells were grown at 
30°C for 3 hours, unless otherwise indicated. 
Raffinose and galactose were dissolved in dd H2O, at a final concentration of 20% (w/v) and 
sterilized by filtration using filters with 0.2 μm pore size. Minimal selective medium were 
also filter sterilized. 
4.2.3. Plasmids 
All plasmids used in this study are listed in Supplementary Table 4-4. The polyQ construct 
used in this study consists of the N-terminal attached FLAG, exon-1 of HTT lacking the 
proline-rich region (PRR), and the C-terminal fusion GFP, under the control of GAL1 
promoter (Supplementary Fig. 4-1a, left box)(Meriin et al., 2002). The constructs were 
subcloned into the pYES2 vector. 
4.2.4. Strains and plasmids construction 
The pYES2-Httex1-103Q-GFP plasmid was transformed into the query stains Y7092 and 
ltn1Δ Y7092. This generated respectively Y7092 pYES2-Httex1-103Q-GFP, ltn1Δ Y7092 
pYES2-Httex1-103Q-GFP. The query strain Y7092 pYES2-Httex1-103Q-GFP was then used 
for the construction of the Httex1-103Q-GFP SGA collection, a yeast single gene knock-out 
collection containing the plasmid pYES2-Httex1-103Q-GFP, which was applied to the 
HCM-based screen. Similarly, the query strain ltn1Δ Y7092 pYES2-Httex1-103Q-GFP was 
used for the construction of the ltn1Δ Httex1-103Q-GFP SGA collection, a collection 
containing double gene knock-out strains and the plasmid pYES2-Httex1-103Q-GFP. The 
ltn1Δ Httex1-103Q-GFP SGA collection was used for identifying suppressors of toxicity 
caused by pYES2-Httex1-103Q-GFP in the ltn1Δ background. All the collections were 
constructed using the SGA methodology described as Tong et al.(Tong et al., 2001; Tong et al., 
2004). 
-98- 
The plasmids pY2H-Httex1-103Q-GFP and pY2H-Httex1-103Q-mRFP were generated based 
on the plasmids pYES2-Httex1-103Q-GFP and pYES2-Httex1-103Q-mRFP, the coding 
sequence of URA3 in pYES2-Httex1-103Q-GFP and pYES2-Httex1-103Q-mRFP was 
replaced by the HphMX4 marker via PCR-mediated gene deletion, the HphMX4 cassette was 
amplified from the template plasmid pAG32. 
The Molecular Barcoded Yeast (MoBY) plasmid, used in the complementation study, was 
made compatible with pYES2-Httex1-103Q-GFP in the double gene knock-out strains, by 
replacing the coding sequence of URA3 in the MoBY plasmid with a LEU2 cassette. The 
template used to amplify the LEU2 cassette is the PRS415 plasmid. 
4.2.5. DAPI staining 
To visualize the nucleus, we used DAPI to stain the DNA. Yeast samples with different 
fluorescence labeled proteins were fixed using 3.7% formaldehyde at RT for 30 min, washed 
with 1X PBS for 3 times. Cells were then incubated in 0.1 μg/mL DAPI at RT for 30 min and 
finally washed 3 times with 1X PBS. 
4.2.6. HCM-based screen system 
All strains from the Httex1-103Q-GFP SGA collection were laid out on a Singer Plus Plate. 
The cells were then transferred to a 96-well plate with minimal selective liquid medium for 
pre-culture, using a SINGER ROTOR HDA Robot (Singer Instrument Co. Ltd). The cells 
were grown at 30°C for 2 days. The OD600nm of the cells was measured in each well by a 
microplate reader (POLARstar Omega, BMG LABTECH). The cells were diluted to 
OD600nm=0.1 in minimal selective medium with 2% raffinose, using liquid handling 
workstation (Hamilton). The OD600nm of the cells was adjusted when necessary and  the cells 
were kept shaking at 30°C until the OD600nm reached 0.5. Next, 2% galactose was added to the 
culture medium, using the liquid handling workstation. Then the cells were incubated again at 
30°C for 3 hours while shaking, to induce the expression of Httex1-103Q. After this, the cells 
were fixed in 3.7% of formaldehyde at room temperature for 30 min in 96-well plates, and 
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washed with 1XPSB for three times. Cells were stained by 0.1 μg/mL of DAPI for 30 min 
before visualization with a fluorescence microscope. A HCM system was applied for 
acquisition of the images. This system includes an automated high content microscope 
ImageXpress MICRO (MDC) and MetaXpress software which can be used to quantify cells 
with different characters. For each sample 15 images were obtained and analyzed and all 
samples were analyzed in double in a separate parallel experiment.  
4.2.7. Conventional fluorescence microscopy 
Cell samples with fluorescently labeled proteins, or stained by a fluorescent dye, were 
prepared as described in the section 4.2.2 Growth conditions, samples were visualized and 
imaged using the Zeiss Axiovert 200M inverted microscope, equipped with apotome and an 
AxioCam MR camera, using filtersets: 38 HE eGFP in green channel, and 49 DAPI in blue 
channel. An exposure time of 200 ms was set for GFP labeled 103Q protein, using the green 
channel. And an exposure time of 50 ms was set for DAPI signal, using the blue channel. 
4.2.8. Super-resolution 3D-SIM 
Sample preparation was performed similarly as described in the section 4.2.2 Growth 
conditions.  
For super-resolution 3D-SIM, we used the same setting as previously described(Song et al., 
2014). Excitation light wavelengths of 405nm (DAPI), and 488nm (GFP) were used 
respectively. Image acquisition, super-resolution processing and calculation were performed 
by ZEN black 2-1SP1 (Carl Zeiss, Jena, Germany).  
4.2.9. Western blot analysis 
Western blots were carried out as previous described (Yang et al., 2016). 
4.2.10. Cell quantification and statistics 
To specify the level of nuclear accumulation of Httex1-103Q, we quantified the “Class 1 cells 
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with 103Q nuclear accumulation (%)”. These Class 1 cells are defined as cells that contain 
only one Httex1-103Q aggregate/inclusion, which shows an overlap with the DAPI signal. All 
cells were quantified using the Image J software. At least 500 cells were quantified in total 
and three replicates were analyzed for each condition. 
To compare mean values between two samples, an unpaired two-tailed t-test was used, 
statistical significance was indicated as * p<0.05; ** p<0.01; *** p<0.001. 
4.2.11. Generation time determinations 
Yeast cells were grown to saturation in medium with glucose as the sole carbon source. Then 
the cells were diluted in medium with raffinose to OD600nm =0.1 and incubated at 30°C while 
shaking until an OD600nm of 0.5 was reached. Subsequently, the OD600nm was adjusted to 0.01 
in medium with galactose, which induces Httex1-103Q expression. Samples were applied to 
the Bioscreen C equipment, which enables the measurement of the cell’s OD600nm 
automatically. Generation time (doubling time) was determined by analyzing the OD600nm of 
the cells at different time point, as described by Warringer and Blomberg (Warringer and 
Blomberg, 2003). The results were calculated from the mean of five repeats. 
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4.3. Results 
4.3.1. A genome-wide HCM screen reveals a role for the RQC in 
nucleocytoplasmic translocation of Httex1-103Q. 
Since neuronal intranuclear inclusions were described in HD mouse models (Davies et al., 
1997; DiFiglia et al., 1997) and nuclear localization of mutant Htt was shown to be critical for 
HD pathology (Peters et al., 1999; Saudou et al., 1998), we sought to study the mechanisms 
involved in the intracellular distribution of polyQ-expanded Httex1 in more detail. To this end 
we opted to use the HCM approach and introduced the galactose-inducible Httex1-103Q-GFP 
construct (Supplementary Fig. 4-1A, left box) (Meriin et al., 2002) into the yeast 
genome-wide single deletion array (SGA-V2) with ~4700 yeast mutants (Tong et al., 2001) 
and the yeast temperature-sensitive (ts) conditional mutant array (ts-V5) with ~500 ts mutants 
(Li et al., 2011) (Fig. 4-1A, B). In the corresponding wild-type (WT) strains, 
Httex1-103Q-GFP formed multiple aggregate foci that are mainly distributed throughout the 
cytoplasm (Meriin et al., 2002), though a small proportion was observed to reside in the 
nucleus (Fig. 4-1C panel 1, D).  
To identify factors affecting the intracellular distribution of Httex1-103Q-GFP, expression 
was induced by galactose for 3h, and then the cells were stained with DAPI to visualize the 
nucleus. Images were taken using a HCM in both the GFP and DAPI channels (Fig. 4-1B). 
Manual inspection of the images confirmed that the distribution of Httex1-103Q-GFP was 
indeed altered in some mutant strains. For further analysis, we focused on those mutant strains 
where a significant increase of Httex1-103Q-GFP in the nucleus was observed. We manually 
confirmed that deficiency of Ltn1, Rqc1, Rnq1 or Hsf1, caused the accumulation of 
Httex1-103Q-GFP in the nucleus, albeit to a different extent (Fig. 4-1C, D, Supplementary 
Table 4-1). In the ltn1Δ strain, approximately 20% of Httex1-103Q-GFP was exclusively 
localized in the nucleus (Class 1 cells with 103Q nuclear accumulation) (Fig. 4-1C panel 2, D 
and E). For the rqc1Δ, rnq1Δ and the ts-allele hsf1-848, this number was lower, ~2%, ~5% 
and ~5%, respectively, though this was still markedly higher than the ~0.5% obtained for the 
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WT strain. 
 
 
 
Figure 4-1. A genome-wide HCM screening identified loss-of-function genes that cause nuclear 
accumulation of Httex1-103Q. (A) Schematic representation of the yeast library construction used in this 
study. 103Q represents the plasmid pYES2-Httex1-103Q-GFP; xxx represents a gene that has been knocked 
out in a strain of the yeast knock-out collection; SGA, synthetic genetic array. (B) Main procedure followed 
for the HCM screen. Sample preparation is described in material and methods. Images were obtained in 
both GFP and DAPI channels. (C) Fluorescence images of mutants identified from the HCM screen that 
show nuclear accumulation of Httex1-103Q, nuclear Httex1-103Q was indicated by a yellow arrow. Scale 
represents 3 μm. (D) Quantification of cells which show nuclear accumulation of Httex1-103Q in class 1 
cells in the indicated strains as described in C. Class 1 cell is defined as a cell that contains only one 
aggregate/inclusion. At least 500 cells were quantified in total and N=3, *p<0.05, **p<0.01, ***p<0.001. 
(E) Super-resolution microscopy revealed the morphology and localization of Httex1-103Q-GFP in ltn1Δ 
cells. The cells were stained with DAPI (blue). Scale represents 1 μm. 
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Since Ltn1 and Rqc1 are core components of the RQC complex (Brandman et al., 2012), our 
data suggest that the RQC machinery plays a crucial role in managing nuclear accumulation 
of polyQ-expanded Httex1. Rnq1 is a yeast prion that was previously shown to be required for 
aggregate formation by polyQ-expanded Httex1(Meriin et al., 2002), and indeed, overall 
aggregation of Httex1-103Q-GFP in the RNQ1 mutant was low and Httex1-103Q-GFP 
accumulated in the nucleus in ~5% of cells. Hsf1 was previously reported to sense 
RQC-mediated translation-stress (Brandman et al., 2012), and thus the nuclear localization of 
Httex1-103Q-GFP in the hsf1-848 mutant may be due to an altered chaperone pool. 
4.3.2. Deficiency of the Ltn1 RING domain causes nuclear accumulation 
of Httex1-103Q 
Ltn1 functions as a RING domain-dependent E3 ubiquitin ligase in quality control of NS 
proteins. To investigate whether the RING domain of Ltn1 is required for regulating the 
nuclear localization of the polyQ protein, we expressed Httex1-103Q-GFP in cells containing 
an Ltn1 mutant with a RING domain deletion (Ltn1-ΔRING). As shown in Supplementary 
Fig. 4-1B, C, the lack of this RING domain caused Httex1-103Q-GFP to accumulate in the 
nucleus as efficiently as in ltn1Δ cells. In addition, we mutated Trp-1542 in the RING domain 
of Ltn1 to either Ala or Glu. These changes were predicted to lower the E2 binding affinity of 
Ltn1 and to impair NS-protein degradation (Bengtson and Joazeiro, 2010). In both the 
W1542A and W1542E Ltn1 mutant strains, nuclear accumulation of Httex1-103Q-GFP was 
observed, although the effect was not as strong as in the ltn1Δ or Ltn1-ΔRING strains 
(Supplementary Fig. 4-1B, C). Thus, deficiency of the Ltn1 RING domain appears to be 
sufficient to trigger nuclear accumulation of Httex1-103Q. 
Next, we asked whether nuclear accumulation of Httex1-103Q might be caused by a general 
failure in ubiquitin-mediated protein degradation. To test this possibility, we deleted the RPN4 
gene, a transcription factor that stimulates expression of proteasome genes. Since proteasomal 
degradation occurs to a large extent in the nucleus (McDonald and Byers, 1997), we expected 
Httex1-103Q-GFP to accumulate in the nucleus of rpn4Δ cells in case the protein is targeted 
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for degradation in this compartment. However, Httex1-103Q-GFP remained mainly 
cytoplasmic in rpn4Δ cells as well as in WT cells treated with the proteasome inhibitor 
MG132 (Supplementary Fig. 4-1E). In contrast, Httex1-103Q-GFP was clearly nuclear in 
rqc1Δ cells in which the Ltn1-mediated ubiquitination is still functional (Fig. 4-2A, 
B)(Brandman et al., 2012; Defenouillère et al., 2013; Yonashiro et al., 2016). This implies that 
the nuclear accumulation of Httex1-103Q is not simply due to deficient nuclear degradation 
of Httex1-103Q in the ltn1∆ cells, though it remains to be investigated how the Ltn1 RING 
domain functions in regulating nucleocytoplasmic translocation of Httex1-103Q. 
4.3.3. Rqc2 is required for nuclear accumulation of Httex1-103Q 
Within the RQC complex, Rqc2 is required for efficient recruitment of Ltn1 to translationally 
stalled proteins (Shao et al., 2015; Shen et al., 2015). Given this central role of Rqc2, we also 
investigated the requirement of Rqc2 for nuclear accumulation of Httex1-103Q. The 
distribution of Httex1-103Q-GFP in the single rqc2Δ deletion strain was similar to that 
observed in the WT strain with inclusions being located in the cytoplasm (Fig. 4-2A, B). 
Surprisingly, however, when the RQC2 deletion was introduced in the ltn1Δ or rqc1Δ 
background it caused the complete suppression of the nuclear accumulation of 
Httex1-103Q-GFP (Fig. 4-2A, B). This suggests that Rqc2 has a crucial role in maintaining 
nuclear accumulation of Httex1-103Q in Ltn1 or Rqc1 mutant cells. As it was reported that 
Rqc2-dependent CAT-tails are present on NCs in ltn1Δ cells or rqc1Δ cells (Choe et al., 2016; 
Shen et al., 2015; Yonashiro et al., 2016), we wondered whether the CAT-tailing activity of 
Rqc2 would be necessary for nuclear accumulation of Httex1-103Q. To test this idea, we 
expressed in ltn1Δrqc2Δ cells either WT Rqc2 or the so-called Rqc2aaa variant that fails to 
synthesize CAT-tails but is still able to recruit Ltn1 to the 60S ribosome (Choe et al., 2016; 
Shen et al., 2015). As expected, the expression of WT Rqc2 fully restored the nuclear 
accumulation of Httex1-103Q-GFP in the ltn1Δrqc2Δ cells, while this was not the case upon 
Rqc2aaa expression (Fig. 4-2C, D). These results demonstrate that CAT-tailing activity of Rqc2 
is required for the nuclear accumulation of Httex1-103Q in RQC-deficient cells. 
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Figure 4-2. Role of RQC in regulating nuclear accumulation of Httex1-103Q. (A) Mutation of certain 
RQC genes alters the distribution of Httex1-103Q. Fluorescence images of WT or indicated RQC mutants 
overexpressing Httex1-103Q (green). Scale represents 3 μm. (B) Quantification of cells which show 
nuclear accumulation of Httex1-103Q in Class 1 cells in the indicated strains as described in A. (C) 
Representative fluorescence images showing the co-expression of empty vector (p413), RQC2 WT or 
variant rqc2aaa with Httex1-103Q in ltn1Δrqc2Δ cells. Scale represents 3 μm. (D) Quantification of cells 
which show nuclear accumulation of Httex1-103Q in Class 1 cells in indicated strains as described in C. 
*p<0.05, **p<0.01, ***p<0.001. 
4.3.4. Btn2 is involved in nucleocytoplasmic transport of Httex1-103Q 
The protein-sorting factor Btn2 and the chaperone Hsp42 direct misfolded proteins to the 
intranuclear quality control compartment (INQ) and to CytoQ deposition sites in the cytosol, 
respectively (Miller et al., 2015). 3D-SIM analysis revealed that Httex1-103Q-GFP does not 
reside at such specific compartments but rather remains randomly distributed in the nucleus of 
ltn1Δ cells (Fig. 4-1E). However, mild overexpression of Btn2 is sufficient to block nuclear 
accumulation of Httex1-103Q in ltn1Δ cells, whereas the level of nuclear accumulation of 
Httex1-103Q increased in ltn1Δbtn2Δ cells as compared to WT cells and the single ltn1Δ 
deletion mutant (Fig. 4-3A, B). This result points to a role of Btn2 in the nucleocytoplasmic 
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translocation of Httex1-103Q. In line with this finding, Btn2 was previously shown to be 
sequestered in the aggregates of NS-proteins in ltn1Δ cells (Choe et al., 2016), which leads to 
the assumption that sequestration of Btn2 in endogenous NS-protein aggregates may cause the 
nuclear accumulation of Httex1-103Q in ltn1Δ cells. Notably, neither the single deletion of 
BTN2 (Fig. 4-3A, B), nor the double deletion of BTN2 and CUR1 (homolog of BTN2) 
(Supplementary Fig. 4-2A, B), caused nuclear accumulation of Httex1-103Q, indicating that 
other factors also contribute to the process of Httex1-103Q nuclear accumulation.  
 
 
 
Figure 4-3. Btn2 counteracts the nuclear accumulation of Httex1-103Q in ltn1Δ cells. (A) Fluorescence 
images of Httex1-103Q (green) expression in the indicated strains. Samples were collected after three hours 
galactose induction. MoBY indicates molecular barcoded yeast, a low copy vector carrying the 
corresponding ORF or empty vector as control. The DNA was stained with DAPI (blue). Scale represents 3 
μm. (B) Quantification of cells which shows nuclear accumulation of Httex1-103Q in Class 1 cells in the 
indicated strains as described in A. At least 500 cells were quantified in total and N=3, *p<0.05, **p<0.01, 
***p<0.001, NS, not significant. 
 
The small heat shock protein, Hsp42, is known to direct the cytosolic misfolded proteins into 
special deposition sites called CytoQ in the yeast cytosol (Miller et al., 2015). To test whether 
Hsp42 plays a role in regulating the localization of Httex1-103Q, we analyzed Httex1-103Q 
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aggregate localization in both Hsp42 mild overexpression and HSP42 deletion strains. In 
contrast to Btn2, neither mild overexpression nor deletion of HSP42 in ltn1Δ cells altered the 
nuclear accumulation of Httex1-103Q (Fig. 4-3A, B). 
4.3.5. Nuclear accumulation of Httex1-103Q enhances its cytotoxicity 
Genome-wide screens for suppressors of Httex1-103Q toxicity in yeast have been performed 
both in single gene deletion (Willingham et al., 2003) and gene overexpression collections 
(Kayatekin et al., 2014; Mason et al., 2013). As expression of Httex1-103Q produce 
significant toxicity in yeast (Meriin et al., 2002), and nuclear accumulation of Httex1-103Q 
enhances polyQ cytotoxicity in ltn1Δ background (Fig. 4-4C, D and E, panel 1 and 2), we set 
out to identify factors that contribute to Httex1-103Q-induced cytotoxicity in ltn1Δ cells. To 
this end, we constructed a yeast double deletion collection, in which each of the single 
deletion strains was combined with the additional deletion of LTN1 and the expression of 
Httex1-103Q-GFP (Supplementary Fig. 4-3). We assessed Httex1-103Q cytotoxicity in 
different double deletion strains by scoring the size of the colonies (Wagih and Parts, 2014) 
and found that the additional loss of several NPC components (Nup60, Nup170, Nup188) and 
one karyopherin (Kap108) significantly suppressed the Httex1-103Q toxicity in the ltn1Δ 
background (Fig. 4-4D, E). Fluorescence microscopy demonstrated that Httex1-103Q-GFP no 
longer entered the nucleus in the ltn1Δnup60Δ, ltn1Δnup170Δ, ltn1Δnup188Δ or 
ltn1Δkap108Δ double deletion mutants (Fig. 4-4A, B). Hence, these results indicated that the 
core scaffold of the NPC, Nup170 and Nup188, as well as the nuclear import factor Kap108 
(ortholog of vertebrate Importin 8) are essential for nuclear entry of Httex1-103Q in ltn1Δ 
cells.  
Subsequent complementation assays further strengthened this conclusion. Indeed, mild 
overexpression of MoBY-NUP60 in ltn1Δnup60Δ cells or MoBY-NUP170 in ltn1Δnup170Δ 
cells was sufficient to restore the nuclear accumulation of Httex1-103Q-GFP (Supplementary 
Fig. 4-4A, B). 
Next, we wondered if other NPCs or karyopherins could mediate nuclear localization and 
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cytotoxicity of Httex1-103Q. This was again performed by testing nuclear accumulation and 
cytotoxicity of Httex1-103Q-GFP in ltn1Δ cells in which non-essential NPC components and 
karyopherins were additionally deleted (Fig. 4-4C, D and E). Besides the core scaffold NPC 
subunits Nup170 and Nup188 and the karyopherin Kap108, Nup60, Mlp1 and Mlp2 were also 
found to be essential for nuclear accumulation and cytotoxicity of Httex1-103Q in the ltn1Δ 
background, while the Ran-GTP Gsp2, which mediates nuclear import of cargo, was not. The 
latter suggests that nucleocytoplasmic transport of mutant Htt could occur independently of 
Ran GTPase function, as previously observed (Cornett et al., 2005). However, it should be 
noted that yeast cells encode a Gsp2 paralogue, Gsp1, which may provide sufficient Ran-GTP 
activity to mediate nuclear import of Httex1-103Q in the absence of Gsp2. 
Finally, we analyzed the correlation between Httex1-103Q nuclear accumulation and 
cytotoxicity. We found that the generation time of the cells increased as more Httex1-103Q 
accumulated in the nucleus (r=0.568, P=0.007, N=21) (Fig. 4-4F). This indicates that nuclear 
accumulation of Httex1-103Q might be critical for toxicity, in line with earlier studies 
performed in mammalian cells where nuclear targeting of polyQ-expanded Htt also enhanced 
its toxicity (Peters et al., 1999; Saudou et al., 1998; Schilling et al., 2004). 
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Figure 4-4. Nuclear Pore Complex (NPC) and karyopherins mediate nucleocytoplasmic transport 
and cytotoxicity of Httex1-103Q. (A) Representative fluorescence images of nuclear transport related 
mutants in ltn1Δ background expressing Httex1-103Q. Scale represents 3 μm. (B) Quantification of Class1 
cells which shows nuclear accumulation of Httex1-103Q in the indicated strains as described in A. (C) 
Quantification of cells which shows nuclear accumulation of Httex1-103Q in Class 1 cells in the nuclear 
transport related mutants in ltn1Δ background. (D) Fitness of cells carrying the pYES2-Httex1-103Q-GFP 
plasmid compared to the pYES2-GFP control plasmid in mutants indicated in C. Generation time was 
calculated as described in the methods section, N=5. (E) Spot test to confirm the growth defect of strains as 
indicated in C. Five-fold serial dilutions of cells are shown, starting from OD600nm =0.5. (F) Graph of 
dispersion reveals a positive relationship between the level of 103Q nuclear accumulation and generation 
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time. Correlation coefficient (r) and significance of the correlation coefficient P-value (P) were calculated 
based on the average of “Class 1 cells with 103Q nuclear accumulation (%)” and the average of 
“Generation time (h)” of each strain indicated in C, N=21. 
4.4. Discussion 
Previous studies have linked the nucleocytoplasmic trafficking of polyQ-expanded Htt to the 
pathology of HD. PolyQ-expanded Htt has indeed been reported to be distributed both in the 
cytoplasm and the nucleus (Davies et al., 1997; DiFiglia et al., 1997), and neuronal 
intranuclear inclusions were suggested to contribute to neurological dysfunction in a 
transgenic mouse model for HD (Davies et al., 1997).  
Taking advantage of the novel HCM system, we identified the RQC machinery as a regulator 
of nucleocytoplasmic translocation of Httex1 polyQ proteins in yeast and confirmed that 
nuclear accumulation of polyQ proteins contributes to cytotoxicity in the yeast model. We 
found that the RQC complex component, Ltn1, plays a critical role in protecting yeast cells 
against nuclear accumulation and cytotoxicity of Httex1-103Q. This is in line with the 
observation that deficiency of Ltn1 causes neurodegeneration in mice (Chu et al., 2009), and 
that Ltn1 is involved in inclusion formation of Httex1 (Yang et al., 2016). Another component 
of the RQC complex, Rqc2, mediates the mRNA-independent elongation of NCs and marks 
the aberrant NS-proteins with CAT-tails for aggregation (Choe et al., 2016; Yonashiro et al., 
2016). Our observation that the CAT-tailing activity of Rqc2 is required for the nuclear 
accumulation of Httex1-103Q, points to a link between the aggregation of endogenous 
NS-proteins and the import of Httex1-103Q into the nucleus. The RQC surveillance system 
works to clear endogenous NS-proteins which are generated during translation. As such, 
failure of the RQC surveillance system results in increased endogenous NS-inclusions. In turn, 
these NS-inclusions are known to sequester other proteins, such as Btn2 (Choe et al., 2016). 
We found that mild overexpression of BTN2 is sufficient to block the nuclear accumulation of 
Httex1-103Q in ltn1Δ cells. This could be due to the imbalance of transport factors caused by 
the formation of the NS-protein aggregate in the ltn1Δ background (Fig. 4-5).  
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Figure 4-5. Schematic model for the RQC machinery in regulating nucleocytoplasmic translocation 
of Httex1-103Q. Httex1-103Q distributes both in the cytoplasm and the nucleus upon overexpression. 
Components of the NPC including Nup60, Nup170, Nup188, and karyopherin Kap108 mediate the import 
of Httex1-103Q. In WT cells, when the RQC system works efficiently, expression of Httex1-103Q largely 
aggregate in the cytoplasm. The RQC system regulates the transport/distribution of Httex1-103Q, by 
affecting the endogenous NS-inclusions formation, as NS-inclusions can sequester proteins (e.g. Btn2, 
Choe et al., 2016) that are involved in regulating the nucleocytoplasmic translocation of Httex1-103Q. 
Other factors that contribute to the RQC-dependent nucleocytoplasmic translocation of Httex1-103Q 
remain to be elucidated. In ltn1∆ cells, defective RQC surveillance results in increased endogenous 
NS-inclusions (Choe et al., 2016). Spatial sequestration of proteins by NS-inclusions, leads to limited 
factors that are required for the export of Httex1-103Q, which is responsible for the nuclear accumulation 
of Httex1-103Q. 
 
It remains unclear whether the expression of Httex1-103Q affects the capacity of the RQC 
machinery or not. Expression of Httex1-103Q may  instigate ribosomal stalling by 
sequestering the translation termination factor Sup35, in the Httex1-103Q aggregates 
(Serpionov et al., 2016), thereby enhancing  translation read-though of stop codons (Gong et 
al., 2012) and increasing pressure on the RQC system. Hence, aberrant translation of polyQ 
protein at the ribosome may have an important role in the polyQ-induced toxicity in yeast. 
Several studies have shown that the nuclear accumulation of Htt fragments is linked to 
HD-like phenotypes (Peters et al., 1999; Schilling et al., 2004) and the induction of neuronal 
apoptosis (Saudou et al., 1998). In line with this, our data produced in yeast indicate that the 
cytotoxicity of Httex1-103Q is significantly reduced when preventing its nuclear import by 
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deletion of the nucleocytoplasmic transport factors.  
Nucleocytoplasmic translocation and the connection with cytotoxicity seem to be a general 
mechanism in disease pathogenesis. Recent studies in human embryonic kidney 293T cells 
demonstrated that cytoplasmic aggregates formed by artificial β-sheet proteins or by disease 
proteins like Htt96Q and TDP-43 fragments cause the sequestration and mislocalization of 
nuclear transport factors into the cytoplasm, which results in defects in nuclear protein import 
and mRNA export (Woerner et al., 2016). Likewise, screens performed in flies identified 
components of the NPC and different nuclear transport factors as modifiers of disease 
phenotypes and toxicity triggered by hexanucleotide repeat expansions in C9orf72, a gene 
associated to a mixed phenotype of frontotemporal dementia and amyotrophic lateral sclerosis 
(Zhang et al., 2015).We now report for the first time that the RQC system interferes with 
NPC-dependent nucleocytoplasmic translocation of Httex1-103Q so as to protect cells from 
polyQ protein cytotoxicity. Thus, enhancing the RQC capability or preventing nuclear import 
of polyQ proteins should be considered as possible strategies for the treatment of polyQ 
disorders. 
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4.5. Supplementary information 
SUPPLEMENTARY FIGURES 
 
 
Supplementary Figure 4-1. Nuclear accumulation of Httex1-103Q is not simply caused by a defect in 
the ubiquitination proteasome system (UPS). (A) Schematic representation of the polyQ construct of Htt 
exon1 lacking the proline-rich region (PRR) (left box, used in this study) (Meriin et al., 2002) and the 
polyQ construct of Htt exon1 with PRR (right box)(Meriin et al., 2007). (B) Fluorescence images show the 
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co-expression of Httex1-103Q and Ltn1 WT/Trp 1542 mutants (Bengtson and Joazeiro, 2010) in ltn1Δ cells. 
(C) Quantification of cells which show nuclear accumulation of Httex1-103Q in Class 1 cells. (D) Western 
blot analysis to detect protein Httex1-103Q expression and ubiquitination of Httex1-103Q from WT, ltn1Δ 
or rpn4Δ cells. Flag-Httex1-103Q-GFP was immunoprecipitated (IP) from cell extracts of WT, ltn1Δ or 
rpn4Δ cells with a FLAG antibody, and followed by anti-FLAG, anti-GFP and anti-Ub immunoblotting (IB) 
respectively. (E) Fluorescence images of Httex1-103Q (green) expression in WT, ltn1Δ or rpn4Δ cells, as 
well as in WT cells treated with the proteasome inhibitor MG132. Disruption of the UPS did not cause 
significant nuclear accumulation of Httex1-103Q. Samples were collected after three hours galactose 
induction, and the DNA was stained by DAPI (blue). Scale represents 3 μm. 
  
-115- 
 
 
Supplementary Figure 4-2. The expression level of Cur1 does not affect nuclear accumulation of 
Httex1-103Q in ltn1Δ cells. (A) Fluorescence images of Httex1-103Q (green) expression in the indicated 
strains. Samples were collected after three hours galactose induction. The DNA was stained by DAPI (blue). 
Scale represents 3 μm. (B) Quantification of cells which shows nuclear accumulation of Httex1-103Q in 
Class 1 cells in the indicated strains as described in A.  
  
-116- 
 
 
Supplementary Figure 4-3. Genome-wide screening to identify factors that suppress Httex1-103Q 
cytotoxicity in the ltn1Δ background. Schematic representation of the plasmid-carried double deletion 
yeast library construction and suppressor screen. 103Q represents plasmid pYES2-Httex1-103Q-GFP; xxx 
represents a gene that has been knocked out from the yeast knock-out collection; SGA, synthetic genetic 
array. 
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Supplementary Figure 4-4. Selected complementation assay to confirm the players that altered the 
nuclear accumulation of Httex1-103Q in the ltn1Δ background. (A) Fluorescence images of 
Httex1-103Q (green) expression in the selected NPC mutants nup60Δ/nup170Δ in the ltn1Δ background, 
while co-expressing with MoBY-NUP60/NUP170 respectively, and the empty MoBY vector (p5586) serves 
as a control. Nuclear accumulation of Httex1-103Q can be restored by adding back a low copy MoBY 
vector containing its corresponding ORF. Scale represents 3 μm. (B) Quantification of cells which show 
nuclear accumulation of Httex1-103Q in Class 1 cells in the indicated strains as described in A.  
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SUPPLEMENTARY TABLES 
Supplementary Table 4-1. Deficient genes that cause significant nuclear accumulation of 
Httex1-103Q. Related to Fig. 4-1 
 
Systematic 
name 
Standard 
name 
Class 1 cells with 103Q 
nuclear accumulation(%) 
YMR247C LTN1 18.89 
YGL073W HSF1 5.29 
YCL028W RNQ1 5.03 
YDR333C RQC1 2.01 
 
 
Supplementary Table 4-2. Loss-of-function suppressors of Httex1-103Q toxicity in the ltnΔ 
background. Related to Fig. 4 and S4. Hits with a score(Wagih and Parts, 2014) >0.8 were picked, and the 
growth effect by mutation of the hits confirmed by the Bioscreen C equipment (5 replicates for each sample) 
are listed in the table. 
 
 
  
Systematic 
name 
Standard 
name 
SGA score 
YFL023W BUD27 2.652012 
YBL079W NUP170 1.857465 
YPL009C RQC2 1.712615 
YCR063W BUD31 1.648322 
YDR002W yrb1-51 1.262108 
YOR083W WHI5 1.254718 
YPR176C bet2-1 1.200333 
YML103C NUP188 1.121265 
YHR003C YHR003C 0.9933 
YAR002W NUP60 0.961654 
YBR236C abd1-5 0.943247 
YOR061W CKA2 0.927038 
YLL026W HSP104 0.909933 
YLR335W NUP2 0.899871 
YIL112W HOS4 0.878885 
YGL019W CKB1 0.84491 
YBR082C UBC4 0.83923 
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Supplementary Table 4-3. S. cerevisiae strains used in this study 
 
NAME BACKGR
OUND 
GENOTYPE SOURCE 
BY4741 BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 EUROSCARF 
Y7092 BY4742 MATα can1∆::STE2pr-Sp_His3 lyp1∆ his3∆leu2∆ ura3∆ 
met15∆ 
Tong and 
Boone, 2001 
Y7092 103Q BY4742 MATα can1∆::STE2pr-Sp_His3 lyp1∆ his3∆leu2∆ ura3∆ 
met15∆ pYES2-Httex1-103Q-GFP 
This study 
Y7092 ltn1Δ 103Q BY4742 MATα  ltn1Δ::natMX4 can1∆::STE2pr-Sp_His3 lyp1∆ 
his3∆leu2∆ ura3∆ met15∆ pYES2-Httex1-103Q-GFP 
This study 
WT 103Q SGA MAT a his3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δ 103Q SGA MAT a ltn1Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
rnq1Δ 103Q SGA MAT a rnq1Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
rqc1Δ 103Q SGA MAT a rqc1Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
hsf1-848 103Q SGA MAT a hsf1-848::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP TS collection 
ltn1Δ 103Q 
pGAD-LTN1-HA 
SGA MAT a ltn1Δ::natMX4 his3Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pGAD-LTN1-HA pYES2-Httex1-103Q-GFP 
This study 
ltn1Δ 103Q 
pGAD-LTN1-W154
2A-HA 
SGA MAT a ltn1Δ::natMX4 his3Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pGAD-LTN1-W1542A-HA 
pYES2-Httex1-103Q-GFP 
This study 
ltn1Δ 103Q 
pGAD-LTN1-W154
2E-HA 
SGA MAT a ltn1Δ::natMX4 his3Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pGAD-LTN1-W1542E-HA 
pYES2-Httex1-103Q-GFP 
This study 
BY4741 
Ltn1-FLAG 103Q 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 LTN1-5xFLAG:: 
KANMX6 pYES2-Httex1-103Q-GFP 
This study 
BY4741 
RINGΔLtn1-FLAG 
103Q 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 ltn1 
Δ4452-5xFLAG::KANMX6 pYES2-Httex1-103Q-GFP 
This study 
rqc2Δ 103Q SGA MAT a rqc2Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ Httex1-103Q-G
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ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP-URA 
FP SGA 
collection 
ltn1Δrqc2Δ 103Q SGA MAT a ltn1Δ::natMX4 rqc2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
rqc1Δrqc2Δ 103Q SGA MAT a rqc1Δ::kanMX4 rqc2Δ::natMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2+  pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δrqc1Δ 103Q SGA MAT a ltn1Δ::natMX4 rqc1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δrqc2Δ p413 
103Q 
BY4741 BY4741 ltn1Δ::NatR rqc2Δ::KanR p413 
pYES2-Htt103Q-GFP 
This study 
ltn1Δrqc2Δ 
p413-RQC2 WT 
103Q 
BY4741 BY4741 ltn1Δ::NatR rqc2Δ::KanR p413-RQC2 WT 
pYES2-Htt103Q-GFP 
This study 
ltn1Δrqc2Δ 
p413-rqc2aaa 103Q 
BY4741 BY4741 ltn1Δ::NatR rqc2Δ::KanR p413-rqc2aaa 
pYES2-Htt103Q-GFP 
This study 
btn2Δ 103Q SGA MAT a btn2Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
hsp42Δ 103Q SGA MAT a hsp42Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 
pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δbtn2Δ 103Q SGA MAT a ltn1Δ::natMX4 btn2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δhsp42Δ 103Q SGA MAT a ltn1Δ::natMX4 hsp42Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δ 
pY2H-Httex1-103Q 
MoBY-BTN2 
BY4741 BY4741 ltn1Δ::Kan pY2H-Httex1-103Q-GFP 
MoBY-BTN2 
This study 
ltn1Δ 
pY2H-Httex1-103Q 
MoBY-HSP42 
BY4741 BY4741 ltn1Δ::Kan pY2H-Httex1-103Q-GFP 
MoBY-HSP42 
This study 
BTN2-GFP 
103Q-mRFP 
BY4741 BY4741 BTN2::GFP-HIS3 pYES2-Httex1-103Q-mRFP This study 
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ltn1Δ BTN2-GFP 
103Q-mRFP 
BY4741 BY4741  ltn1Δ::Nat BTN2::GFP-HIS3 
pYES2-Httex1-103Q-mRFP 
this study  
ltn1Δ 103Q SGA MAT a ltn1Δ::natMX4 his3Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δkap108Δ 
103Q 
SGA MAT a ltn1Δ::natMX4 kap108Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup60Δ 103Q SGA MAT a ltn1Δ::natMX4 nup60Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup170Δ 
103Q 
SGA MAT a ltn1Δ::natMX4 nup170Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup188Δ 
103Q 
SGA MAT a ltn1Δ::natMX4 nup188Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup59Δ 103Q SGA MAT a ltn1Δ::natMX4 nup59Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup42Δ 103Q SGA MAT a ltn1Δ::natMX4 nup42Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δgsp2Δ 103Q SGA MAT a ltn1Δ::natMX4 gsp2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δlos1Δ 103Q SGA MAT a ltn1Δ::natMX4 los1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δkap114Δ 
103Q 
SGA MAT a ltn1Δ::natMX4 kap114Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δkap120Δ SGA MAT a ltn1Δ::natMX4 kap120Δ::kanMX4 ltn1Δ 
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103Q can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δpom33Δ 103Q SGA MAT a ltn1Δ::natMX4 pom33Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δpom34Δ 103Q SGA MAT a ltn1Δ::natMX4 pom34Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δpom152Δ 
103Q 
SGA MAT a ltn1Δ::natMX4 pom152Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δpdr6Δ 103Q SGA MAT a ltn1Δ::natMX4 pdr6Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δhsn1Δ 103Q SGA MAT a ltn1Δ::natMX4 hsn1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δmlp2Δ 103Q SGA MAT a ltn1Δ::natMX4 mlp2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δmlp1Δ 103Q SGA MAT a ltn1Δ::natMX4 mlp1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup100Δ 
103Q 
SGA MAT a ltn1Δ::natMX4 nup100Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
ltn1Δnup2Δ 103Q SGA MAT a ltn1Δ::natMX4 nup2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-Httex1-103Q-GFP 
ltn1Δ 
Httex1-103Q-G
FP SGA 
collection 
WT vector SGA MAT a his3Δ::kanMX4 can1Δ::STE2pr-Sp_his5 lyp1Δ 
ura3Δ0 leu2Δ0  met15Δ0 LYS2 pYES2-GFP 
This study 
ltn1Δ vector SGA MAT a ltn1Δ::natMX4 his3Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
This study 
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LYS2 pYES2-GFP 
ltn1Δnup60Δ 
vector 
SGA MAT a ltn1Δ::natMX4 nup60Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δnup170Δ 
vector 
SGA MAT a ltn1Δ::natMX4 nup170Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δnup188Δ 
vector 
SGA MAT a tn1Δ::natMX4 nup188Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δnup59Δ 
vector 
SGA MAT a ltn1Δ::natMX4 nup59Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δnup42Δ 
vector 
SGA MAT a ltn1Δ::natMX4 nup42Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δgsp2Δ vector SGA MAT a ltn1Δ::natMX4 gsp2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δlos1Δ vector SGA MAT a ltn1Δ::natMX4 los1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δkap114Δ 
vector 
SGA MAT a ltn1Δ::natMX4 kap114Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δkap120Δ 
vector 
SGA MAT a ltn1Δ::natMX4 kap120Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δpom33Δ 
vector 
SGA MAT a ltn1Δ::natMX4 pom33Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δpom34Δ 
vector 
SGA MAT a ltn1Δ::natMX4 pom34Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δpom152Δ 
vector 
SGA MAT a ltn1Δ::natMX4 pom152Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δpdr6Δ vector SGA MAT a ltn1Δ::natMX4 pdr6Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δhsn1Δ vector SGA MAT a ltn1Δ::natMX4 hsn1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
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ltn1Δmlp2Δ vector SGA MAT a ltn1Δ::natMX4 mlp2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δmlp1Δ vector SGA MAT a ltn1Δ::natMX4 mlp1Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δnup100Δ 
vector 
SGA MAT a ltn1Δ::natMX4 nup100Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δnup2Δ vector SGA MAT a ltn1Δ::natMX4 nup2Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
ltn1Δkap108Δ 
vector 
SGA MAT a ltn1Δ::natMX4 kap108Δ::kanMX4 
can1Δ::STE2pr-Sp_his5 lyp1Δ ura3Δ0 leu2Δ0  met15Δ0 
LYS2 pYES2-GFP 
This study 
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Supplementary Table 4-4. Plasmids used in this study 
 
NAME SOURCE 
pYES2-Httex1-103Q-GFP Meriin et al., 2002 
pY2H-Httex1-103Q-GFP This study 
pYES2-GFP Preveral et al., 2006 
pY2H-GFP Lab stock 
pGAD-LTN1 Bengtson  et al., 2010 
pGAD-LTN1 W1542A Bengtson  et al., 2010 
pGAD-LTN1 W1542E Bengtson  et al., 2010 
p413 Choe et al., 2016 
p413RQC2- RQC2 WT Choe et al., 2016 
p413RQC2-rqc2aaa Choe et al., 2016 
p4339 Tong et al., 2001 
p5586 MoBY collection (Ho et al., 2009) 
MoBY-HSP42 MoBY collection (Ho et al., 2009) 
MoBY-BTN2 MoBY collection (Ho et al., 2009) 
MoBY-NUP60 MoBY collection (Ho et al., 2009) 
MoBY-NUP170 MoBY collection (Ho et al., 2009) 
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Chapter 5 
General discussion and future perspectives 
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Yeast is one of the best characterized eukaryotes with valuable features such as easy 
maintenance and culturing, rapid growth, as well as its well-characterized genome. 
Importantly, yeast and human share many aspects in cell biology and much of our 
fundamental biological knowledge comes from studies in yeast. In the past years, human 
disease-related proteins without a yeast ortholog have been successfully studied in yeast. 
These so-called humanized yeast models reproduce major features of the disease-related 
proteins similar as seen in mammalian model systems and, as such, the insights obtained from 
the studies in yeast have already contributed greatly to our understanding of the molecular 
mechanisms underlying the pathogenicity of these disease-related proteins (Braun et al., 2010; 
Fruhmann et al., 2017; Khurana and Lindquist, 2010; Winderickx et al., 2008). 
In this thesis, we used yeast as a model to investigate the PD-related protein Synphilin-1 and 
the HD-related protein Htt. More specifically, in the first part we focused on how genetic 
alterations affect Synphilin-1 inclusion formation. In the second part, we investigated the 
influence of genetic alterations on the distribution and translocation of the polyQ proteins. So 
far, these processes are poorly understood. However, it is critical to obtain a more detailed 
insight in the basic molecular mechanisms of these processes to be able to develop effective 
diagnostic biomarkers as well as therapies for both neurodegenerative diseases. Using 
different genome-wide yeast screens we were able to identify key players in both processes. 
Here, we discuss the main findings of these studies and their role in the protein misfolding 
research, especially in PD and HD research. 
5.1. Spatial sequestration of Synphilin-1 inclusion 
The PQC system ensures that protein synthesis and folding occurs accurately, therefore 
aberrant products will be recognized and targeted for degradation. However, overwhelming 
aberrant products or defects in the PQC system will lead to sequestration of misfolded 
proteins in specific cellular compartments such as aggresomes, JUNQ/INQ, IPOD and CytoQ 
(Miller et al., 2015). Spatial sequestration of misfolded proteins is a common strategy of the 
cell’s defense against various types of stress, for example, overexpression of aberrant proteins 
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such as high temperature induced misfolded Ubc9ts and unassembled VHL induce cellular 
compartment formation (Kaganovich et al., 2008; Miller et al., 2015); Heat-shock treatment 
also induces endogenous misfolded protein aggregation that associates with Hsp104 (Glover 
and Lindquist, 1998). Furthermore, microtubule-dependent aggresome formation was 
identified for several misfolded proteins (Kopito, 2000), including Synphilin-1 (Swinnen et al., 
2011; Zaarur et al., 2008). Interestingly, it was also shown that Lewy bodies, which include 
Synphilin-1, share many similar properties with aggresomes. These findings combined with 
the identification of cytoskeleton components as important players in Synphilin-1 inclusion 
formation suggests that small Synphilin-1 inclusions present in most of the cells during 
exponential phase merge into large inclusions in stationary phase by traveling along the 
microtubules or actin cytoskeleton to a specific cellular compartment such as aggresomes. 
These inclusions might also share some similarities to the heat-shock induced Hsp104 
associated aggregates, which are transported along actin cables to prevent aggregate 
accumulation in progeny (Liu et al., 2010; Swinnen et al., 2011). The exact mechanism of 
Synphilin-1 inclusion formation, however, is probably more complex, as Synphilin-1 
inclusion formation not only depends on the actin cytoskeleton, but also on microtubules 
(Büttner et al., 2010; Zaarur et al., 2008; Zhao et al., 2016), while the formation of Hsp104 
associated aggregates simply depends on actin cables (Liu et al., 2010). Future investigation 
needs to focus on the microtubule-dependent/independent mechanisms of Synphilin-1 
inclusion formation, using leading edge techniques, such as super-resolution live cell video 
microscopy. This will enable researchers to obtain information about the dynamic interactions 
of the actin cytoskeleton and the microtubule network with the Synphilin-1 inclusions. Such 
studies will provide us more details of the role of the cytoskeleton in the process of 
Synphilin-1 inclusion formation, and will provide valuable insights in the nature of cellular 
aggregate/inclusion formation. 
Previous studies also showed that Synphilin-1 associates with cell membrane structures such 
as lipid droplets and lipid rafts in mammalian and yeast cells (Büttner et al., 2010; Takahashi 
et al., 2006), which implies that lipid raft binding of Synphilin-1 might also be involved in 
spatial sequestration of Synphilin-1. Indeed, we found that a conserved glycolipid modified 
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complex, the GPI-anchor, is involved in Synphilin-1 inclusion formation. Defects in 
GPI-anchor biosynthetic players caused a decrease in the level of Synphilin-1 inclusions, 
thereby suggesting that the GPI-anchor integrity is essential for Synphilin-1 inclusion 
formation. Interestingly, an earlier study also reported that expression of a prion protein in 
mice lacking GPI anchors affected the amyloid structure formation of the prion protein 
(Chesebro et al., 2005). Together, these findings suggest that GPI anchors might be crucial for 
the aggregate/inclusion formation of different disease proteins. Further in-depth investigation 
of the interplay between Synphilin-1, GPI-anchor and cell membrane structures will provide 
novel clues about the pathological role of Synphilin-1. 
Since Synphilin-1 inclusion formation was studied in a haploid background, which does not 
involve sister chromatid segregation, we were surprised to find out that components of the 
Ctf18 RFC-like complex affect Synphilin-1 inclusion formation. This implies that the Ctf18 
RFC-like complex has multiple functions rather than playing simply a role in sister chromatid 
cohesion. In this respect it has also been reported that Ctf18-RFC has additional important 
functions in preserving genome stability (Gellon et al., 2011). Furthermore, the Ctf18 protein 
co-localizes with the replication fork during DNA replication where it plays an important role 
in sister chromatid cohesion (Lengronne et al., 2006). In line with this, we found that the 
DNA replication initiation/Primase complex also influences Synphilin-1 inclusion formation. 
However, much of the details still need to be further investigated. 
Although inclusion formation is a hallmark of many neurodegenerative disorders, it is still 
controversial whether the inclusions are toxic or cytoprotective to the cells. Synphilin-1 
inclusions was considered to be the toxic species in some studies, due to the observation that 
Synphilin-1 inclusions associated with the cerebellum (Nuber et al., 2010) and dopaminergic 
neurons (Krenz et al., 2009). Whereas increasing evidences supports the hypothesis that large 
inclusions are more likely to sequester malfunctioning misfolded proteins (Arrasate et al., 
2004; Balchin et al., 2016; Choe et al., 2016; Yang et al., 2016). In our study, we observed a 
growth defect in mutants that fail to form large Synphilin-1 inclusions, supporting the 
hypothesis that Synphilin-1 inclusion formation has a cytoprotective effect to cells.  
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Overall, our study underlines the relevance of using yeast models to study protein misfolding 
diseases, and further investigation of disease proteins such as Synphilin-1 can provide novel 
insights for our understanding of the mechanisms of PD pathogenesis, as well as other protein 
folding disorders. 
Although the use of this yeast model in a genome-wide screen was successful in identifying 
genes involved in Synphilin-1 inclusion formation, the exact role of these players in 
Synphilin-1 inclusion formation is still unclear. Thus, future studies need to 
• confirm the findings in mammalian models, especially orthologs of candidates 
identified in this study that are involved in Synphilin-1 inclusion formation. 
• investigate the exact role of actin cables and microtubule in managing Synphilin-1 
inclusion formation, for example, using super-resolution live cell video microscopy, to 
analyze the dynamic interactions of the actin cytoskeleton and the microtubule 
network with Synphilin-1. 
• investigate the biological processes that are required for the Synphilin-1 inclusion 
formation in detail (for example, test the role of lipid rafts in spatial distribution of 
Synphilin-1, and test if the involvement of lipid rafts is common in misfolded 
aggregate/inclusion formation). 
5.2. The connection between the RQC machinery and the 
nucleocytoplasmic distribution of polyQ proteins 
The non-pathological native Htt protein plays an important role in the early embryonic 
development (Cattaneo et al., 2005; Walker, 2007). This native Htt is mainly distributed in the 
cytoplasm (De Rooij et al., 1996; DiFiglia et al., 1995). In contrast, mutant Htt forms 
insoluble aggregates and distributes in the cytoplasm and the nucleus and thereby confers 
cytotoxicity in mice (Mangiarini et al., 1996) or yeast (Krobitsch and Lindquist, 2000). These 
findings suggest that mutations with polyQ-expanded Htt are the main cause of HD. Earlier 
studies have shown that the nuclear accumulation of mutant Htt is at least in part responsible 
for the HD pathogenesis (Davies et al., 1997; De Rooij et al., 1996; DiFiglia et al., 1997).  
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Recent studies identified the RQC as the machinery that ensures accurate translation at the 
ribosome, and recognizes aberrant translational products that are later targeted for degradation 
(Bengtson and Joazeiro, 2010; Brandman et al., 2012; Defenouillère et al., 2013). In our study, 
we found that deficiency of RQC components (e.g. Ltn1 or Rqc1) alters the subcellular 
distribution of the polyQ protein Httex1-103Q. However, it is not entirely clear how this 
machinery affects the subcellular distribution of Httex1-103Q. 
At first sight it is expected that nuclear accumulation of Httex1-103Q in ltn1∆ cells might be 
the result of substrates that fail to become ubiquitinated by the E3 emzyme Ltn1, and 
consequently accumulate in the nucleus. Accordingly, deficiency of the Ltn1 RING domain 
causes nuclear accumulation of Httex1-103Q, as efficient as the deletion of LTN1. Thus, the 
ubiquitination-associated Ltn1 RING domain is responsible for changes in the subcellular 
distribution of Httex1-103Q. However, further investigation revealed that nuclear 
accumulation of Httex1-103Q is not simply due to deficient nuclear degradation of 
Httex1-103Q in ltn1∆ cells, since nuclear accumulation of Httex1-103Q was not observed 
when perturbing the UPS degradation alone. 
Given that the RQC is machinery controls the nascent polypetides, it is unlikely that the RQC 
directly mediates nucleocytoplasmic translocation of Httex1-103Q. Defect of the RQC 
machinery, either by gene deletion, or by overwhelming stress from misfolded protein 
expression, has deteriorated consequence, which trigger NS-aggregate formation (Choe et al., 
2016; Defenouillère et al., 2016; Yonashiro et al., 2016), and sequesters the chaperones Btn2 
and Sis1 (Choe et al., 2016). We found that Btn2 regulates the nucleocytoplasmic transport of 
Httex1-103Q (Zheng et al., 2017), and that an imbalance of the transport factors (e.g. Btn2) 
caused by NS-aggregate formation further influence the nucleocytoplasmic distribution of 
Httex1-103Q. We hypothesize that the RQC system interferes with the subcellular distribution 
of polyQ proteins, possibly by affecting the endogenous NS-inclusions formation and the 
chaperone pool, in which Btn2 plays a critical role. However, other chaperones that have not 
yet been identified could play a role in this process as well. Future investigations to identify 
more transport factors or chaperones that participate in the nucleocytoplasmic transport of 
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Httex1-103Q will increase our understanding of Httex1-103Q nucleocytoplasmic 
translocation machinery. 
It is still not clear whether overexpression of Httex1-103Q affects the capacity of the RQC 
machinery or not. Sequestration of Sup35, a translation termination factor, by Httex1-103Q 
(Fig. 2-10) (Serpionov et al., 2016), probably results in lower levels of available Sup35 that 
might increase the chance for ribosomal stalling, which in turn further elevates translational 
read-though of stop codons (Gong et al., 2012) and increases pressure on the RQC system. 
This may be one of the reasons that overexpression of Httex1-103Q introduces strong toxicity 
in wild type yeast (Meriin et al., 2002).  
Another interesting question is what the exact role of Rqc2 and CAT-tails is in protein quality 
control. Addition of CAT-tails to substrates by Rqc2 triggers NS-aggregate formation (Choe et 
al., 2016; Yonashiro et al., 2016). Furthermore, a recent study reported that CAT-tails serve as 
a signal that provides a fail-safe mechanism that enables the degradation of RQC substrates, 
which were not recognized by Ltn1 (Kostova et al., 2017). This suggests that the short Ala- 
and Thr-rich CAT-tails are cellular signals that are involved in the protein quality control at 
the ribosome. Although we were able to show the CAT-tail tagging activity of Rqc2 is 
required for the nuclear distribution of Httex1-103Q, it is not clear whether aberrant 
Httex1-103Q is actually modified by CAT-tails or not (Zheng et al., 2017). Therefore it will be 
interesting to find out whether CAT-tails can serve as a NLS under certain circumstances. 
Future studies might provide answers to this question by mass spectrum analysis of 
Httex1-103Q and NS-proteins. 
Next, the involvement of the Htt exon-1 PRR in the subcellular distribution of the polyQ 
protein needs to be further addressed. This PRR is critical for large inclusion formation and 
detoxification of polyQ proteins (Dehay and Bertolotti, 2006; Duennwald et al., 2006a). In 
parallel with our HCM screening in which we used the Httex1-103Q without the PRR, a 
similar HCM screening was performed using the polyQ protein reporter containing the PRR 
(Httex1-103QP) to identify factors that are required for inclusion formation of Httex1-103QP. 
This study revealed that RQC regulates compartmentalization of Httex1-103QP (Yang et al., 
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2016). However, in our study using the reporter Httex1-103Q without the PRR, we found that 
RQC regulates the subcellular distribution of polyQ protein (Zheng et al., 2017), instead of 
compartmentalization. Thus, the PRR not only determines the inclusion formation of 
polyQ-expanded Htt exon-1, but also has an impact on the distribution of polyQ-expanded Htt 
exon-1. The distinct role of the RQC in the presence/absence of PRR, suggests that the RQC 
is closely connected to polyQ domain of Httex1 regardless of the presence of the PRR. Future 
studies that investigate the exact role of PRR and Ltn1 in protein aggregation, will provide 
valuable clues to elucidate the connections between RQC and PRR. 
Finally, we demonstrated that deficiency of certain NPC components and transport factors 
suppresses the toxicity caused by Httex1-103Q in the ltn1∆ background, and blocks the 
nuclear accumulation of Httex1-103Q. In line with this it has been reported that nuclear 
accumulation of polyQ proteins promotes its cytotoxicity in neuronal cells (Saudou et al., 
1998). In addition, several studies show that nucleocytoplasmic translocation is connected 
with disease pathogenesis in many aspects. In this respect, aberrant NPC was found to 
associate with neurofibrillary tangles in neurons from AD patients, which may contributes to 
the pathogenesis of AD (Sheffield et al., 2006). Furthermore, cytoplasmic aggregate formation 
of β-sheet proteins or the disease proteins Htt-96Q and TDP-43 fragments cause the 
sequestration and mislocalization of nuclear transport factors into the cytoplasm, which 
results in defects in nuclear protein import and mRNA export (Woerner et al., 2016). 
Furthermore, expression of hexanucleotide repeat expanded C9orf72 either in flies (Freibaum 
et al., 2015; Zhang et al., 2015) or yeast (Jovičić et al., 2015), identified NPC components and 
different nuclear transport factors as potential modifiers of disease phenotypes and toxicity. 
5.3. Concluding remarks 
Protein misfolding is a common feature of different neurodegenerative diseases. Several 
studies have shown that the state of protein aggregation, their formation and the subcellular 
localization of the aggregates are associated with cytotoxicity. Since the molecular basis of 
protein homeostasis and the toxic properties of proteins are conserved from simple organisms 
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such as yeast to human, studies in yeast models can provide valuable clues to understand the 
aggregation-management of disease proteins. In this thesis, we developed different 
high-content imaging-based screening methods based on yeast models and showed that 
aggregation of misfolded proteins is a complex system that involves multiple biological 
processes. Furthermore, we demonstrated that the subcellular distribution of the protein 
aggregates plays a crucial role in modulating the cytotoxicity. 
First, the PD-related protein Synphilin-1 forms large inclusions upon expression in yeast. We 
investigated factors that are required for this Synphilin-1 inclusion formation and we 
established a high-content image-based screening approach that allowed us to analyze 
aggregate formation in a systematic manner. We observed that certain genetic alterations lead 
to failure of Synphilin-1 inclusion formation. These genetic alterations involve biological 
processes including cytoskeleton organization, histone modification, sister chromatid 
segregation, glycolipid biosynthetic process, DNA repair and replication. Although it is still 
elusive how these processes regulate the inclusion formation of Synphilin-1, further 
investigations will have to reveal how these processes may cooperate and, subsequently, 
confirmation of these findings in other PD models will be required. Importantly, we observed 
increased toxicity in the strains that failed to form larger Synphilin-1 inclusion, indicating that 
merging of smaller inclusions into larger deposits is indeed a cytoprotective cellular strategy. 
Our results provide an unbiased global view on the complexity of the machinery underlying 
the formation of these larger deposits and support the hypothesis that these deposits reflect 
inert entities sequestering the true toxic culprits. 
Secondly, we explored the subcellular localization, translocation and toxicity of Htt polyQ 
proteins and found that that the nucleocytoplasmic distribution of Htt polyQ might be 
important for the polyQ-induced pathology in HD. By examining the subcellular localization 
of Httex1-103Q systematically with the HCM system, we identified factors that alter the 
subcellular distribution of Httex1-103Q, and validated that deficiency of RQC components 
significantly affects the distribution of Httex1-103Q. These observations led us to investigate 
the role of the RQC in managing the nucleocytoplasmic translocation of Httex1-103Q. Failure 
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of the RQC system causes NS-aggregate formation, which sequesters chaperones, including 
Btn2, a protein sorting factor that is essential for the nucleocytoplasmic transport of 
Httex1-103Q. In a later screen, which we developed to identify modifiers of Httex1-103Q 
toxicity involving the nucleocytoplasmic transport, we found that nucleocytoplasmic transport 
of Httex1-103Q is depended on the NPC, and confirmed that nuclear accumulation of Httex1 
polyQ proteins in yeast enhanced Htt-cytotoxicity. Together, our findings led to the hypothesis 
that the RQC machinery regulates the nucleocytoplasmic distribution of Httex1 polyQ 
proteins by affecting the chaperone pool, which is critical in assisting nucleocytoplasmic 
transport of proteins. Thus, enhancing the RQC capability or preventing nuclear import of 
polyQ proteins should be considered as possible strategy for the treatment of polyQ disorders. 
Earlier studies have shown that during ageing, cells gradually lose the ability to filter out 
damaged proteins and dysfunctional mitochondria (Higuchi et al., 2013; Liu et al., 2010; 
Nyström and Liu, 2014), which occurs together with an increased imbalance in the regulation 
of vacuolar acidity (Hill et al., 2016; Hughes and Gottschling, 2012; Wilms et al., 2017). As 
PD and HD are age-dependent neurodegenerative disorders, our findings on the spatial 
distribution and merging of Synphilin-1 inclusions as well as the role of the RQC machinery 
in protecting cells from misfolded polyQ proteins, suggests that these strategies play a role in 
anti-ageing and age-related diseases. Indeed, the reduced capability to handle misfolded and 
damaged proteins by sequestration and subsequent clearance via either the proteasome or via 
vacuolar degradation appears to be a common hallmark in different neurodegenerative 
disorders. Hence, future studies are necessary to investigate this capability in more detail 
during ageing and progress of age-related diseases. For instance, to investigate the inclusion 
formation of Synphilin-1 at different age-stages, this may be achieved by isolating young and 
old cells, quantifying the level of Synphilin-1 inclusion formation and correlating this to the 
number of offspring and survival. Mutants showing a lower ability to sequester misfolded 
Synphilin-1 in larger deposits potentially play a role in managing the ageing process. The 
monitoring of life-span of these mutants in yeast and other model systems might be useful to 
help us gain a better understanding of PD progression and ageing. To investigate the 
connection between RQC capability and ageing, studies may include the monitoring of 
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protein levels of RQC components (e.g. Ltn1 and Rqc2) in young cells and aged cells, or 
measuring the life-span, mitochondrial integrity and vacuolar acidity in cells with/without 
overexpression of RQC components. Based on findings of this thesis, it would be interesting 
to systematically evaluate the viability and aggregate morphology of different disease proteins 
(e.g. Synphilin-1, Htt, α-synuclein and Aβ42) in yeast in combination with additional RQC 
components (e.g. Ltn1 and Rqc2). These studies will provide valuable insights in whether 
enhanced RQC capability will alter the fitness and aggregate formation of certain disease 
protein or not. Eventually, these studies will provide clues about which molecular processes 
and pathways that are involved in altering phenotypes of these disease proteins in the 
presence of enhanced RQC capability. 
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Appendix 
Medium protocol for the construction of the Synphilin-1 SGA collection 
All components of the mediums used for the construction of the Synphilin-1 SGA collection 
are listed below, and all mediums described below are normalized to the final volume of 1L, 
the key steps and the corresponding medium protocol for the Synphilin-1 SGA collection 
construction are described in Fig. 2-2. 
(1) Mating: YEPD + ADE 
Reagent Amount to add (per 1 L final volume) 
Adenine 120mg 
Yeast extract 10g 
Peptone 20g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, mix thoroughly and then pour the plates. 
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(2) Diploid: SD-Ura + G418 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Dropout mix SD-Ura 0.77g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 1ml 200mg/ml G418 (final 
concentration 200mg/L), mix thoroughly and then pour the plates. 
(3) Sporulation: Spore medium –Ura 
Reagent Amount to add (per 1 L final volume) 
Potassium acetate 10g 
Yeast extract 1g 
Glucose 0.5g 
Amino-acids supplement powder 
mixture for sporulation (mix of 
2g His, 2g Lys, 10g Leu) 
0.1g 
Agar 20g 
a. Dissolve all compounds in the table in 1000mL DDH2O in a 1-L flask and autoclave. 
b. While stirring the autoclaved mixture on a magnetic stir plate. Cool down the medium to 
approximately 65°C, mix thoroughly and then pour the plates. 
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(4) Haploid: SD-His/Arg/Lys/Ura + canavanine & S-AEC 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. – His 
Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L) and 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L), mix 
thoroughly and then pour the plates. 
(5) KanR Selection: SD-His/Arg/Lys/Ura + canavanine, S-AEC & G418 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. – His 
Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
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b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L), 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L) and 1ml 
200mg/ml G418 (final concentration 200mg/L), mix thoroughly and then pour the plates. 
Medium protocol for the construction of the Httex1-103Q SGA collection 
The medium protocol is identical as the protocol described in the construction of the 
Synphilin-1 SGA collection as described above. 
Medium protocol for the construction of the ltn1Δ Httex1-103Q SGA collection 
All components of the mediums used for the construction of the ltn1Δ Httex1-103Q SGA 
collection are listed below, and all mediums described below are normalized to the final 
volume of 1L, the key steps and the corresponding medium protocol for the ltn1Δ 
Httex1-103Q SGA collection construction are described in Fig. 2-5. 
(1) Mating: YEPD + ADE 
Reagent Amount to add (per 1 L final volume) 
Adenine 120mg 
Yeast extract 10g 
Peptone 20g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
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plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, mix thoroughly and then pour the plates. 
 
(2) Diploid: SD-Ura + G418 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Dropout mix SD-Ura 0.77g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 1ml 200mg/ml G418 (final 
concentration 200mg/L) and 1ml 100mg/ml clonNAT (final concentration 100mg/L), mix 
thoroughly and then pour the plates. 
(3) Sporulation: Spore medium –Ura 
Reagent Amount to add (per 1 L final volume) 
Potassium acetate 10g 
Yeast extract 1g 
Glucose 0.5g 
Amino-acids supplement powder 
mixture for sporulation (mix of 
2g His, 2g Lys, 10g Leu) 
0.1g 
Agar 20g 
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a. Dissolve all compounds in the table in 1000mL DDH2O in a 1-L flask and autoclave. 
b. While stirring the autoclaved mixture on a magnetic stir plate. Cool down the medium to 
approximately 65°C, mix thoroughly and then pour the plates. 
(4) Haploid: SD-His/Arg/Lys/Ura + canavanine & S-AEC 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. – His 
Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L) and 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L), mix 
thoroughly and then pour the plates. 
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(5) KanR Selection: SD-His/Arg/Lys/Ura + canavanine, S-AEC & G418 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. – His 
Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L), 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L) and 1ml 
200mg/ml G418 (final concentration 200mg/L), mix thoroughly and then pour the plates. 
(6) NatR Selection: SD-His/Arg/Lys/Ura + canavanine, S-AEC, G418 & clonNAT 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. – His 
Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
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b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L), 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L), 1ml 
200mg/ml G418 (final concentration 200mg/L) and 1ml 100mg/ml clonNAT (final 
concentration 100mg/L), mix thoroughly and then pour the plates. 
Medium protocol for the construction of the Httex1-103Q-mRFP Yeast GFP 
Clone Collection 
All components of the mediums used for the construction of the Httex1-103Q-mRFP Yeast 
GFP Clone Collection are listed below, and all mediums described below are normalized to 
the final volume of 1L, the key steps and the corresponding medium protocol for the 
Httex1-103Q-mRFP Yeast GFP Clone Collection construction are described in Fig. 2-6. 
(1) Mating: YEPD + ADE 
Reagent Amount to add (per 1 L final volume) 
Adenine 120mg 
Yeast extract 10g 
Peptone 20g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
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d. Cool down the medium to approximately 65°C, mix thoroughly and then pour the plates. 
(2) Diploid: SD-Ura-His 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Dropout mix SD-Ura-His 0.77g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, mix thoroughly and then pour the plates. 
(3) Sporulation: Spore medium –Ura 
Reagent Amount to add (per 1 L final volume) 
Potassium acetate 10g 
Yeast extract 1g 
Glucose 0.5g 
Amino-acids supplement powder 
mixture for sporulation (mix of 
2g His, 2g Lys, 10g Leu) 
0.1g 
Agar 20g 
a. Dissolve all compounds in the table in 1000mL DDH2O in a 1-L flask and autoclave. 
b. While stirring the autoclaved mixture on a magnetic stir plate. Cool down the medium to 
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approximately 65°C, mix thoroughly and then pour the plates. 
(4) Haploid: SD-Leu/Arg/Lys/Ura + canavanine & S-AEC 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. –Leu 
Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L) and 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L), mix 
thoroughly and then pour the plates. 
(5) SD-His Selection: SD-Leu/His/Arg/Lys/Ura + canavanine, S-AEC 
Reagent Amount to add (per 1 L final volume) 
Y.N.B. w/o amino acids and 
ammonium sulfate 1.7g 
Monosodium gluatmic acid 1g 
Drop-out mix (D.O. – Leu 
His Arg Lys Ura) 2g 
Agar 20g 
a. Dissolve the compounds in the table (except agar) in 200mL DDH2O and filter sterilze the 
-148- 
sollution (0.2μm pore size, 500mL, Thermo Scientific). 
b. Add 20g agar to 750mL DDH2O in a 1-L flask and autoclave. 
c. While stirring the autoclaved mixture and 200mL filter sterilzed sollution on a magnetic stir 
plate, add 50 mL of sterile 40% (w/v) glucose per liter of medium. 
d. Cool down the medium to approximately 65°C, add 0.5 mL 100 mg/mL canavanine (final 
concentration 50mg/L) and 0.5 mL 100 mg/mL S-AEC (final concentration 50mg/L), mix 
thoroughly and then pour the plates. 
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